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Abstract
Two extracardiac sources, the cardiac neural crest and proepicardial organ (PEO), provide 
cells that are essential for cardiac morphogenesis. Cardiac neural crest cells generate a 
range of cell types, including both neuronal and non-neuronal adventitial cells and smooth 
muscle. Endothelin (ET) signalling plays an important role in the development of cardiac 
neural crest cell lineages, yet the mechanism(s) by which ET may act to control this 
development remain largely unclear. Analysis of the expression of ET signalling 
components revealed dynamic patterns of expression, suggesting that only a sub­
population of neural crest cells in particular locations are responsive to ET signaling at 
specific developmental time-points. Constitutive expression of preproET-1, a precursor of 
mature ET-1 ligand, in the cardiac neural crest resulted in a selective expansion of the 
adventitial cell population in the great vessels of the heart, at least partially due to 
increased cell survival. This suggests that localized ET production acts as a spatial 
regulator to control the development of a specific subset of cardiac neural crest cells. To 
address the issue of the spatial and temporal segregation of cardiac neural crest lineages, 
we have constructed an alkaline-phosphatase-expressing retroviral vector for future cell 
tracing studies.
We also examined the role of the PEO-derived epicardium in development and patterning 
of the myocardium. Animal models lacking an epicardium show cardiac abnormalities, 
most notably an abnormally thin myocardial wall. We generated epicardium-deficient 
hearts to characterize the cell biological effects on the compact ventricular myocardium. 
Analysis of myocyte proliferation revealed that the transmural gradient of myocyte 
proliferation across the myocardial wall was maintained in the absence of the epicardium.
However, a moderate decrease in the rate of myocyte proliferation in the compact 
myocardium appears sufficient to generate the thin myocardial wall. This data indicates 
that myocardial proliferation can occur independently of signals from the epicardium. 
However, the presence of the epicardium is essential for normal myocardial development 
and epicardial signaling acts primarily to exert subtle yet essential influences over 
myocyte proliferation.
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Chapter 1; Introduction
Introduction
The development of the heart has been the source of intense curiosity and investigation 
for centuries, dating back to the studies of Aristotle in ancient Greece and continuing with 
the anatomical observations of Leonardo Da Vinci in the fourteenth and fifteenth 
centuries. The heart is the first organ to function in the embryo and is vital for 
development of the rest of the organism, providing essential nutrients and oxygen to the 
forming tissues of the body. Amazingly, the heart must begin performing these functions 
even while it is itself under development, going through the processes of growth, 
differentiation and considerable remodelling. It is not surprising therefore that many 
defects in the development of the heart are likely to result in embryonic lethality, since 
this organ supports some of the most basic functions of the developing embryo.
The embryonic heart originally develops from two tissue layers, which form a simple 
tubular structure: the endocardium forms the inner lining of the heart and is enveloped by 
a muscular tissue layer, the myocardium. These tissues form a large portion of the cells 
of the heart and arise from the cardiogenic mesoderm, also known as the “primary heart 
field”. However, two extracardiac sources also contribute cells essential for development 
of the heart: the proepicardial organ provides cells that form the outermost layer of the 
heart, the epicardium, which in turn gives rise to the cells of the coronary vasculature. 
The cardiac neural crest provides cells important for the development of the great arteries 
of the heart, as well as a cell population necessary for septation of the outflow tract into 
the pulmonary and aortic vessels. Together, these three sources of cells, the primary heart 
field, proepicardial organ and cardiac neural crest, generate a range of cardiac cell types.
including myocytes, vascular smooth muscle cells, endothelial cells, fibroblasts and 
impulse-conducting cells.
The development of the mature heart involves a fascinating and intricate series of events. 
From the formation of a simple tubular structure, a complex process ensues that remodels 
the primitive heart into a four-chambered, double circulatory system, transporting 
oxygenated blood to the body via the systemic circulation and then to the lungs for re­
oxygenation. The coordination of blood flow in this system is vital for efficient delivery 
of oxygen and nutrients to all tissues of the body, as well as for the removal of waste 
products.
In light of the complexity involved in heart morphogenesis and the importance of the 
functions the heart performs, it is not surprising that defects in cardiovascular formation 
are a major cause of infant mortality in humans. As the study of heart development itself 
has been the focus of much attention for centuries, so too has the investigation of 
cardiovascular malformations: Tetralogy of Fallot, the complex of anomalies that 
represent a fairly common cause of congenital heart disease, was first reported in 1671 by 
Stensen (quoted in “Pathology of the Heart and Blood Vessels”, (Gould, 1953)). One cell 
population that has been implicated in many congenital cardiovascular defects is the 
cardiac neural crest. Defects in great vessel formation as well as in septation and 
alignment of the outflow vessels and chambers of the heart are common abnormalities 
seen in animal models of aberrant cardiac neural crest development (Creazzo et al., 
1998). Importantly, these mimic many of the congenital heart defects seen in humans. 
Essential to our understanding of the pathogenesis of congenital heart disease is a 
comprehensive understanding of the elaborate network of events involved in formation of
the heart. The cardiac neural crest has therefore been an area of much interest in recent 
years as a source of cells essential for later stages of heart development.
The two extracardiac cell populations, the cardiac neural crest and the proepicardial 
organ, are the two sources of heart tissue that have been investigated in the studies 
described within this thesis. As an introduction to these two cell populations, an 
overview of heart development is first presented, followed by an overview of current 
knowledge of the roles of both the cardiac neural crest and proepicardial organ in 
cardiovascular development.
Heart Cell Specification and Early Morphogenesis
The vertebrate heart tube is a mesodermally derived structure, originating from cells of 
the cardiogenic field, located lateral to the primitive streak (Rawles, 1943). Fate mapping 
studies have shown that the primary source of these cells is the lateral plate mesoderm 
(Rosenquist and De Haan, 1966; Garcia-Martinez and Schoenwolf, 1993). Heart 
precursors are among the first cells to gastrulate, ingressing through a broad region of the 
primitive streak, excluding Hensen’s node most rostrally, as well as the most caudal 
primitive streak. These precursors complete ingression through the streak by around 
Hamburger and Hamilton (HH; Hamburger and Hamilton, 1951) stage 4 (Garcia- 
Martinez and Schoenwolf, 1993). (For outline of HH staging system, refer to Appendix 
II).
During gastrulation, heart precursor cells become restricted to particular cardiac lineages 
that are aligned along the rostrocaudal axis of the heart tube (Fig. 1.1a). Fate-mapping 
studies
Figure 1.1 Heart morphogenesis in the avian embryo, (a) HH stage 3. Heart precursor 
cells are located in the primitive streak. Those cells migrating through the rostral streak 
will occupy rostral positions in the linear heart tube, contributing to the outflow and 
ventricular regions. Those migrating through the caudal streak will generate atrial and 
inflow cells, (b) HH stage 7-8. After formation of the three germ layers, endocardial pre­
cursor cells delaminate aways from the myocardial lineage. HH stage 10, cross-section 
(c) and ventral view (d). The bilateral primordia of the heart fuse to form a bi-layered 
tube, consisting of an inner endocardial layer and a muscular outer tissue layer, the 
myocardium, separated by the cardiac jelly, (e) HH stage 15. The heart is looping and 
cushion formation begins in the outflow and atrio-ventricular regions, (f) HH stage 27. 
The four-chambered heart. The primitive atria and ventricles are septated and outflow 
remodeling is underway to divide this vessel into the aorta and pulmonary artery. 
Subsequent remodeling brings the outflow tract into alignment with the septa.
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have shown that cells ingressing through rostral regions of the primitive streak contribute 
to more rostral regions of the tubular heart i.e. the outflow tract and ventricles. 
Conversely, cells ingressing through the caudal streak generate cells of the caudal tubular 
heart, namely cells that will become part of the atria and inflow regions (Garcia-Martinez 
and Schoenwolf, 1993; Cohen-Gould and Mikawa, 1996). At most time-points studied, 
labelled cells give rise to both endocardial and myocardial cells. By HH stage 4, there is 
very little contribution to the heart from the primitive streak, except from cells migrating 
through Hensen’s node that give rise to some, though not all, of the endocardial cells of 
the outflow tract (Garcia-Martinez and Schoenwolf, 1993). Importantly, these studies did 
not identify the source of myocardial cells that form the corresponding region of the 
outflow tract.
As part of the mesodermal layer, cardiac precursor cells move rostrolaterally at the 
leading edge of the expanding germ layer, forming a crescent of cells by the full-streak 
stage (HH stage 6) (Rosenquist and De Haan, 1966). By HH stage 8, the lateral plate 
mesoderm splits to form two epithelial layers, the somatic mesoderm and the splanchnic 
mesoderm in which the cardiac precursors are found (Manasek, 1968). At this time, two 
cardiogenic populations are generated from the splanchnic mesoderm: the first, remaining 
part of the splanchnic layer, is an N-cadherin-positive epithelium that is destined to 
differentiate into myocardium, while the second down-regulates N-cadheiin expression, 
delaminates from the original population, and gives rise to the endocardial endothelium 
(Manasek, 1968; Linask, 1992) (Fig. 1.1b). Single cell labelling of cardiogenic precursors 
in the heart field gives rise to clones consisting of only one cell type, either myocardial or 
endocardial, demonstrating that these two populations have already become segregated by 
the time of heart-field formation (Cohen-Gould and Mikawa, 1996). More recently, Wei
and Mikawa (2000) have used the same technique to show that segregation of these two 
lineages occurs even earlier than this stage and that distinct myocyte and endocardial cell 
lineages are already established within the primitive streak.
At approximately HH stage 9, as the lateral body wall closes at the level of the heart, the 
two lateral cardiogenic fields migrate towards the midline of the embryo and fuse 
rostrally to caudally (Rawles, 1943; Rosenquist and De Haan, 1966). Upon fusion, the 
simple beating heart tube is created, with the endocardial endothelial cells comprising the 
inner layer and the myocardial cells constituting the outer layer, separated by a complex 
extracellular matrix, known as the cardiac jelly (Manasek, 1968) (Fig. 1.1c).
Chamber Specification
Even before formation of the tubular heart, the differentiating myocardial populations that 
will form the atria and ventricles are already diversified. As described above, cells 
migrating through particular regions of the primitive streak are destined to contribute to 
particular regions of the primitive heart tube, and as those ingressing through the most 
rostral regions of the streak migrate away before those ingressing more posteriorly, there 
is little mixing of populations here. Analysis of chamber-specific gene expression in the 
early stages of heart formation revealed the differential expression of contractile protein 
genes in cells that will form the atria and those that will form the ventricles. AMHC-1, a 
marker of atrial myocardial tissue, is expressed only in posterior myocytes of the fusing 
heart tube i.e. those cells that will go on to form the atria, while posterior myocytes 
express both VMHC-1 and AMHC-1 (Bisaha and Bader, 1991; Yutzey et al., 1994). 
Alongside formation of the heart tube, differentiation of cardiomyocytes begins in an 
anterior to posterior wave of progression. Each chamber piimordium forms sequentially.
such that along the rostro-caudal axis of the heart tube, the primitive ventricle region 
forms first and then the atrioventricular (AV) region, followed by the sinoatrial segment, 
which will give rise to the atria most caudally (Yutzey and Bader, 1995). The most 
rostral and caudal regions of the heart tube, the conotruncus and inflow region, 
respectively, are formed somewhat after the tube itself; the major source of these cells has 
become an area of intense investigation in recent years (see “The Secondary Heart Field”, 
below for further explanation).
The restricted and segmented expression of a number of genes in the tubular heart has led 
to the idea that by this stage, the segments of the heart that will go on to develop into 
particular chambers are already specified and exhibit unique patterns of gene expression. 
The first such genes identified were the basic helix-loop-helix transcription factors, 
dHAND and eHAND (Srivastava et al., 1997). Expression of dHAND in the mouse 
embryo is initially found throughout the tubular heart at embryonic day (E) 8.0, in both 
the myocardium and endocardium, but then becomes restricted to the putative 
conotruncus and future right ventricle by E9.5. Similarly, eHAND expression becomes 
restricted to the most rostral and caudal regions of the linear heart tube, those regions 
which the authors claim are fated to become the conus and left ventricle. Although these 
expression patterns are suggestive of early segregation of heart tissue into designated 
chamber-forming regions, to date, there is no evidence of conserved lineage between cells 
expressing dHAND or eHAND at the tubular heart stage and those that become cells of 
the right and left ventricles, respectively. Gene inactivations of dHAND in the mouse 
results in embryos with a single, left-sided ventricular chamber (Srivastava et al., 1997). 
Whether this chamber represents the definitive left ventricle and dHAND mutation 
specifically abolishes right ventricular development, however, cannot be concluded from
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simple morphological observations, and the identity of this remaining chamber therefore 
remains unclear.
While molecular evidence suggests that cell populations that will form particular 
chambers of the heart are specified at an early stage, recent data suggests a more 
complicated scenario. Redkar et al. (2001) have constructed a detailed fate map of the 
heart-forming region of the avian embryo as early as HH stage 4 and demonstrate that the 
descendants of labelled cells may be found in multiple regions of the developing heart, 
rather than restricted to particular axial levels of the heart tube. Therefore, while more 
rostral cells of the heart-forming region at HH stage 4 are more likely to become located 
in rostral regions of the heart tube, there is also considerable overlap with more caudal 
populations. Furthermore, comparison of this new fate map of the primary heart field 
with the cardiogenic markers Nkx2.5 and BMP2 reveal that the expression of these 
molecular markers does not precisely denote the area of the heart-forming region. Thus, 
in the same way that eHAND cannot be said to be a definitive marker of the left ventricle, 
Nkx2.5 cannot be considered a marker of all cardiac precursors.
The idea that the segmented layout of the linear heart tube represents a blueprint for the 
development of the mature, four-chambered heart remains debatable and has recently 
been challenged. Christoff els et al. (2000) propose that the simple model in which heart 
segments are mapped out along the rostro-caudal axis does not take into account the 
differences in development between the outer and inner curvatures of the heart (i.e. the 
walls of the looping-stage heart that face outwards into the pericardial cavity and inwards, 
respectively; Fig. l.le). For example, the endocardial cushions of the AV and 
conotruncal regions are separate along the outer curvature but are contiguous along the
inner curvature; trabeculae are found in the ventricular segment of the heart, but along the 
outer curvature only, while the inner curvature remains untrabeculated (Vuillemin and 
Pexieder, 1989). Additionally, expression analysis of many factors spatially localized 
during heart development had previously focused on expression along the rostro-caudal 
axis and localization to specific segments along this axis, while largely ignoring 
differences in expression between regions contributing to the inner and outer curvature 
that arise from dorsal and ventral regions, respectively. Based on a re-evaluation of the 
expression of a range of factors in the mouse embryo, such as ANF, connexin 43, MLC2v, 
Irx5 and Tbx5, Christoffels et al. propose a two-step model for formation of the chambers. 
This model suggests that transcriptional programs in the cardiac crescent and the linear 
heart tube set up the basic plan of the “primary myocardium”, providing rostro-caudal 
polarity throughout the tube. Factors such as ANF and Irx5 are expressed in broad 
regions of the heart tube, but only ventrally, corresponding to areas that become the outer 
curvature of the looping heart. Accordingly, these factors continue to be expressed in the 
outer regions of the looping and four-chambered heart, while the inner curvature remains 
negative for these signals. What establishes the ventral-specific signals is unknown, but 
this model hypothesizes that it is a combination of rostro-caudal (or anterior-posterior) 
signals with dorso-ventral cues that specify the positions of the developing “chamber 
myocardium”. The transcriptional program is largely initiated in the ventral, or future 
outer curvature cells, suggesting that segmentation and specification of the future 
chambers occurs at the outer curvature only. This is an appealing model for consideration 
of the later steps in heart morphogenesis, namely alignment of the inflow and outflow 
vessels and the various septa. Since the inner curvature plays a crucial role in this 
process, undergoing significant remodelling and regression in some areas, a model in 
which the dorsal myocardium forming this inner curvature is not segmented or diversified
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(i.e. deteraiined as left or right ventricular tissue) is favourable for understanding how 
readily different regions of the inner curvature interact.
Step two of the model, after establishment of chamber position, deals with ventricular 
chamber growth. The outer curvature of the heart has been shown to be the site of the 
highest rates of proliferation (Rumyantsev, 1977). This coupled with change in cell shape 
(Manasek et al., 1972) results in a “ballooning out” or a preferential expansion of the 
ventricular chambers in these regions. Despite the attraction of this model, direct data has 
yet to be presented to support these tissue movements. Cell lineage analysis, for example, 
would provide evidence that cells of the ventral region of the tubular heart do in fact 
generate those cells later located along the outer curvature of the heart.
The Secondary Heart Field
Although the cells of the primitive heart tube constitute most of the cells of both the 
endocardial and myocardial populations of the adult heart, a number of studies have 
pointed to the fact that these cells do not account for all the cells that make up the 
anteriormost and posteriormost segments of the heart. Rosenquist (1966) performed fate- 
mapping studies of early stages of cardiac development using tritiated thymidine as a 
marker of transplanted donor tissue. From these experiments, it was inferred that the 
cells of the tubular heart represent the progenitors of all myocardial and endocardial cells 
of the mature heart. However, later studies suggested that this was not in fact the case 
and that cells of the inflow and outflow regions of the heart were accrued at later stages of 
development (Stalsberg and DeHaan, 1969; Castro-Quezada et al., 1972; de la Cruz et al., 
1977, 1989). de la Cruz et al. (1977) extended their fate map to much later development, 
to study the accumulation of tissue of the outflow tract, using in vitro and in vivo labelling
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techniques to map cell populations from HH stage 9 to HH stage 35 (E8.5-9). The 
outflow tract can be divided into two regions: the conns, or proximal outflow tract, that is 
continuous with the future right ventricle at the looping stage, and the truncus arteriosus 
located more distally that connects the conus to the aortic sac. These experiments showed 
that labelled cells at the most anterior region of the tubular heart at HH stage 9 give rise 
to cells that contribute to the caudal region of the conus. Cells of more distal regions of 
the outflow tract appeared to be added to the primitive heart tube at later stages of 
development: cells labelled in the most rostral regions of the heart tube at one stage were 
displaced caudally by later stages, while other cells had accumulated rostrally to them. 
The latest stage of labelling cells in the most rostral, outflow region of the heart was HH 
stage 22, and by HH stage 35, these cells were located at the conal-truncal boundary. 
Clearly, from these experiments it appears that segments of the outflow region of the 
heart are sequentially added to the primitive heart tube until relatively late stages in 
development. Similarly at the caudal end, analogous labelling experiments have shown 
that the primitive atria are not present in the linear heart tube, but are added shortly after 
as the heart is looping (Castro-Quezada et al, 1972). The most caudal regions of the heart 
tube present at HH stage 9 give rise to cells of the trabeculated region of the left ventricle 
(de la Cruz etal., 1989).
As a result of attempts to locate the sources of cells that generate the outflow regions of 
the heart, Waldo et al. (2001) have suggested the presence of a “secondary heart field” 
located in the splanchnic mesoderm underlying the ventral pharynx. This region 
expresses a number of factors that are found in the primary cardiogenic fields in the early 
stages of cardiogenesis, and are essential for myocardial differentiation. These include 
Nkx2.5, a homeobox-containing gene that is the avian homologue of the Drosophila
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tinman gene. While tinman is required for formation of the dorsal vessel, the equivalent 
of the vertebrate heart in Drosophila (Bodmer et al., 1990), its vertebrate orthologues 
appear important for later events of cardiac development in the corresponding species 
(Schultheiss et al., 1995; Grow and Krieg, 1998). Other factors expressed in this putative 
secondary heart field are GATA-4, a zinc finger protein expressed in pre-cardiac 
mesoderm which binds to consensus sites in several myofibrillar genes (Molkentin, 2000) 
and BMP-2. BMP family members have been shown to be essential for myocardial 
differentiation. In the same study, cell labelling was performed with mitotracker, a 
fluorescent dye which is incorporated into mitochondria, and showed that cells of this 
field labelled at stage 14 later populated the conus of the outflow tract. As in the 
experiments of de la Cruz et al. (1977), an unlabeled segment of the outflow tract was 
added to the heart after the stage 14 labelling. Although this study confirms that the 
primary heart tube does not contain all myocardial precursors of the mature heart, no 
evidence has yet been presented to confirm whether this so-called secondary heart field is 
generated from a set of precursors separate from those of the primary heart field at the 
cardiac crescent stage, or whether this group of cells map to a region of the primary heart 
field that had been previously overlooked. Early fate mapping experiments by Rosenquist 
(1966), for example, did not examine all regions of the blastoderm at cardiac crescent 
stages and so it is unknown whether a population continuous with the previously mapped 
primary cardiogenic field may give rise to the cells of the distal outflow tract. As yet, a 
source for the cells of the inflow region of the heart remains unknown, though the studies 
of de la Cruz et al. (1989, 1989) and Waldo et al. (2001) suggest that these cells may 
simply be generated from the primary heart field, albeit at a stage later than formation of 
the primitive heart tube. Despite the knowledge that has been gained from these fate 
mapping studies as to the origins of the myocardium of the outflow region, there has not
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been mention of the source of the endocardium of these regions, be it from the 
“secondary heart field” or elsewhere. Thus, the origin of these cells remains an intriguing 
area for investigation.
Myocardial Differentiation
As the tubular heart is developing along the rostrocaudal axis, accumulating myocardial 
tissue at both ends, so too is there significant development of the myocardium along the 
transmural axis, i.e. from the outer myocardial wall to the inner myocardial wall apposed 
to the endocardium. At the early tubular heart stage, the myocardial wall is just one or 
two cell layers thick, composed of a cuboidal epithelium connected by junctional 
complexes (Manasek, 1968). Upon looping of the heart tube, morphogenesis of the 
myocardial wall brings about formation of wedge-shaped protrusions on the inner, 
luminal surface known as trabeculae. This begins at HH stage 16 or 17 in the chick 
within the outer curvature of the primitive ventricle (reviewed by Sedmera et al., 2000). 
These trabeculae increase the endocardial surface area, either for more efficient diffusion 
of oxygen into the myocardium prior to formation of an effective coronary vasculature or 
for clearing of metabolic waste, though it is likely that both processes are enhanced by 
this expansion. The first step in the process of trabeculation involves epithelialization of 
myocytes, followed by cell division. Analysis of myocyte proliferation in the chick 
embryo, shows that cells closer to the outer myocardial wall proliferate at a higher rate 
than those closer to the endocardium in the so-called “compact layer” of the myocardium 
(Jeter and Cameron, 1971; Rumyantsev, 1977). Single cell retroviral labelling has been 
used to demonstrate the clonal relationship between cells of the trabeculated myocardium. 
Chick embryos were infected with replication-incompetent retrovirus expressing the lacZ 
reporter gene at various stages of development, between HH stages 4 and 15. Replication-
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incompetent retroviruses utilize the cellular machinery of infected host cells for 
expression of the viral genome. Since they lack the structural genes for formation of an 
encapsidated viral particle, the genome of these viruses is transferred exclusively to 
daughter cells during host cell division, thus providing a means of tracing the lineage of 
infected cells (reviewed by Hyer and Mikawa, 1997). Infection in these experiments was 
targeted to the myocardium. Analysis at later stages revealed that clones often traversed 
the myocardial wall from the epicardial to endocardial side, forming cone-shaped 
colonies that were wider at the epicardial side (Mikawa et al., 1992, 1996). These labelled 
clones were intermingled with non-labelled cells, suggesting that individual trabeculae 
formed from more than one myocardial progenitor. Additionally, clone size was greater 
in the left ventricle than the right ventricle, reflecting the greater degree of trabeculation 
seen in this chamber upon morphological and histological analysis (Icardo and 
Femandez-Teran, 1987; Sedmera et al., 1997).
As the embryo develops, ventricular blood volume increases, the coronary vessels form 
and the myocardium remodels to cope with the increasing demands placed on the heart. 
There is a significant thickening of the compact myocardial layer, while the trabeculae 
become relatively shorter and less abundant. It is not however known whether the 
thickening of the myocardium occurs through fusion of the trabeculae or due to ingrowth 
of the myocytes from the outer compact layer.
A number of factors have been shown to play a role in the process of trabeculation in the 
ventricular myocardium. Neuregulin, a secreted peptide growth factor, is expressed by 
the endocardium, in both the chick and mouse (Meyer and Birchmeier, 1995; Kramer et 
al., 1996; Ford et al., 1999) while at least two of its receptors, erbB2 and erbB4 are
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expressed by the myocardium (Lee et al., 1995; Gassmann et al., 1995; Meyer and 
Birchmeier, 1995). ErbB2 and erbB4 are receptor tyrosine kinases (RTKs) related to the 
epidermal growth factor receptor (Burden and Yarden, 1997). Mutation of neuregulin 
(Meyer and Birchmeier, 1995) or of either of these receptors (Gassmann et al., 1995; Lee 
et al., 1995) in the mouse results in embryonic lethality due to endocardial cushion 
defects as well as a striking loss of trabeculation in the ventricles, while the compact 
myocardial layer remains largely unaffected. Recent studies have suggested that the role 
of neuregulin is in the proliferation and survival of myocytes (Zhao et al., 1998; Hertig et 
al., 1999).
Neurotrophin-3 (NT-3) has also been implicated as a factor important in formation of the 
trabeculae. The neurotrophins represent another family of growth factors, whose 
activities are also mediated by binding to RTKs and have been extensively characterized 
due to their role in neuronal differentiation and survival (Snider and Wright, 1996). NT-3 
binds preferentially to the tyrosine receptor kinase (Trk)-C receptor (Tsoulfas et al., 1993) 
and both are expressed by cardiac myocytes in the mouse and chick embryo (Tessarollo 
et al., 1993; Donovan et al., 1996; Lin et al., 2000). Recently, disruption of Trk-C 
signalling in the chick embryo via overexpression of a truncated trk-C receptor has 
demonstrated a decrease in myocyte clone size, due to decreased myocyte proliferation 
(Lin et al., 2000). Interestingly, after HH stage 24, the expression of NT-3 and trkC in the 
chick myocardium becomes more prominent in the trabeculated region, suggesting the 
preferential mitogenic influence of NT3 signalling on this population at later stages. 
Mutations of trkC and NT-3 generate thinner ventricular myocardial walls as well as 
outflow tract and ventricular septal defects, indicating possible roles for these factors in
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the compact myocardium of the ventricles and also in cardiac neural crest populations 
(Donovan et al., 1996; Tessarollo et al., 1997).
An additional factor that has been implicated in the patterning and development of the 
myocardium is fibroblast growth factor (FGF). FGFs are members of a heparin binding 
protein family that mediate a range of cellular responses, including stimulation of 
proliferation, angiogenesis and induction of mesoderm (reviewed by Szebenyi and Fallon, 
1999; Wilkie et al., 1995). In Drosophila, a mutated form of FGFR-1, heartless, is 
unable to induce cardiac myogenesis from mesoderm (Gisselbrecht et al., 1996). Of the 
FGF receptors, FGFRl is the most highly expressed in the developing chick heart, with 
only low level of expression of FGFR2 and -3 (Patstone et al., 1993). FGFRl is first 
expressed in the precardiac endoderm at HH stage 6 in the chick, but by HH stage 9, it is 
expressed in both the endocardium and the myocardium (Patstone et al., 1993; Sugi et al., 
1995). At later stages, myocardial expression of FGFRl diminishes, but expression in the 
endocardium is maintained (Parlow et al., 1991). The expression of this receptor has also 
been identified in the myocardium of mouse and rat embryos, though the ontogeny of its 
expression has been less well studied in mammalian species (Engelmann et al., 1991; Jin 
et al., 1994; Sheikh et al., 1997).
FGF ligands FGFl, FGF2, FGF4 and FGF7 are also expressed in the myocardium of 
avian and rodent species (Joseph-Silverstein et al., 1989; Consigli and Joseph-Silverstein, 
1991; Engelmann et al., 1991; Parlow et al., 1991; Spirito et al., 1991; Engelmann et al., 
1993; Grothe et al., 1996; Zhu et al., 1996; Morabito et al., 2001). Interestingly, the 
expression of one of these ligands, FGF2, has been shown to exhibit a gradient of 
expression in the chick embryonic myocardium after early uniform expression across the
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myocardial wall: from E7 onwards, there is higher expression of FGF2 in the compact 
myocardium, with lower expression in the trabeculated region (Consigli and Joseph- 
Silverstein, 1991). This correlates with the transmural gradient of the rate of myocyte 
proliferation, suggesting that FGF is an important mitogenic factor for cardiac myocytes. 
This hypothesis is supported by the studies of Mima et al. (1995) in which mutations of 
FGFR-1 in the precardiac mesoderm result in diminished proliferation of myocytes of the 
ventricular myocardium at later stages of development. Additionally, inhibition of FGF2 
or FGFRl expression by anti-sense oligonucleotides or antibodies, respectively, prevents 
myocyte proliferation (Sugi etal., 1993, 1995).
The localization of both FGF receptors and ligands to the myocardium of the developing 
heart suggests that autocrine and/or paracrine FGF signalling acts to stimulate myocyte 
proliferation. Although the expression of FGF members in the neighbouring epicardium 
has received comparatively little attention, immunohistochemical analysis has identified 
the ligands FGF-1, -2 and -7  in the epicardium as well as the myocardium of the chick 
embryo. These factors have been shown to be capable of induction of epithelial-to- 
mesenchymal transformation of epicardial cells in vitro and are likely inducers of this 
transformation in vivo, allowing these cells to invade the myocardium and generate cells 
of the coronary vasculature (Morabito et al., 2001). However, it remains a possibility that 
FGF family members expressed in the epicardium may also play a role in myocardial 
proliferation, particularly of sub-epicardial myocytes of the compact layer.
The role of the epicardium in myocardial development has been convincingly illustrated 
by other studies in which epicardial defects result in myocardial dysmorphogenesis. The 
lack of an intact epicardium results in defects in myocardial development, preferentially
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in the outer compact layer rather than the trabeculae (Manner, 1993; Kwee et al., 1995; 
Yang et al., 1995). A range of factors have been implicated in epicardial-mediated 
signalling to promote myocardial development, including retinoic acid as well as a 
number of transcription factors and cell adhesion molecules (Kastner et al., 1994; Sucov 
et al., 1994; Kwee et al., 1995; Yang et al., 1995; Jaber et al., 1996). These are discussed 
in more detail below (see “The Epicardium and Myocardial Morphogenesis”).
Looping and Septation
At HH stage 10 the heart tube loops, to bring the chambers into their final positions, so 
that the atria are positioned above the ventricles (Fig. Lie). Correct movement of the 
heart tube at this stage is essential to ensure subsequent accurate alignment of the heart 
chambers with the septa of the heart and the outflow tract (Levin, 1997), such that the 
once tubular heart is remodelled into a four-chambered organ (Fig. l.lf).
As looping occurs, the primary regional divisions of the heart, namely the interventricular 
and interatrial septa as well as the outflow tract septum, begin to develop. At two specific 
sites along the heart tube, the AV and conotruncal regions, endothelial cells of the 
endocardium undergo an epithelial-to-mesenchymal transformation and invade the 
underlying cardiac jelly (Markwald et al., 1975, 1977). Concurrently, the corresponding 
myocardium in these segments secretes more matrix molecules such as laminin, collagen 
and fibronectin, organized as a basement membrane that contacts the endocardial 
basement membrane (Markwald et al., 1977). These processes lead to the expansion of 
these regions, known as endocardial “cushions”, which eventually fuse and will form the 
septa and valves of the conotruncal and AV region. Only endocardial cells in the 
atrioventriucular or outflow tract regions can give rise to cushion mesenchyme in vitro
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(Eisenberg and Markwald, 1995). This suggests that endocardial cells in these regions are 
unique within the endocardium, or that they are receiving different instructive cues. Two 
factors expressed in this region are the TGpp receptors, TBRII (Brown et al., 1996) and 
TBRIII (Brown et al., 1999). TBRIII is preferentially expressed by endocardial cells of 
the AV cushions and by migrating mesenchymal cells, while TBRII, along with TBRI is 
also expressed in ventricular endocardium, where endocardial cushions are not usually 
formed. Overexpression of TBRIII using retroviral -mediated gene transfer in ventricular 
explants results in increased levels of epithelial-to-mesenchymal transformation. 
Conversely, in vitro assays using TBRIII antibody applied to AV cushion explants 
demonstrate inhibition of epithelial-to-mesenchymal transformation of this tissue (Brown 
et al., 1999). Since TGFp receptors function as dimers, it has therefore been hypothesized 
that the interaction of TBRII and TBRIII induces epithelial-to-mesenchymal 
transformation, and that the restriction of TBRIII expression to the region of the AV canal 
localizes transformation to this region. The dimerization of TBRII and TBRIII is known 
to facilitate binding of TGFp-2 ligand, which is expressed in the AV cushion and outflow 
tract of both the chick and mouse heart (Dickson et al., 1993; Lopez-Casillas et al., 1993; 
Barnett et al., 1994). Similarly, the addition of TGFp3 ligand to endocardial cells in vitro 
has been shown to elicit epithelial-to-mesenchymal transformation. Importantly however, 
this requires prior interaction of the endocardium with the adjacent myocardium, since 
inductive signals, which are exclusively expressed in the myocardium adjacent to 
cushion-forming regions of the endocardium, induce the initial epithelial-to-mesenchymal 
transformation of endocardial cells. Thus, induction of endocardial cell transformation is 
a result of initial extrinsic signals from the myocardium, followed by intrinsic endocardial 
signalling (Ramsdell and Markwald, 1997).
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Similar to AV septation, outflow tract septation arises from the fusion of two opposing 
endocardial cushions. An important difference in this process at the outflow tract is that 
the expansion and completion of septation is facilitated by the invasion of the cushions by 
an extracardiac cell population, the cardiac neural crest. This contribution was first 
identified with the use of quail/chick chimeras (Kirby et al., 1983). This involves the 
transplantation of quail cells into corresponding regions of a chick host (or vice versa). 
With successful transplantation, the development of the host embryo should proceed as 
normal (Le Douarin, 1973) and the donor cells can be histologically identified by the 
difference in the chromatin of their nuclei, which is more condensed than in chick nuclei. 
The same technique has been used by Kirby et al. to map in detail the colonization of the 
outflow tract of the heart by cardiac neural crest cells (Kirby et al., 1983; Phillips et al., 
1987; Miyagawa-Tomita et al., 1991; Waldo et al., 1998). As mentioned previously, the 
outflow tract can be divided into distinct regions: most distally (i.e. furthest from the 
heart) is the aortic sac, which connects the heart to the dorsal aorta via the aortic arch 
arteries that branch from it. More proximally there is the truncus arteriosus, and further 
proximally is the conus, which connects to the ventricles and largely becomes integrated 
into the right ventricle at subsequent stages.
Neural crest cells first enter the aortic sac at around HH stage 25 from the region between 
arch arteries 4 and 6 (Waldo et al., 1998). These mesenchymal cells separate the sac into 
two channels, the primitive aorta and pulmonary trunk. Further proximally (i.e. moving 
towards the heart), this mass of neural crest cells separates into two “prongs”, one dorsal 
and one ventral that each penetrate one of the truncal endocardial cushions (Thompson 
and Fitzharris, 1979). These two prongs of neural crest cells make up a central core of 
mesenchymal tissue in each cushion, with more neural crest cells invading the dorsal
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prong rather than the ventral one, at least in the chick embryo. Around HH stages 26-29 
there is extensive remodelling of this outflow region: there is a twisting of the distal 
aortic and pulmonary vessels around each other so that the pulmonary vessel comes to lie 
ventrally, with respect to the aorta. After a period of outflow vessel lengthening, there is 
then a significant shortening of the outflow tract, associated with peak levels of apoptosis 
in the myocardial ring of tissue circling the proximal outflow tract (Watanabe et al.,
1998). Apoptosis is also a feature of the aorticopulmonary septum at this stage (Poelmann 
et al., 1998), though it is not yet clear whether this localized cell death is important for 
separation of the two outflow vessels from each other, by means of clearing cells, or 
whether changes associated with apoptosis may acts as a trigger for subsequent events. 
At this distal region, neural crest cells become integrated into the walls of the two outflow 
vessels, which will eventually separate from each other. More proximally, neural crest 
cells continue to invade the ventral and dorsal truncal cushions, populating the semi-lunar 
valves. Septation of the distal, aorticopulmonary region is largely complete by around HH 
stage 30. Subsequently, neural crest cells can be seen below this region, populating the 
conal cushions, subjacent to the endocardium in the regions that become the lines of 
fusion of the conal cushions. Lastly, a few scattered neural crest cells are found at the site 
of interventricular septation (Waldo et al., 1998).
Clearly, the neural crest is an essential element in the septation and remodelling of the 
single outflow vessel into two separate channels. The effects of neural crest ablation or 
disruption of cardiac neural crest development have drastic implications for 
cardiovascular development, likely in humans as well as in experimental animal models, 
as discussed later, and the septation defects associated with neural crest abnormalities are 
some of the major causes of congenital heart disease. The study of cardiac neural crest
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development and the molecular mechanisms that govern neural crest migration, 
proliferation and differentiation are therefore essential to the understanding of 
cardiovascular development and the aetiology of congenital heart diseases.
Pharyngeal Arch and Great Vessel Morphogenesis
As mentioned above, the aortic sac is connected to the dorsal aorta and systemic 
circulation by the aortic arch arteries. During embryogenesis, these arch arteries develop 
into the great arteries of the heart (i.e. the aorta, pulmonary artery and main branches 
from these vessels) as a result of remodelling and recruitment of smooth muscle cells and 
fibroblasts. The arch arteries develop concomitantly with the pharyngeal arches that 
surround them and therefore the correct patterning of these arches is necessary for the 
normal development of the arteries themselves.
Pharyngeal arches are a feature of all vertebrates, evolved for the functions of feeding and 
respiration. The upper arches form skeletal components of the head and neck. The lower 
arches in fish form the gills, while in birds and mammals, these become structures of the 
throat and the great arteries. Each pharyngeal arch is composed of four primary elements: 
There is an outer ectodermal layer which gives rise to epidermis and sensory neurons 
(DAmico-Martel and Noden, 1983; Couly and Le Douarin, 1990) and an inner endoderm 
which lines the pharynx and contributes cells to the thymus, thyroid and parathyroid 
glands (Le Douarin and Jotereau, 1975). Between these two layers are neural crest cells, 
which make up the bulk of the arch tissue and form mesenchyme and connective tissue of 
the head, neck and great vessels (Le Lièvre and Le Douarin, 1975; Noden, 1983; Couly et 
al., 1993). These mesenchymal cells surround a mesodermal core, which generates the
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musculature as well as the endothelial cells of the arch arteries that connect to the dorsal 
aorta (Noden, 1983; Trainor e ta l, 1994).
The three lower arches of the chick, designated arches 3, 4 and 6 (since arch 5 is a 
transient structure) will develop into the great arteries. They originally develop as paired 
arches on either side of the midline. As the upper arch arteries regress, these lower arch 
arteries remodel, undergoing changes in which some arteries persist and others 
degenerate, thus forming the final pattern of the great vessels: the right fourth artery will 
develop into the definitive aorta, the sixth arch arteries become the left and right 
pulmonary arteries, and the third arch arteries become the left and right brachiocephalic 
arteries (Carlson, 1996). While the neural crest-derived cells of the upper arches will 
develop into cartilage and bone forming the skeletal structures of the head and neek, in 
the lower arches, neural crest cells differentiate into smooth muscle cells that form the 
tunica media of the great arteries, fibroblasts of the adventitial layer, parasympathetic 
neurons, as well as contributing cells to the endodermally-derived glandular organs 
(reviewed by Kirby, 1999).
Analysis of Hox gene expression has suggested a role for neural crest cells in the 
patterning of the pharyngeal arches. The Hox genes are the vertebrate homologues of the 
Drosophila homeobox genes. They are transcription factors involved in setting up 
positional identities along the anterior-posterior axis (McGinnis and Krumlauf, 1992). It 
has been shown that different axial levels of hindbrain neural plate express specific 
combinations of Hox genes in both the mouse (Wilkinson et al., 1989; Krumlauf, 1994) 
and the chick (Kuratani and Eichele, 1993; Prince and Lumsden, 1994). The boundaries 
of expression of different combinations of Hox genes appear to correspond to
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rhombomere boundaries with a two-segment periodicity. In the chick, pharyngeal arch 1 
does not express any Hox genes, arch 2 expresses Hoxa2, arch 3 expresses both Hoxa2 
and Hoxa3 and arches 4 and 5 express Hoxa2, Hoxa3 and Hoxb4 (Prince and Lumsden, 
1994; Couly et al., 1996). This segmental gene expression therefore suggests that Hox 
genes play a role in the patterning of the cephalic neural crest. It was found that neural 
crest cells express some of the same Hox genes as the rhombencephalon from the same 
axial level that they emerge from and continue to do so as they migrate into the 
pharyngeal arches. From this, it was hypothesized that each arch therefore expresses the 
Hox gene combination characteristic of its neural crest cells through a transfer of this 
positional information from the hindbrain to the neural crest (Hunt, 1991). When 
rhombomeres are transplanted to ectopic sites they continue to express their characteristic 
Hox genes (Guthrie et al., 1992; Kuratani and Eichele, 1993) thereby acting in an 
autonomous manner, consistent with the morphological findings of earlier transplantation 
studies. More recently, however, it has become clear that there are separate regulatory 
elements for expression of Hox genes in the rhombencephalon and in the migrating neural 
crest (Frasch et al., 1995; Maconochie et al., 1998). Therefore, although positional 
information is not transferred via the Hox code, these Hox genes are essential for normal 
development of the neural crest components of the arches. For example, targeted 
mutation of the mouse Hox 1.5 gene leads to craniofacial defects and absence or 
hypoplasia of the thymus, thyroid and parathyroid, though no cardiac defects are 
observed (Chisaka and Capecchi, 1991). Interestingly, Hoxa2 mutations in the mouse 
generate transformations of the second arch skeleton into derivatives typical of the first 
arch (Rijli et al., 1993), suggesting a more complicated integration of neural crest- 
dependent and -independent signals.
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Many studies have suggested an instructive role for the neural crest in patterning the other 
components of the pharyngeal arches, including analysis of expression of molecular 
markers, such as the Hox genes described above and analysis of morphological changes 
resulting from neural crest transplantations. In a classic study, Noden (1983) performed 
transplantation experiments in which pre-migratory crest destined for the first pharyngeal 
arch was grafted into the region in which second arch neural crest cells usually emanate. 
As a result, these transplanted cells populated the second arch region but generated first 
arch derivatives (i.e. jaw components rather than hyoid structures). Additionally, this 
shift of neural crest cells was thought to direct second arch mesoderm to generate 
musculature typical of the first arch, suggesting an inductive effect of the neural crest on 
surrounding pharyngeal arch tissue. More recently however, similar experiments have 
generated different findings which suggest that neural crest cells differentiate according 
to the environment into which they are transplanted (reviewed by Trainor and Krumlauf, 
2000). This paradox in the literature has since been resolved by deduction of the 
difference in the extent of tissue that was transplanted in Noden’s experiments compared 
to that used in the later studies. Trainor et al. (2002) have demonstrated in the mouse 
embryo that rather than intrinsic signals from the neural crest cells patterning their 
environment, it is a signalling center located at the midbrain/hindbrain boundary that 
transfers information to its environment, via FGF8 expression, to dictate subsequent 
pharyngeal arch patterning.
Thus, the neural crest does not appear to be essential for patterning of the pharyngeal 
arches, although it is required for later maintenance of the arch arteries. Veitch et al. 
(1999) performed neural crest ablations in the chick embryo and found that the 
pharyngeal arches can form in the absence of the neural crest. Furthermore, the arches
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express factors such as BMP7, FGF8 and Paxl and the correct spatial and temporal 
patterns of expression of these is found in the absence of the neural crest, suggesting that 
regionalization of the arches is maintained. Waldo et al. (1996) have also observed the 
initial formation of the endothelium of the arch arteries in cardiac neural crest ablated 
avian embryos. Although these arteries become maldeveloped upon initiation of blood 
flow, it appears that at least the earliest stages of arch artery formation do not rely on 
inductive signals from the cardiac neural crest.
An alternative inductive tissue that has been suggested to have a role in arch patterning is 
the endoderm. As in the neural crest population, the endoderm of the arch region 
expresses a pattern of Hox genes in a regionalized matter. This appears to be associated 
with the organization of the pharyngeally-associated glands along the anterior-posterior 
axis, such that the thyroid forms at the level of the second endodermal pouch, the thymus 
derives from the third pouch and the parathyroid from the fourth pouch (Manley and 
Capecchi, 1995, 1998). Furthermore, the endoderm has been shown to require retinoic 
acid signalling for normal development, and disruption of this signalling prevents 
pharyngeal arch formation (Wendling et al., 2000). It therefore appears that it is the 
integration of various signals from the neural crest, endoderm, a signalling center at the 
midbrain/hindbrain boundary and also likely some signalling from the mesoderm and/or 
ectoderm of the arches that must be assimilated for proper patterning of the pharyngeal 
arches.
Formation of the Cardiac Conduction System
In the tubular heart, a wave of contraction is generated as epithelioid myocytes become 
electrically active, producing action potentials that propagate through the myocardium via
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gap junction channels (Kamino et al., 1981). At this early stage (HH stage 7-8 in the 
chick embryonic heart) the myocytes do not yet possess contractile ability. Until 
interventricular septation of the heart takes place at E7, the electrical wave of contraction 
continues unidirectionally, emanating from the primitive sinoatrial region, posteriorly, to 
the anterior region of the heart. At these stages, impulse conduction is slow, peristaltic 
and of uniform velocity throughout both the atrial and ventricular myocardium.
Once the four-chambered heart is formed, a more highly regulated conduction system is 
necessary for generation of force to move blood through these chambers. This 
mechanism involves four structural components that together make-up the mature cardiac 
conduction system: the sinoatrial node (that possesses pacemaker activity), the AV node 
and ring, the AV bundle and the Purkinje fibres (reviewed by Lamers et al., 1991; 
Moorman et al., 1998). After ventricular septation, a dramatic shift in impulse conduction 
takes place: impulses generated in the sinoatrial node, located in the right atrium, are 
transmitted to the AV node via the atrial myocardium. Fibrous insulation surrounding the 
AV node prevents spread of these impulses directly to the basal regions of the ventricle. 
The AV node is located at the base of the interatrial septum and upon arrival at this tissue, 
the pacemaking impulse is slowed, causing a delay in transmission to the ventricles. 
Interestingly, few gap junctions are expressed in the AV and sinoatrial node. One that is 
expressed here, connexin45, is a low conductance gap junction (Alcolea et al., 1999). 
The delay in action potential transmission through the AV node facilitates sequential 
contraction of the atrial and then ventricular chambers to control the direction of blood 
flow. From the AV node, impulses are transmitted to the ventricular myocardium via the 
AV bundle, or His bundle. This is located at the tip of the ventricular septum and 
bifurcates into the right and left bundle branches. The bundle branches are continuous
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with the most distal elements of the cardiac conduction system, the Purkinje fibres. 
These fibres penetrate the subendocardial myocardium and in some species also ramify 
through the deeper layers of the myocardium. In the chick embryo, these fibres become 
active by E7 and, through gap junction-mediated electrical coupling to neighbouring 
myoctes, a contraction of the ventricles is effected, in a sequential apex-to-base direction 
(i.e. from the posterior of the ventricles to the atria). Ventricular conduction cells 
preferentially express connexin40 (previously known as connexin42; (Gourdie et al., 
1993)), though no conduction defects have been identified in the connexin40 knockout 
mouse, suggesting the involvement of other connexin proteins in impulse conduction in 
the distal conduction system. The coordination of impulse conduction through the 
elements of the cardiac conduction system produces a wave of contraction emanating 
from the right atrium directed towards the AV junction, followed by propagation in the 
interventricular septum and final contraction of the ventricles. Thus, blood is propagated 
from the inflow regions of the heart, through the atria to the ventricles, and is then 
pumped out of the heart to the lungs and systemic circulation via the outflow vessels.
Until recent years, the cellular origin of the most distal elements of the conduction 
system, the Purkinje fibres, remained unclear. Although Purkinje fibre cells express 
muscle-specific proteins, such as slow-twitch skeletal muscle myosin heavy chain and 
atrial myosin heavy chain (Gonzalez-Sanchez and Bader, 1985) they also express neural 
crest markers, including HNK-1 (Gorza et al., 1988) and EAP-300 (McCabe et al., 1992) 
which led to the suggestion that they might originate from either the myogenic or neural 
crest cell lineages. Retroviral lineage experiments in the chick embryo however 
demonstrated that only ventricular myocytes, and not neural crest cells, differentiate into 
Purkinje fibres in vivo and that this occurs in close proximity to developing coronary
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arteries and subendocardial tissue (Gourdie et al., 1995; Cheng et al., 1999). 
Interestingly, this recruitment process occurs until hatching, while local conversion of 
proximal conduction system elements is largely complete by the time of ventricular 
septation (McCabe et al., 1995; Cheng et al., 1999).
Recent experiments demonstrated that an important factor in the recruitment of myocytes 
to Purkinje fibres is endothelin (ET) (Gourdie et al., 1998). This factor has been shown to 
induce myocytes in vitro to differentiate into cells expressing Purkinje fibre markers, 
while in vivo, the ectopic expression of the precursor of the ET ligand, preproET-1, and 
its converting enzyme, ECE-1, essential for production of mature, biologically active 
ligand, is sufficient to generate cells of a conduction cell phenotype. The localization of 
Purkinje fibres to periarterial and sub-endocardial regions is at least partly due to the 
restricted expression of ECE-1 to these areas, while the ET receptor, ET^, is ubiquitously 
expressed throughout the myocardium. While ECE-1 therefore plays a role in the spatial 
localization of Purkinje fibre differentiation, the temporal expression profiles of the ET 
receptors is thought to control the competency of ventricular myocytes to convert to a 
Purkinje fibre phenotype, since the combined expression levels of receptors ET^ and ET^ 
peak at ElO, concomitant with the onset of Purkinje fibre differentiation. Similarly, as 
ET receptor expression declines, so too does differentiation of Purkinje fibre cells 
(Kanzawa et al., 2002).
More recently, it has been suggested that ET signalling is not the sole factor responsible 
for recruitment of ventricular myocytes to a conduction cell phenotype, since ectopically 
induced conversion of myocytes to “conduction cells” produces cells that do not 
upregulate the full complement of genes, such as Nkx2.5 and GATA4, typically expressed
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by bona fide Purkinje fibre cells (Takebayashi-Suzuki et al., 2001). Furthermore, 
Purkinje fibres in mammalian species are found only sub-endocardially and not 
periarterially, and it has been suggested therefore that an endocardial-specific signal is 
responsible for localized recruitment in these species. Although no other factor has been 
definitively identified as a mediator of Purkinje fibre recruitment from myocytes, one 
candidate is the peptide growth factor, neuregulin. This factor is expressed by the 
endocardium, while its receptors, erbB2 and erbB4 are expressed in the myocardium. It 
is capable of inducing a number of conduction cell markers, such as ANF and skeletal 
muscle protein (Zhao et al., 1998). Mutations of neuregulin in the mouse lead to defects 
in cardiac cushion and trabeculae formation. These mice also exhibit irregular heartbeats 
that may be a result of impaired contractile capacity (Gassmann et al., 1995; Lee et al., 
1995; Meyer and Birchmeier, 1995; Moorman et al., 1998). Neuregulin is itself 
upregulated by ET (Zhao et al., 1998), suggesting that these factors may act both in a 
single pathway and/or parallel pathways to induce conduction cell differentiation. 
Whether neuregulin is indeed an in vivo regulator of conduction cell development, 
however, remains to be determined.
Cell Death in the Developing Heart
At the same time that cells are being added to the heart from extracardiac sources, cells 
are also being removed from the heart through the process of apoptosis, or programmed 
cell death. Apoptosis is an important feature of development of an embryo, acting as a 
means to control cell number, sculpt tissues, and to remove damaged or harmful cells 
(reviewed by Jacobson et al., 1997). In contrast to necrosis, the largely disorganized form 
of cell death that occurs in pathological conditions, apoptosis, also known as programmed 
cell death, generally occurs at specific time-points and sites during development.
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Apoptosis is essential to the modelling of a number of tissues in the embryo, including 
the distal elements of the growing limb and wing bud (Saunders, 1962), neuronal 
elements of both the central and peripheral nervous system (Bennet et al., 2002) and the 
heart (Pexieder, 1975).
Whereas necrotic cells tend to swell and rupture after injury, spilling their contents 
extracellularly and inducing an inflammatory response, apoptotic cells undergo a set of 
characteristic changes that cause minimal damage to their environment. Apoptotic cells 
shrink and condense, while maintaining the integrity of their plasma membranes. Within 
the cell, there is chromatin condensation and DMA is degraded by endonucleases, 
producing fragments that form a characteristic DNA ladder when electrophoresed on a 
gel (Cohen et al., 1994). The nucleus also condenses and the dying cell often fragments 
into apoptotic bodies, which are rapidly phagocytosed by neighbouring cells or 
macrophages. The impetus for initiation of the apoptotic pathway can be the result of 
intrinsic signals (Ellis et al., 1991) or due to external stimuli, such as the removal of 
growth factors. Apoptosis is regulated by a number of “death factors”, including the 
caspase family of cysteine proteases, and Fas Ligand (Brunner et al., 1995; McGahon et 
al., 1995). The Bcl-2 family of genes, the mammalian homologues of the C. elegans ced 
genes, represent a group of both pro-and anti-apoptotic genes, the balance of which 
determines whether or not a cell will undergo apoptosis (reviewed by Zimmermann et al., 
2001).
Temporal and spatial distributions of apoptosis within the heart have been extensively 
studied using various techniques, including immunohistochemical and vital dye staining 
(Pexieder, 1975; Hurle and Ojeda, 1979), electron microscopy (Manasek, 1969b;
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Pexieder, 1975; Hurle et al., 1977; Hurle and Ojeda, 1979), terminal transferase-mediated 
dUTP nick end labelling (TUNEL) analysis for detection of DNA fragmentation 
(Poelmann et al., 1998; Watanabe et al., 1998; Cheng et al., 2002) and 
immunohistochemistry (Watanabe et al., 1998). The study of Pexieder (1975) identified 
31 regions of the embryonic chick heart in which significant levels of apoptosis were 
seen. Apoptosis is particularly prevalent in areas undergoing morphological changes. 
One such area is the outflow tract of the heart, in two specific regions: the mesenchyme 
of the endocardial cushions, at least some of which is neural crest-derived (Hurle and 
Ojeda, 1979; Poelmann et al., 1998) and the myocardial ring circumscribing the outflow 
tract (Watanabe et al., 1998). Levels of apoptosis in the outflow tract of the chick embryo 
begin to rise above background levels at around HH stage 25 and peak at HH stage 29 
(Watanabe et al., 1998; Cheng et al., 2002). This timing correlates with fusion of the 
endocardial cushions to form the aorticopulmonary septum, as well as the shortening of 
the outflow tract, which is hypothesized to be as a result of compaction of the outflow 
myocardial tissue. The fact that cell death is occurring at significant levels at time-points 
of extensive remodelling of the outflow tract points to an important role for apoptosis in 
the morphogenetic events taking place in this region. Another area where apoptosis 
appears to be important is in the atrio-ventricular cushions as they are fusing (Poelmann 
et al., 2000; Zhao and Rivkees, 2000). As well as for the simple removal of cells from an 
area where tissues are fusing, it has been proposed that apoptosis in the endocardial 
cushions of the outflow tract and atrio-ventricular canal may act as a trigger for 
myocardialization of these cushions. Poelmann et al. (1998, 2000) have suggested that 
the release of substances from neural crest cells undergoing apoptosis may cause local 
changes in pH which will then activate latent TGFp, known to be expressed in these 
cushions (Nakajima et al., 1997). As TGFps are involved in cell differentiation, it is
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further hypothesized that the production of TGFp may trigger the myocardialization of 
the endocardial cushions.
Other regions where apoptosis is higher than background levels include cells of the 
cardiac conduction system, and again it has been suggested that cell death here may play 
a role in their recruitment or differentiation from cardiomyocytes (Cheng et al., 2002). At 
late stages of chick development, the aorta and to a lesser extent, the pulmonary artery 
also contain many cells undergoing apoptosis (Cheng et al., 2002) and this may be related 
to the rapidly increasing physiological demands of the embryo as it grows. Interestingly, 
the ventricular myocardium does not display high levels of apoptotic cells during 
embryonic development (Pexieder, 1975; Lin et al., 2000; Zhao and Rivkees, 2000; 
Cheng et al., 2002) suggesting that modelling of this tissue, particularly formation of 
trabeculae, is largely a result of organized and oriented proliferation rather than clearing 
of unnecessary cells.
Clearly, apoptosis has an essential role in shaping the developing heart. It is not known 
whether defects in heart development correlate with disruption of normal patterns of 
apoptosis, though areas in which cell death are prominent in normal development are 
commonly abnormal in congenital heart disease, particularly the endocardial cushions.
Extracardiac Sources of Heart Cells: The Cardiac Neural Crest
Besides the major contribution of cells to heart formation from the cardiogenic 
mesoderm, and the recently proposed “secondary heart field”, two extracardiac sites are 
known to provide cells to the heart that are essential for its normal development: the 
cardiac neural crest and the proepicardial organ (discussed in more detail below).
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The neural crest represents a transitory, embryonic cell population that is important in 
many areas of the developing embryo. This vertebrate innovation has often been referred 
to as the “fourth germ layer” for the fact that is gives rise to diverse cell types, including 
the bone and cartilage of the head and neck, peripheral neurons and glia and pigment cells 
of the skin (Hall, 1999). A particular region of the neural crest, the cardiac neural crest, 
generates cells that are essential for septation of the outflow tract of the heart, an 
important process by which an initially undivided outflow vessel emanating from the 
heart is divided into two vessels, the aorta and pulmonary artery (Kirby et al., 1983). 
These cells emanate from the dorsal neural tube at the axial level between the otic 
placode and somite 3, from HH stages 8 and at least up to HH stage 11 (Kirby et al., 
1983). Additionally, the cardiac neural crest provides support for the arch arteries that 
develop into the great arteries (i.e. the aorta and pulmonary artery and their more distal 
branches), contributing almost the entire smooth muscle cell layer, or tunica media, to 
these vessels, as well as parasympathetic neurons running through the outer adventitial 
layer of the vessels (Le Lièvre and Le Douarin, 1975; Kirby and Stewart, 1983). Since 
outflow tract septation and incorrect great vessel remodelling are key components of 
many congenital heart diseases, defects in the cardiac neural crest are thought to have a 
major role in such diseases.
The cardiac region of the neural crest is unique among neural crest cells in a number of 
respects. For example, generally, in the absence of a region of neural crest cell following 
ablation, neighbouring populations can compensate for this loss and generate a new 
population of neural crest cells to fill this void (Couly et al., 1996; Vaglia and Hall, 
1999). However, following ablation of the cardiac neural crest, other cells can regulate to
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compensate for this loss, but only to a certain extent. The compensatory cells can replace 
most of the neuronal cells that derive from the neural crest, but do not generate enough 
mesenchymal cells to completely septate the outflow tract. This lack of neural crest cells 
therefore results in embryonic lethality (Kirby and Stewart, 1983). Furthermore, the 
migratory pathways of cardiac neural crest cells are somewhat different from other neural 
crest populations (Kuratani and Kirby, 1991, 1992), representing the identity of the 
cardiac neural crest as an intermediate population between the cranial and trunk neural 
crest. It is therefore clear that the general biology of trunk and cranial neural crest cells 
cannot be assumed to apply to the cardiac neural crest. Furthermore, as mentioned above, 
defects in or absence of the cardiac neural crest results in a host of cardiovascular 
abnormalities highly reminiscent of the leading causes of congenital heart disease in 
humans, including abnormalities in division of the ventricles and the outflow tract, 
remodelling of the great arteries and functional characteristics of the heart. Despite the 
fact that these defects have been well characterized on an anatomical and physiological 
level, little is known about the underlying mechanisms of cardiac neural crest function 
and how cardiac neural crest cell migration, proliferation, differentiation, etc are 
regulated. Interestingly, certain myocardial defects arise in neural crest-ablated hearts at 
time-points before neural crest cells would normally have entered the heart, and the 
cardiac neural crest was also shown to be important in patterning of both cardiac 
conduction cells and the coronary vasculature (Hood and Rosenquist, 1992; Hyer et al.,
1999). Clearly, the cardiac neural crest is a fascinating cell population that has diverse 
and essential roles in the formation of the mature cardiovascular system. Together, these 
factors point to an essential need for the study of the cardiac neural crest cell population, 
both for the understanding of cardiac morphogenesis per se and a means to elucidate and 
prevent the embryological processes that lead to congenital heart diseases. In view of
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this, an overview of cardiac neural crest cell biology is outlined below, against a wider 
background of more general neural crest cell biology.
The Origin of Neural Crest Cells
The neural crest population was first identified in the chick by Wilhelm His, who noted 
these cells as a band of tissue lying between the presumptive epidermis and the neural 
tube and called it the Zwischenstrang (1868, 1879, quoted in Horstadius, 1950). In all 
vertebrates, neural crest cells arise from this dorsal region of the neural tube at the 
junction between this presumptive epidermis and the prospective neural plate (Fig. 1.2).
The timing of separation of neural crest cells from the remaining neural epithelium varies 
between species and even according to axial level within an embryo. In the axolotl, neural 
crest emigration is consistently coordinated with fusion of the neural folds to form the 
neural tube along the entire rostral-caudal axis (Lofberg and Ahlfors, 1978; Spieth and 
Keller, 1984). Similarly in avian species, cranial neural crest cells migrate away from the 
neural epithelium upon neural tube closure, before separation of the overlying ectoderm, 
but do not leave the neural tube in more caudal regions until the neural tube is definitively 
formed and detached from the epidermis (Tosney, 1978; Duband et al., 1995). In 
mammals, neural crest emigration occurs in the head prior to fusion of the neural folds 
(Nichols, 1986), but in the trunk, as in avian embryos, this oceurs after neural tube 
cclosure. In both avian and mammalian species, this detachment at somitic levels runs 
parallel to sclerotome formation from the somites, suggesting a possible correlation of 
these events (Williamson, 1910, from Duband et al. (1995)).
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Figure 1.2 Generation of the neural crest, (a) Neural crest cells arise from the lateral 
regions of the neural plate, (b) Intrinsic forces cause cell shape changes within the 
neural plate, resulting in contraction of cells at the apical border, (c) The neural plate 
therefore folds, bringing the bilateral presumptive neural crest populations towards the 
midline, (d) Finally, the neural tube is formed, with the most lateral regions of the 
ectoderm overlying it and forming the epidermis. Neural crest cells arise from the 
junction between these two tissues. Adapted from Gilbert, 1997.
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Based on his studies of the axolotl Ambystoma mexicanum. Raven (1931, quoted in 
Horstadius, 1950) suggested that both the neural plate and the overlying ectoderm are 
able to give rise to neural crest cells. Many years later, further experiments in this species 
confirmed these findings (Moury and Jacobson, 1989; Mancilla and Mayor, 1996). To 
understand whether a similar inductive mechanism occurred in avian species, Selleck and 
Bronner-Fraser (1995) performed quail/chick recombinations of prospective neural plate 
and presumptive epidermis to elucidate which tissues generate neural crest. By 
combination of prospective quail neural plate and presumptive chick epidermis in culture, 
it was found that neural crest cells are generated and can arise from both the epidermis 
(non-neural ectoderm) and neural ectoderm.
Induction of the Neural Crest
Although only cells in the dorsalmost region of the neural tube normally form neural crest 
cells, a number of studies have shown that cells from other regions of the neural tube and 
non-neural ectoderm are capable of forming neural crest cells under particular conditions. 
The work of Moury and Jacobson in Ambystoma mexicanum (Moury and Jacobson, 1989,
1990) suggests that neural folds form whenever neural plate and epidermis (i.e. non- 
neural ectoderm) are juxtaposed. Some cells within the folds will then give rise to neural 
crest derivatives. This was demonstrated in experiments using regions of tissue that do 
not normally contribute to neural crest, such as ventral epidermis. Tissues were 
distinguished by grafting between pigmented and albino axolotls. In these experiments 
neural crest cells were generated, suggesting that the interaction between epidermis and 
neural plate may be sufficient for neural crest formation.
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Similarly, in chick, neural plate that usually gives rise to ventral neural tube cells (and 
therefore don’t normally contribute to neural crest populations) were cultured with 
prospective epidermis, from HH stage 4-10 embryos. After 6-7 days in culture, this 
resulted in a wide range of neural crest derivatives, both neuronal and non-neuronal 
(Selleck and Bronner-Fraser, 1995), suggesting that the interaction of any region of the 
neural plate with epidermis can give rise to neural crest cells.
The ability of almost any region of neural plate to give rise to neural crest cells explains 
the regenerative capacity of lateral neural tube cells. For example, as mentioned above, 
ablation of the neural folds both alone and in combination with adjoining dorsal 
neuroepithelium, from the midbrain and hindbrain levels results in compensation from 
ventral neural tube cells which migrate out of the neural tube into regions normally 
populated by the neural crest cells. These compensatory cells then go on to form neural 
crest cell derivatives themselves (Scherson et al., 1993) and are therefore able to change 
their fate such that they then became part of the neural crest cell lineage, rather than 
pursuing their normal fate as cells of the central nervous system. Cells as far ventrally as 
just above the floor plate have been shown to have this compensatory ability to change 
their fate after neural fold ablation, at least up until the time that neural crest migration 
out of the neural tube normally begins (Scherson et al., 1993; Vaglia and Hall, 1999).
The molecular signals that are thought to dictate the induction of the neural crest in the 
dorsal region of the neural tube arise from a number of sources. Genes that are markers 
of the dorsal neural tube are initially expressed throughout the neural plate. These genes 
include Msxl, Pax3, dorsalin-1 and Slug (Liem et al., 1995). Their restriction to the 
dorsal region of the neural tube involves repression in the ventral and lateral neural tube
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by sonic hedgehog signalling from the notochord (Smith and Schoenwolf, 1989; van 
Straaten et al., 1989; Yamada et al., 1991). As described above, this dorsal fate also 
requires the interaction of the neural epithelium and non-neural ectoderm. Analysis of 
BMP expression in the epidermis of HH stage 10 chick embryos and addition of BMP4 
and BMP? to ventral neural tube explants suggest that BMP is at least one inductive 
signal arising from the epidermis to generate neural crest cells (Liem et al., 1995, 1997; 
Watanabe and Le Douarin, 1996).
Besides inductive mechanisms that generate neural crest cells exclusively in the dorsal 
neural tube, there are a number of other possible reasons why neural crest cells do not 
arise from other regions of the neural tube. Firstly, neural crest cells are incapable of 
penetrating a basement membrane (Erickson, 1987) and while there is a continuous 
basement membrane around almost the entire neural tube, this is interrupted along the 
dorsal edge of the neural tube (Tosney, 1978; Erickson and Weston, 1983). Secondly, 
associated with emigration of neural crest cells is the dynamic change in expression of cell 
adhesion molecules. During neurulation, the forming neural tube expresses N-cadherin 
and cadherin-6B (Nakagawa and Takeichi, 1998), which then become restricted to the 
dorsal neural tube as it closes. Neural crest cells dissociating from the neural tube down- 
regulate these cadherins and instead begin to express cadherin-7 (Nakagawa and Takeichi, 
1998). N-cadherin is associated with adherens junctions and may therefore be important 
for maintaining the integrity of epithelial structures such as the neural tube. The lack of 
expression of N-cadherin by neural crest cells both prior and during migration therefore 
suggests that this molecule may be important in the epithelial-to-mesenchymal 
transformation of these cells, allowing them to detach from the neural tube.
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The Diversity of Neural Crest Cell Derivatives
The neural crest has been the focus of much interest over the last century for many 
reasons, but in particular, because these precursor cells are able to generate such a huge 
variety of cell types. Understanding the tissue inductions and signals involved in creating 
such diversity is one of the key areas of research in the field of neural crest biology and 
much progress has been made, particularly in the last two decades. Two concepts that are 
especially important when considering such diversity of progeny are the ideas of “fate” 
and “potential”: do neural crest cells emerge from the neural tube as pluripotent “stem” 
cells that have the capacity to generate the full range, or potential, of neural crest 
derivatives? Is each neural crest cell predetermined to develop into a specific cell type 
(i.e. assume a particular fate) before it initiates its migration away from the neural tube? 
Or is the situation for most neural crest cells somewhere between these two extremes? 
These ideas have been studied in a number of ways, to understand the timing and 
interactions involved in fate decisions of the neural crest population.
The Potential of Neural Crest Cells
The range of cell types that neural crest cells give rise to has been elucidated over the 
course of the last century by a number of techniques. These include labelling of neural 
crest cells with vital dyes, transplanting cells from one species into another species with a 
different cellular morphology (such as quail cells into chick hosts) or other characteristic, 
and removal of the neural crest and examination of the subsequent deficiencies (reviewed 
by Le Douarin, 1982).
Cohen and Konigsberg (1975) studied the potential of neural crest cells in vitro with the 
isolation of clonal cultures of quail neural crest cells. They showed that a single neural
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crest cell could give rise to a homogeneous population of either pigmented or 
unpigmented cells or a mixed population of both cells. Further studies demonstrated 
similar findings and with the use of markers for neural crest derivatives, the multipotency 
of trunk and cranial neural crest cells was observed (Sieber-Blum and Cohen, 1980; 
Baroffio et al., 1988, 1991; Ito and Sieber-Blum, 1993). Neural crest cells therefore 
appeared to be either unipotent, multipotent, or to have a restricted potential, giving rise 
to only certain neural crest derivatives. The situation in mammalian neural crest cells was 
found to be the same (Stemple and Anderson, 1992; Ito and Sieber-Blum, 1993). 
Furthermore, Stemple and Anderson (1992) showed that neural crest cells could 
themselves generate cells exhibiting multipoteney, in a self-renewing manner 
characteristic of stem cells.
In vivo experiments have also shown that neural crest cells can differentiate into multiple 
cell types. Cell targeting techniques for the labelling and tracing of individual cells have 
shown that many neural crest cells are multipotent prior to their emigration from the 
neural tube, and can give rise to both neural and non-neural cell types, while others will 
only give rise to one derivative (Bronner-Fraser and Fraser, 1988, 1989; Frank and Sanes,
1991). This latter finding does not confirm that a neural crest cell is unipotent, but may 
imply that inductive cues that the neural crest cell encounters instruct it to develop into 
only one cell type. Labelling techniques often give rise to labelled cells in both the neural 
tube as well as the neural crest (Bronner-Fraser and Fraser, 1988) or in the neural tube, 
neural crest and epidermis (Selleck and Bronner-Fraser, 1995; Baker et al., 1997). It may 
therefore be that the neural tube and neural crest cell lineages do not diverge until cells 
delaminate or migrate away from the neural tube, and that the epithelial-to-mesenchymal 
transformation of these cells specifies them as neural crest cells (Baker et al., 1997).
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Studies in amphibians and mice have demonstrated similar findings (Collazo et al., 1993; 
Serbedzija et al., 1994).
The wealth of evidence suggests that most premigratory neural crest cells are 
multipotential, giving rise to a number of phenotypes, though most likely not all possible 
derivatives. The fate of many, if not the majority of neural crest cells is therefore likely 
determined somewhere after emigration from the neural tube and by the time a cell 
arrives at its destination. Together, the data suggests that neural crest cells display an 
amazing level of plasticity, even after migration from the neural tube. The potential of 
these cells is also not restricted to neural crest lineages, but these premigratory cells are 
also able to generate epidermal and neural tube derivatives. One important aspect of 
neural crest potential that has yet to be explored is that of cardiac neural crest potential. 
Cardiac neural crest cells have been shown through fate mapping to generate a range of 
cell types, including neurons, smooth muscle and fibroblasts, though no studies have yet 
addressed the ability of individual cardiac neural crest cells to generate more than one cell 
type. It therefore remains unclear whether the fate of a cardiac neural crest cell is 
determined early in its development or whether environmental influences at later stages 
of migration dictate the commitment of a cardiac neural crest cell to a particular lineage.
The potential and final fate of a neural crest cell appears to be established by the 
combination of a number of factors. Some aspects that clearly have a role here include 
the site and timing of emigration from the neural tube and the pathway of migration taken 
by a neural crest cell. As mentioned above, some molecular signals that are competent to 
induce particular neural crest cell fates have also been identified.
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Axial Differences in Neural Crest Cell Differentiation
In the 1970’s, Nicole Le Douarin pioneered the use of the quail/chick chimera system, as 
described above, to perform detailed fate mapping experiments of neural crest cells (Le 
Lièvre and Le Douarin, 1975). Such experiments revealed the fate of neural crest cells 
from different regions of the neural tube along the anterior-posterior axis. Some neural 
crest cell fates, such as melanocytes, were found to derive from neural crest precursors 
along almost the entire length of the embryo while others were generated from restricted 
areas along the axial level of the neural tube: bone and cartilage, for example, is only 
generated from cells migrating out from the cranial neural crest region (Le Lièvre and Le 
Douarin, 1975).
Interestingly, transplantation experiments in which quail neural crest from one axial level 
was transplanted to a different axial level in the chick revealed that the fate of such cells 
could be challenged. These heterotypic transplantations showed that a neural crest cell, 
when moved from one region to another gives rise to the derivatives characteristic of 
neural crest cells from the new axial level. For example, cells from the cranial neural 
crest which normally give rise to parasympathetic ganglia, can be transplanted to the 
region of trunk neural crest where they will generate melanocytes, cells of the dorsal root 
ganglia and sympathetic ganglia, as if they were native to the trunk neural crest. This 
phenomenon however does not occur universally. The cranial neural crest for example is 
the only neural crest population that can generate cartilage. Trunk neural crest cells that 
are transplanted into the anterior neural tube will not give rise to cartilage cells, and 
conversely cranial neural crest cells that are transplanted to more caudal regions of the 
neural tube will continue to generate cartilage or bone, as well as cell types typical of the 
new axial level (Le Douarin and Teillet, 1974; Le Douarin et al., 1975). It therefore
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appears that the potential of cranial neural crest cells is somewhat greater than that of the 
trunk neural crest. Similarly, cardiac neural crest cells generate parasympathetic neurons 
and mesenchymal cells, and, importantly, although other regions of neural crest are able 
to generate these cell types when grafted into the cardiac neural crest region, none are 
able to effect complete truncal septation as native cardiac neural crest cells do (Kirby, 
1989).
Timing of Neural Crest Cell Migration:
The timing of migration away from the neural tube is also an influence on the fate of a 
neural crest cell. In the trunk of chick and mouse embryos, it has been shown that neural 
crest cells that migrate early from the neural tube move in a ventral direction and have the 
potential to form a wider range of derivatives, while those that migrate much later are 
restricted to a dorsolateral route of migration and consequently only differentiate into 
melanocytes (Weston, 1963; Weston and Butler, 1966; Serbedzija et al., 1989; Erickson 
et al., 1992; Serbedzija et al., 1994). Similarly, in the cranial neural crest, those cells 
migrating early can fill both dorsolateral and ventral sites and have the potential to form 
cartilage, bone, neurons and melanocytes (Baker et al., 1997), while those migrating later 
only migrate dors ally and form little cartilage or bone.
It appears however that this restriction of cell fate is not truly due to the restricted 
potential of late-migrating neural crest cells. Baker et al., (1997) performed heterochronic 
transplantations i.e. grafting of older cranial neural crest regions of embryos into younger 
embryos at the same axial level, or vice versa. They found that the potential of late- 
migrating neural crest cells is not restricted when transplanted into younger embryos, and 
that they can differentiate into ventral derivatives, including cartilage and bone as well as
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melanocytes and neuronal derivatives. Conversely, early-migrating neural crest cells 
transplanted into older embryos behave as if they were late migrating and will not form 
bone or cartilage. In other words, transplanted neural crest cells behave in a manner 
consistent with their new environment. The reason for this restriction in cell fate with 
time could be due either to a genuine restriction of potential of neural crest cells as the 
embryo develops or because of a change in the environment of the neural crest cells with 
increasing age. This question was addressed by ablating neural folds from embryos at the 
6-9 somite stage, and then grafting 12-somite stage (i.e. late-migrating) quail neural crest 
into these chick hosts (Baker et al., 1997). Without the physical interference of early- 
migrating neural crest cells, these grafted cells are able to generate the full range of 
cranial neural crest derivatives, indicating that their potential is not intrinsically limited 
by their age at migration, but is impeded by the presence of early-migrating neural crest 
cells in their environment.
In the cardiac neural crest population, no such heterochronic experiments have been 
performed, though recent fate mapping experiments by Boot et al. (2002) utilizing 
retroviral labelling of neural crest cells suggest that cardiac neural crest cells migrating 
earlier (from HH stages 9-10) populate the tunica media layer of the great vessels as well 
as the outflow tract septum, while later emigrating cardiac neural crest cells (labelled in 
the neural tube at HH stage 11) do not reach the outflow tract septum, instead 
differentiating in the great vessels. This suggests that there may be a similar restriction of 
fate in the cardiac neural crest population, based on timing of migration and possible also 
due to the presence of cardiac neural crest cells in more ventral sites, preventing further 
migration of late-arriving neural crest cells. The relationship of cardiac neural crest 
migration pathways to timing of migration is further discussed below.
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Route of Neural Crest Cell Migration:
As mentioned above, neural crest cells in the avian trunk are able to migrate both 
ventrally and dorsolaterally. This migration is separated temporally such that the early- 
migrating cells, leaving the neural tube from around HH stage 12-13, move ventro- 
medially through the rostral half of each somite, while those migrating in the second 
wave that begins around HH stage 19 move dorsolaterally between the somites and the 
ectoderm. The fates of the two waves of cells are also different as a result of their 
pathways (and not as a result of timing - see above). Those that migrate through the 
somite later give rise to the dorsal root ganglia (Weston, 1963; Le Douarin, 1982) those 
migrating ventrally will generate neurons and glia, while the latter population will 
generate melanocytes (Bronner-Fraser, 1986; Loring and Erickson, 1987).
Vital dye labelling of pre-migratory cranial neural crest cells in both the chick and mouse 
suggest a similar pattern of neural crest migration as in the trunk, with early populations 
filling ventral sites first and later-migrating cells migrating dorsolaterally (Serbedzija et 
al., 1992). However the labelling studies of Noden (1975) in the chick embryo suggest a 
more complicated pattern of migration, in which subdivisions of the cranial neural crest 
display unique patterns of migration. It appears therefore that more detailed analysis of 
smaller neural crest cell populations, and preferably lineage analysis, are necessary to 
resolve this controversy.
Much of our knowledge of the migratory pathways of cardiac neural crest cells has been 
generated from studies performed by Kirby et al. These studies have for the most part 
involved the use of quail/chick chimeras (see “Looping and Septation” for discussion of
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cardiac neural crest migration into the great vessels and outflow tract), though 
immunohistochemical analysis has also been utilized, particularly for the study of early 
patterns of cardiac neural crest migration. Using the neural crest markers anti-HNK-1 
and anti-E/C8 antibodies, Kuratani and Kirby (1991, 1992) examined the routes of 
migration of cardiac neural crest cells from the neural tube to the nascent pharyngeal 
arches. Similar to trunk and cranial neural crest populations, waves of cardiac neural 
crest migration were seen, that followed different pathways according to the timing of 
migration. In contrast to the trunk (and possibly the cranial) neural crest however, the first 
cardiac neural crest cells were observed along the dorsolateral pathway, rather than the 
ventral pathway. These cells then populated a region at the edge of the emerging 
pharyngeal arches, designated “the circumpharyngeal crest”. They appeared to arrest in 
this site until outgrowth of the arches began, and then populated the emerging arches, 
providing a mesenchymal layer between the endoderm and ectoderm. As the pharyngeal 
pouches (of endodermal origin) expand laterally, this forcibly segregates the neural crest 
mesenchyme in the arches, separating it from other cardiac neural crest populations and 
likely sealing its fate as pharyngeal mesenchyme. Other cardiac neural crest populations 
in this region contribute to two tracts of cells, one anterior tract that later forms the root of 
the glossopharyngeal nerve (Kuratani and Krby, 1992) and a posterior tract that is the 
vagus nerve root primordium (Kuratani and Krby, 1991). At later stages, two ventral 
pathways become apparent, one ventrolatral between the sclerotome and the 
dermamyotome, and another ventromedial between the dermamyotome and the neural 
tube. A fourth migratory pathway between the somites is also observed (Loring and 
Erickson, 1987).
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Although the fate of neural crest cells has been challenged within broad regions of the 
pre-mi gratory neural crest, to date there is no information regarding the timing of 
commitment of cardiac neural crest cells to particular lineages. It is not known whether 
particular cells are predisposed to become mesenchymal cells of the pharyngeal arches or 
neuronal cells, or whether fate decisions are made according to the environment in which 
cardiac neural crest cells find themselves, which in turn may be regulated by the timing of 
their emigration from the neural tube (as suggested by the fate mapping experiments of 
Boot et al. (2002), or the somite level from which they leave the neural tube. An 
understanding of the temporal and spatial restriction of cell fate decisions and lineage 
relationships between cardiac neural crest cells would allow us to further understand the 
relationship of these cells to the signalling factors present in their environment and the 
differential interactions of cardiac neural crest cells with this environment that govern 
their development.
Cardiac Neural Crest Ablation
The cardiac neural crest is clearly essential to heart development as it provides cells in 
regions that are hotspots of congenital heart disease. The importance of the cardiac 
neural crest in heart development has been further illustrated by laser ablation of these 
cells prior to migration out of the neural tube. In cardiac neural crest-ablated embryos, 
heart development is abnormal in 90% of embryos surviving to E8-11. The most 
common defects involve abnormal development of the outflow tract (Kirby et al., 1985; 
Nishibatake et al., 1987).
The extent of the heart defect is dependent on the size of the ablation and its location: 
unilateral or bilateral ablations over 2 somite-lengths or more of the neural crest result in
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a high incidence of persistent truncus arteriosus, whereby the outflow tract of the heart 
fails to separate into its constituent aorta and pulmonary artery, and ventricular septal 
defects, where the interventricular septum is incomplete and an opening therefore exists 
between the left and right ventricles (Kirby et al., 1985; Besson et al., 1986; Nishibatake 
et al., 1987). If the ablation is less than two somite-lengths of the neural crest, the most 
common defects are again ventricular septal defects and also double outlet right ventricle, 
where the aorta and pulmonary artery are misaligned with the inter-ventricular septum 
and so both arise from the right ventricle (Besson et al., 1986). In all of these cases it 
appears that an error in the final stages of heart development occurs i.e. alignment of the 
septal structures of the heart and outflow tract and remodelling of the great vessels. 
Furthermore, even a small lesion of cardiac neural crest can result in substantial defects.
The incidence of heart defects in these ablation studies varies with the timing of the 
ablation: the highest incidence of heart defects occurs after ablations at HH stage 8 (and is 
correlated with a high incidence of overriding aorta) while ablations after stage 11 result 
in a very low occurrence of heart defects (Besson et al., 1986). The vast majority of 
neural crest cells migrate out of this region of the neural tube between stages 8 and 11, 
and so by this latter stage, most neural crest cells have already left the neural tube and are 
migrating towards the heart.
In the absence of cardiac neural crest cells, alterations in the heart and great vessels occur 
even before the time of septation of the heart (Bockman et al., 1987). By E3, abnormal 
remodelling of the arches has begun, with loss of bilateral symmetry and unusual 
enlargement or regression of some arches (Bockman et al., 1987). The quantity of 
mesenchyme in the arches is significantly reduced, so much so that in some cases,
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endothelium is in direct contact with epithelium. As a result, blood flow has to adjust to 
the abnormal environment and this has effects on development of the heart itself. 
Microcinephotography (Leatherbury et al., 1990) has shown that soon after neural crest 
ablation, the shape of the conotruncus is altered so that it is shorter and wider. The heart 
tube also undergoes incomplete looping - this is thought to disrupt subsequent events 
resulting in misalignment of the outflow vessels and valves with the interventricular 
septum. The truncal cushions are often incompetent. Functional changes occur, with 
many hearts exhibiting depressed contractility and a compensatory ventricular dilation. 
Further on in development, these hearts have reduced ejection fractions and their poor 
function is reflected in a decrease in embryo weight and oedema (Creazzo et al., 1994). 
Despite this decrease in embryo weight, the hearts themselves do not exhibit a change in 
weight, suggesting ventricular hypertrophy. The myocardium also exhibits defects in its 
contractile apparatus. There are further indirect effects associated with cardiac neural 
crest ablation. These include abnormal patterning of the coronary vasculature, such that 
either the right or left coronary artery is missing as well as changes in the patterning of 
branches of these main vessels that act to compensate for this loss (Hood and Rosenquist, 
1992). Since elements of the cardiac conduction system, namely the Purkinje fibres, rely 
on signals from the coronary arteries for recruitment from ventricular myocytes, defective 
coronary vessel development subsequently affects patterning of the cardiac conduction 
system (Hyer et al., 1999).
Other defects are associated with ablation of cardiac neural crest: the pharyngeally 
derived organs that receive contribution from the cardiac neural crest are affected, 
resulting in either absent or hypoplastic thymus, thyroid and/or parathyroids (Bockman 
and Kirby, 1984). Parasympathetic innervation is also impaired in cardiac neural crest-
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ablated hearts, though not to the extent that would be expected. After complete ablation 
of the cardiac neural crest, parasympathetic innervation of the heart is only impaired by 
approximately 30%, as measured by thymidine-labelled choline uptake (Kirby and 
Stewart, 1983). It was later discovered that compensation in ablated embryos is provided 
by cells from another region of neural ectoderm, the nodose placode. These cells 
normally provide neurons of the distal vagal ganglia i.e. sensory innervation, but in 
ablated embryos they can differentiate into parasympathetic ganglia, regenerating up to 
70% of the missing cells (Kirby, 1988). This group of cells also has the potential to 
become mesenchymal cells (though they do not generate this cell type under normal 
conditions) that can seed the pharyngeal arches and migrate into the outflow tract of the 
heart in ablated embryos, yet this ectomesenchyme is not capable of effecting complete 
conotruncal or aorticopulmonary septation (Kirby, 1988). This is probably due to the fact 
that cardiac neural crest cells migrate between stages 8 and 10, but cells of the nodose 
placode do not begin migration until HH stage 14 (DAmico-Martel and Noden, 1983) 
and therefore arrive late into the heart. These embryos do not survive beyond gestation. If 
the nodose placode is also ablated along with the cardiac neural crest, serious defects 
arise in the heart and outflow tracts of these embryos (Rosenquist et al., 1989): in half of 
these embryos, only one great vessel survives, a large undivided outflow vessel formed 
from aortic arch artery 3. Other arteries are ectopic or asymmetrical and hypoplastic and 
these embryos cannot survive beyond E12.
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Figure 1.3 Migration of cardiac neural crest cells, (a) Cardiac neural crest cells (blue) 
arise from the dorsal region of the neural tube between the otic placode and the caudal 
boundary of somite 3. (b) These cells migrate through pharyngeal arches 3, 4 and 6. 
(c) While some remain within the pharyngeal arches and develop as the smooth muscle 
cells of the tunica media and fibroblasts of the adventitia, other cells migrate towards the 
outflow tract of the heart. Here, these cells will populate the outflow tract septum, thus 
dividing the aorta and pulmonary artery.
The Role of Endothelin Signalling in Cardiac Neural Crest Development 
The use of quail/chick chimeras and immunohistochemical identification of cardiac 
neural crest cells and their progeny have elucidated the major pathways of migration 
(Fig. 1.3) that these cells take and the range of phenotypes that they generate in vivo. 
Furthermore, the phenotypes observed upon ablation of the pre-mi gratory cardiac neural 
crest have illustrated the essential role of this extracardiac source of cells for normal 
cardiac morphogenesis. A number of gene inactivations in the mouse have recapitulated 
these phenotypes, implicating a range of factors in the development of the cardiac neural 
crest. Components of the endothelin (ET) signalling pathway are expressed in the 
developing embryo in locations that suggest a role for these molecules in cardiac neural 
crest signalling and cardiovascular development. Furthermore, gene knockout of the ET^ 
receptor in the mouse generates the range of phenotypes seen upon cardiac neural crest 
ablation in the chick, with a high degree of penetrance. Consequently, ET signalling is 
hypothesized to have a role in the development of the cardiac neural crest and 
subsequent cardiovascular morphogenesis.
The ETs are a family of peptide hormones, first characterized by their potent 
vasoconstrictive properties (Yanagisawa et al., 1988). The family consists of three 
ligands, ET-1, -2 and -3 that are encoded by three different genes (Inoue et al., 1989). 
Mature ET-2 and ET-3 differ from ET-1 in their amino acid sequences by 2 and 6 amino 
acids, respectively (Inoue et al. 1989). The ET ligands bind to two classes of G-protein- 
coupled receptors, ET^ and ETg, with varying affinities: ET-1 has greater affinity for 
receptor ET^ than either ET-2 or ET-3, while all three ligands have similar affinities for 
receptor ETg (Arai et al., 1990; Sakurai et al., 1990; Sakamoto et al., 1993). The ET 
ligands are biologically inactive until they undergo a two-step proteolytic processing.
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This involves conversion of the precursor preproET, approximately, 200 amino acid 
residues long, to an intermediate “big-ET”, approximately 40 amino acids long, via a 
non-specific furin proteolytic reaction (Laporte et al., 1993). Formation of big-ET is 
followed by its cleavage to a mature, biologically active ET peptide of 21 amino acids. 
This second step is catalysed by endothelin-converting-enzyme (ECE), a member of the 
type II membrane-bound metalloprotease family (Xu et al., 1994; Emoto and 
Yanagisawa, 1995). Two isoforms of ECE have been identified, ECE-1 and ECE-2. 
Both enzymes catalyse the formation of ET-1 more efficiently than ET-2 or ET-3 in vitro. 
In the embryonic mouse heart, ECE-2 mRNA expression is restricted to the mesenchyme 
of the endocardial cushions (Yanagisawa et al., 2000). Although mice null for ECE-2 are 
healthy and apparently develop normally, when bred into an ECE-1 null background, 
these mice develop cardiovascular defects that are more severe than mice null for ECE-1 
alone, indicating at least partial functional redundancy between these enzymes. 
Importantly, in both ECE-1^ and ECE-1 '''\ ECE-2 '' mice, residual combined levels of 
mature ET-1 and ET-2 are detected and are depleted by about half of wild-type levels. 
This suggests that another protease is capable cleavage of big-ET precursors to produce 
mature ET ligands (Yanagisawa et al., 2000).
ET signalling components are expressed in a wide variety of tissues and cell types, 
including vascular cells and cardiac myocytes. They are also expressed by a range of 
non-vascular cells, particularly those of cranial and trunk neural crest origin (Sakamoto et 
al., 1991; Nataf et al., 1998; Yanagisawa et al., 1998a). The localization of ET ligands in 
close proximity to their receptors suggests that ET signalling occurs via local, paracrine 
interactions. This is further supported by data that show plasma levels of ET are usually 
much lower than the threshold concentrations required for pharmacological activity
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(Wagner et al., 1992). Binding of ET ligands to their receptors generates downstream, 
intracellular events characteristic of G-protein coupled receptors, including activation of 
adenylate cyclase, phospholipase A and phospoholipase C, the latter leading to increases 
in intracellular calcium concentrations and activation of protein kinase C (Simonson and 
Dunn, 1990; Simonson et al., 1990). The response to this signalling varies, depending on 
the target cell type. For example, the contraction of vascular smooth muscle cells, 
conversion of cardiac myocytes to Purkinje fibres, or the promotion of neural crest cell 
proliferation are all initiated in response to ET ligands (Yanagisawa et al., 1988; Lahav et 
al., 1996; Gourdie et al., 1998).
Expression patterns of all the components of the ET family have been analysed to some 
extent in the mouse and to a lesser extent in avian species and humans (Yanagisawa et al., 
1998a, 1998b) (Maemura et al., 1996) (Kempf et al., 1998) (Brand et al., 1998; Clouthier 
et al., 1998; Nataf et al., 1998; Nataf et al., 1998; Kanzawa et al., 2002). There is a 
general division of ET signalling such that ET^/ET-l expression predominates in the 
upper portion embryo and appears to be involved in craniofacial, cardiovascular and 
neuronal development, while ETg/ET-S expression predominates in the trunk and has a 
role in neurogenesis and pigmentation. This division however is not definitive and some 
overlap exists. As mentioned above, ET family members are often expressed by and in 
the vicinity of neural crest cells and their derivatives. Their role in neural crest 
development has been further supported by a number of lines of evidence, including gene 
inactivations in the mouse and pharmacological ET receptor inactivation in the chick. 
Since the ET^/ET-l signalling pathway predominates in cardiovascular development, 
details of the expression of these factors and their putative functions are described in 
more detail below.
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In the mouse and human embryo, neural crest cells express the ET receptor, ET^, as soon 
as they leave the neural tube (Brand et ah, 1998; Clouthier et al., 1998). The expression 
of ET^ receptor mRNA in the developing chick however does not begin until around E3, 
in the pharyngeal arches. In the pharyngeal arches, it is seen in the “ectomesenchyme”, 
that is, the ectodermally-derived mesenchyme (i.e. of neural crest origin) surrounding the 
aortic arteries (Maemura et al., 1996; Brand et al., 1998; Clouthier et al., 1998; Kempf et 
al., 1998; Nataf et al., 1998). Complimentary to ET^ expression, mRNA expression of 
the ET precursor, preproET-1, is found in regions of the pharyngeal arches surrounding 
neural crest cells, i.e. in the ectoderm, mesodermal core and endoderm of the arches as 
well as the endothelium of the arch arteries; this pattern of expression is found in both the 
chick and mouse (Brand et al., 1998; Clouthier et al., 1998; Kempf et al., 1998; Nataf et 
al., 1998; Yanagisawa et al., 1998a). There are little data regarding the subsequent 
expression of either ET^ or preproET-1 in the great arteries which develop from the 
caudal pharyngeal arches. However, in situ hybridisation analysis reveals that these 
genes are expressed in the developing heart: in the human, mouse and chick embryo, ET^ 
mRNA is found in the atrial, ventricular and outflow tract myocardium. (Brand et al., 
1998; Clouthier et al., 1998; Kempf et al., 1998; Kanzawa et al., 2002). In the mouse, 
preproET-1 mRNA is found in the endocardium of the outflow region, including the 
endocardial cushions (Kurihara et al., 1995; Clouthier et al., 1998). Nataf et al. (1998) 
have noted expression of preproET-1 mRNA in the chick heart up to E6, but they did not 
describe the tissue localization of this expression.
Elsewhere in the chick, ET^ is prevalent in the mesoderm of other organs, such as the 
bronchi and anterior gut (Kempf et al., 1998) and in the thyroid and parathyroid glands 
(Nataf et al., 1998). It is also found in the head region, in cranial ganglia (though only
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transiently, at E3 and E4) and at later stages of development in cephalic neural crest 
derivatives such as the mesenchyme of feather buds in the cephalic dermis and in the 
periocular muscles (Nataf et al., 1998). However, preproET-1 expression was not 
detected in the vicinity of ET^ expression in the cephalic region.
The major enzyme for conversion of preproET-1 to a mature, biologically active ET 
ligand is ECE-1. In the mouse, ECE-1 mRNA expression is found in the pharyngeal 
arches in both the mesenchyme and surface and arch artery epithelium (where it is 
colocalised with preproET-1) at E9.5. In the heart, ECE-1 is seen in the endocardium. In 
the head it is expressed in the mesenchyme adjacent to the neuroepithelium and elsewhere 
in the liver primordium and foregut (Yanagisawa et al., 1998a, 1998b). In the human 
embryo, ECE-1 mRNA is also expressed in the heart by all endocardial cells and by the 
endothelium of all arteries (Brand et al., 1998; Korth et al., 1999). In the chick embryo, 
whole mount in situ hybridization analysis demonstrates the presence of ECE-1 mRNA in 
the pharyngeal arches. In the heart it is expressed in restricted regions, namely by the 
endocardium and by the endothelium of coronary arteries and arterioles (Takebayashi- 
Suzuki et al., 2000).
Taken together, ECE-1 is expressed in areas in proximity to, or overlapping preproET-1 
expression, just as preproET-1 is generally found in the vicinity of ET^ expression. It has 
been hypothesized that the local restriction of these factors may set up a 
microenvironment for restriction of ET signalling (Clouthier et al., 1998; Yanagisawa et 
al., 1998a). A major question that arises from this hypothesis is whether this restricted 
signalling has implications for downstream events. Complimentary and restricted 
expression patterns of ET signalling factors in the pharyngeal arches, for example, may
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trigger inductive interactions, typical of other areas of epithelial-mesenchymal 
interactions in development. A prime example of this is in the developing limb, where 
expression of FGF in the apical ectodermal ridge, the outer ectodermal layer of the limb 
bud, provides mitogenic signals to the underlying mesenchyme to induce proximo-distal 
growth (Niswander et al., 1993; Ohuchi et al., 1997). In the pharyngeal arches, similar 
ectomesenchymal interactions likely take place. A number of studies have suggested the 
presence of signalling cascades in which epithelial secretion of ET-1 triggers expression 
of factors such as dHAND, Msx-1 and Dix genes (Thomas et al., 1998; Clouthier et al., 
2000). The cell biological mechanisms that may be induced by expression of such 
transcription factors in the developing arches and great arteries that arise from these 
arches, however, remain unclear.
The restricted expression of ET signalling components may also act to localize ET 
signalling to subsets of migrating cardiac neural crest cells. A similar scenario is evident 
in the developing myoeardium, where restricted ET-1 production in sub-endocardial and 
peri-arterial regions localizes the recruitment of myocytes to a conduction cell fate 
(Gourdie et al., 1998; Takebayashi-Suzuki et al., 2000). Clouthier et al. (1998) have 
suggested that the apposition of ETA and ET-1 expression in the developing arch arteries 
provides the inductive signals for subsequent arch remodelling. It is intriguing, however, 
to postulate further that the restricted expression of these factors in such regions results in 
selective signalling within sub-populations of the cardiac neural crest, thus providing a 
means to segregate cardiac neural crest lineages. Until now, this possibility has not been 
addressed.
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As previously mentioned, ET-3/ ETg signalling is largely restricted to the caudal regions 
of the embryo. Here, this signalling is essential for melanocytic development and enteric 
innervation of the distal colon (Baynash et al., 1994; Hosoda et al., 1994; Puffenberger et 
al., 1994). However ET-3 and ETg mRNAs have also been detected in some regions of 
the anterior half of the embryo. ETg receptor mRNA expression in the chick begins as 
early as HH stage 8 in neural crest cells as soon as they detach from the neural tube 
(Nataf et al., 1996). In the pharyngeal arches, ET^ mRNA is expressed by the 
endothelium of the aortic arch arteries, while in the heart it is present in the endocardium. 
Recently, a second ETg receptor, ETg 2, has been identified in avian species (Lecoin et 
al., 1998). Like ETg, ETg 2 has similar affinities for all three ET ligands. Its expression is 
considerably more limited than either ET^ or ETg and in the heart it is expressed only in 
the AV valve leaflets (Kanzawa et al., 2002). preproET-3 mRNA is expressed in the 
pharyngeal arches, though in contrast to preproET-1, which is expressed in the vicinity of 
neural crest cells, preproET-3 is expressed in the neural crest-derived ectomesenchyme 
(Nataf et al., 1998). Interestingly, despite the presence of ETg and preproET-3 in the 
heart and pharyngeal arches, mutations of these genes do not display defects in 
cardiovascular development (Baynash et al., 1994; Hosoda et al., 1994) but rather defects 
are restricted to the enteric innervation of the gut and pigmentation of the skin. Similarly, 
pharmacological antagonism of ETg receptors does not give rise to any of the 
cardiovascular or neuronal defects associated with ET^ receptor antagonism (Kempf et 
al., 1998). This suggests that ETg signalling is not functional, at least during the first half 
of development, within the cardiac neural crest population.
In contrast, targeted disruption of the ET^ gene in mice results in severe craniofacial and 
cardiovascular anomalies. In the head, abnormal bone structure due to cartilage defects
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are seen and result in constriction of the airways and subsequent death soon after birth. 
Additionally, ET^ null mice display defects in tongue, middle ear and thymus 
development (Clouthier et al., 1998). Furthermore, neural development is impaired, with 
the trigeminal and facial nerves not reaching the most distal regions of the arches. An 
analysis of the effects of ET^ inactivation on a range of transcription factors reveals that a 
lack of ET signalling reduces the expression of factors such as goosecoid, Dlx-2, Dlx-3, 
dHAND and eHAND in the ectomesenchyme of the pharyngeal arches, concomitant with 
impeded arch growth and elevated levels of apoptosis (Clouthier et al., 1998, 2000). It is 
not yet known whether all the above transcription factors act directly downstream of ET 
signalling or whether a coordinated network of signalling is involved. As mentioned 
above, one pathway of ET signalling has been suggested by Thomas et al. (1998), who 
postulate that ET-1, expressed by epithelia, stimulates ectomesenchymal expression of 
dHAND and subsequent regulation of Msxl expression in the developing arches. This 
hypothesis is based on analysis of ET-T '^ mice as well as dHAND' mice, in which, 
interestingly, increased levels of apoptosis of the arch mesenchyme were also observed in 
dHAND null embryos. Recently, a dHAND enhancer element has been identified that 
requires ET-1 signalling for activation and expression in the upper pharyngeal arches, 
possibly requiring the transcription factor Dlx6 as a mediator of this interaction (Charité 
et al., 2001).
At later stages of development, all ET^-deficient embryos have some form of 
cardiovascular defect. Most common are interruption of the aorta and tubular hypoplasia. 
Of the great vessels, fourth arch artery derivatives and the right subclavian artery are most 
profoundly affected and septation defects such as ventricular septal defects, double outlet 
right ventricle and persistent truncus arteriosus are commonly found (Clouthier et al.,
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1998). ET-1-deficient mice exhibit the same range of craniofacial abnormalities as seen 
in ETA-knockout mice (Kurihara, 1994). However, the penetrance of cardiovascular 
defects is incomplete in ET-1''' mice and no craniofacial or cardiovascular defects are 
seen in ET-1 heterozygotes. To test whether compensation from other ET isoforms may 
act in the absence of ET-1, neutralizing antibodies to the ET^ receptor were administered 
to pregnant heterozygotes, resulting in more penetrant and severe cardiovascular defects 
(Kurihara et al., 1994; Kurihara et al., 1995), suggesting that there is some functional 
redundancy between different ET ligands. Additionally, gene inactivation of ECE-1 in 
mice results in craniofacial and cardiovascular defects. Importantly, defects in 
development of enteric neurons and melanocytes are also observed (Yanagisawa et al., 
1998b), recapitulating the phenotypes of ET  ^ and ET3 null mice and illustrating the 
necessity of ECE-1 not only for production of mature ET-1, but also for production of 
mature ET-3 ligand. The cardiovascular phenotypes observed in ET^, ECE-1 and ET-1 
deficient embryos are typical of the abnormalities observed in the chick embryo after 
cardiac neural crest ablation. Coupled with the expression of ET^, ECE-1 and preproET- 
1 mRNA by and in the vicinity of cardiac neural crest cells, this strongly implicates ET 
signalling as having an important role in normal development of the cardiac neural crest 
and its derivatives.
Further analysis of cardiac neural crest cells in ET^- and ECE-1-deficient embryos 
provides some clues as to the role of ET signalling in cardiac neural crest development. 
This reveals that early migration of these cells is not strikingly affected: neural crest cells 
are seen along typical migratory pathways, in streams from the neural tube to pharyngeal 
arches 3,4 and 6 (Yanagisawa et al., 1998a, 1998b). The first defect in the arches is 
detected at El 1.5 where, instead of symmetrical patterns of pairs of arch arteries, arch
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artery 3 is enlarged in ET/'' embryos and arch arteries 4 and 6 are narrowed. 
Subsequently, abnormal patterns of regression and persistence of arch arteries as well as 
abnormal branching of these arteries is seen (Yanagisawa et ah, 1998a). This abnormal 
remodelling results in great arteries malformations and defects typical of abnormal neural 
crest cell development (i.e. double outlet right ventricle, persistent truncus arteriosus, 
etc.). This study illustrates the importance of ET-signalling in maintaining aortic arch 
artery development. Although ET signalling does not appear to be essential for initial 
pharyngeal arch formation, subsequent remodelling of the arch arteries is defective in 
mice in which this signalling is disrupted. Again, this correlates with the phenotype of 
chick embryos in which the cardiac neural crest population has been ablated, since this 
does not affect formation of the pharyngeal arches (Waldo et al., 1996). The arches form 
from with an inner endodermal lining and an outer ectodermal layer, although these two 
tissues are directly apposed in the pouches. The endothelium of the aortic arch arteries is 
intact at early stages, but later in development, the patterning of these arteries is disrupted 
and again abnormal persistence and regression of these arteries is observed (Bockman et 
al., 1989; Waldo et al., 1996).
In the chick embryo, pharmacological blockade of ET receptor signalling compliments 
the results of gene-targeting studies in the mouse. Upon administration of antagonists to 
ETa, a range of defects arise (Kempf et al., 1998). In ETA-disrupted embryos, 
abnormalities are found in the heart, including septal defects and abnormal remodelling of 
the great vessels. Craniofacial abnormalities are also seen, as well as hypoplasia of the 
thyroid and thymus. This study also highlights the time-point of ET-signalling that is 
crucial at least for normal craniofacial development: administration of ETa antagonists at 
E2 induces the maximum penetrance of defects, but treatment at 96 hours (E4) results in
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no craniofacial abnormalities. These investigators propose that the likely time-lag for full 
exposure to the antagonists and development of subsequent abnormalities is 
approximately 24 hours. They therefore hypothesize that the developmental time- 
window in which ET^ signalling is essential in these pharyngeally-derived structures is 
between E3 and E4 in the chick (Kempf et al., 1998).
The expression patterns of ET^, ET-1 and ECE-1 in the pharyngeal arches and heart 
strongly suggest the involvement of ET signalling in neural crest development, with 
subsequent effects on craniofacial and cardiovascular development. This is further 
supported by gene inactivations and receptor antagonism in the mouse and chick, 
respectively. However, the cell biological mechanisms regulated by ET signalling remain 
unknown. A role for ET signalling in post-migratory development of neural crest cells is 
proposed, since early migration of these cells appears normal, yet how later events in 
craniofacial, and particularly cardiovascular development are affected by ET signalling 
remains somewhat mysterious. Some insight has been gained from in vitro analysis of 
trunk neural crest cells and the effects of exogenous ET-3 ligand on these cells. ET-3 
promotes proliferation of trunk neural crest cells, although not uniformly: there is
selective promotion of the melanocyte cell lineage and, to a lesser extent, the glial cell 
lineage in cultures of avian trunk neural crest cells (Lahav et al., 1996; Lahav et al., 
1998). However, there have been no studies on the in vitro effects of ET signalling on 
cardiac neural crest development. Analysis of ET action on vascular cell types has 
demonstrated that ET is mitogenic for vascular smooth muscle cells (Ziche et al., 1995). 
Whether ET-1 expression promotes proliferation of vascular smooth muscle cells of 
cardiac neural crest origin during embryonic development, or whether ET signalling plays
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a significant role in other aspects of cardiac neural crest development, such as cell 
differentiation and survival, is not yet known.
In recent years, the ETs have received much attention due to their putative role in cardiac 
disease. In the adult heart, a number of pathologies, including hypertension, ischaemia, 
myocardial changes and vascular remodelling are often associated with elevated levels of 
both circulating and tissue levels of ET and these levels are often an indicator of the 
degree of organ damage (Kobayashi et al., 1999; Ueno et al., 1999; Zolk et al., 1999). 
Currently, research into ET antagonists as treatments for heart disease is a burgeoning 
field, though the complex and often opposing effects of the ET^ and ETg receptors have 
complicated the development of successful treatments (reviewed in Suresh et al., 2000; 
Hunley and Kon, 2001). There is a wide range of stimuli for ET production, including 
angiotensin II, thrombin, interleukin-1, TGpp and physical stimuli, including pressure 
and shear stress (Malek and Izumo, 1992; Morawietz et al., 2000; Sugo et al., 2001; van 
Wamel et al., 2001; Watanabe et al., 2001). In the mouse and chick embryo, disruption 
of ET signalling, as outlined above, gives rise to a wide range of defects that mimic those 
seen in syndromes such as CATCH-22 (comprising of a range of defects, including 
cardiac anomaly, anomalous face, thymus hypoplasia/aplasia, cleft palate and 
hypocalcaemia; Wilson et al., 1993), and therefore mutations of ET genes may be 
involved in the aetiology of such syndromes. Furthermore, disruption of ETg signalling 
generates defects of the enteric nervous system that recapitulate those abnormalities 
observed in patients with Hirschsprung’s disease (Baynash et al., 1994), primarily, failure 
of innervation of the distal colon. In fact, a missense mutation in patients with 
Hirschsprung’s disease has been identified within the ETg gene on chromosome 13 
(Puffenberger et al., 1994). Research into the action of ET signalling is therefore not only
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essential for elucidation of mechanisms involved in cardiovascular defects due to cardiac 
neural crest disruption, but also to diseases resulting from abnormalities in trunk neural 
crest-derived tissues and furthermore, cardiovascular disease in the mature heart.
In summary, experiments over the last three decades have identified the cardiac neural 
crest as an essential population for development of the vertebrate heart. The use of 
various cell labelling techniques have allowed the elucidation of the migratory pathways 
of these cells in a number of species, while cardiac neural crest ablation studies have 
emphasized the necessity of this cell population for the later stages of cardiac 
morphogenesis. Beyond our knowledge of the migratory and differentiative capacities of 
the cardiac neural crest, significant progress has been made in the identification of 
signalling factors that govern the development of these cells. Yet, what remains to be 
clearly determined is the specific role and that these factors play in influencing the 
mechanisms of cardiac neural crest cell proliferation, differentiation, survival, etc. 
Additionally, analysis of the spatial and temporal requirements of each of these factors 
for cardiac neural crest development will aid in the elucidation of the sequence of 
interactions and cell fate decisions that generate particular lineages of the cardiac neural 
crest.
Extracardiac Sources of Heart Cells: The Proepicardial Organ
As well as the cardiac neural crest population, a second extracardiac source of cells 
essential to normal heart development is the proepicardial organ (PEO). PEO-derived 
cells give rise to the epicardial covering of the heart, cells of the coronary vasculature and 
fibroblast populations. Additionally, the PEO-derived epicardium has more recently been
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implicated as having a separate role in patterning and/or morphogenesis of the 
myocardium.
The Proepicardial Organ and Coronary Vasculogenesis
Just as the purpose of the heart is to provide a blood supply to the rest of the body, the 
heart itself also requires the delivery of oxygenated blood to its own tissue. During early 
embryogenesis, the myocardium of the heart is thin enough that diffusion alone is 
sufficient as a means of oxygen supply. However, as the heart continues to grow and the 
myocardium thickens, it must develop a more sophisticated means of blood supply to 
provide oxygen and nutrients to the deeper layers of the myocardium. As in the systemic 
circulation, arteries, veins and capillaries are generated that connect to the aorta. This 
occurs largely through the process of vasculogenesis (de-novo formation of blood 
vessels) rather than angiogenesis (sprouting of new vessels from existing vessels) 
(Mikawa and Fischman, 1992). Congenital defects in coronary vessel development are 
potentially damaging, though their effects on cardiac function have only been poorly 
characterized. Interestingly though, there is quite a lot of variation in patterning of the 
coronary vasculature in both animals and humans. Despite dramatic abnormalities in 
vessel patterning, humans often live normally and these differences go undetected until 
found by chance.
Some debate originally arose as to the origin of the coronary vasculature. Le Lièvre and 
Le Douarin (1975) had shown with the use of quail/chick chimera experiments that cells 
of the cardiac neural crest provide smooth muscle cells to the great vessels of the heart. 
Since the blood vessels of the heart connect to the systemic blood supply through the wall 
of the aorta, whose tunica media layer is primarily composed of cardiac neural crest-
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derived smooth muscle cells, it was thought that the smooth muscle of the coronary 
vasculature may also be of neural crest origin. However, again using the quail/chick 
chimera technique, Waldo et al. (1994) established that the tunica media of the coronary 
arteries was not cardiac neural crest-derived. Despite this, clusters of cardiac neural crest 
cells were associated with the tunica media surrounding the ostia, or origins, of the 
definitive coronary artery stems. Furthermore, parasympathetic neurons and glia, also of 
cardiac neural crest origin are associated with sites of right and left coronary artery 
connections to the aorta, but not with the non-coronary sinus where connections to the 
aorta occur, but eventually regress. This suggested that though they might not directly 
contribute to coronary vessel formation, cardiac neural crest cells may be important for 
patterning of the coronary vasculature. This was confirmed in studies in which the 
cardiac neural crest population was ablated, resulting in abnormal development of the 
coronary arteries, often involving loss of the left or right coronary artery stem, and a 
general decrease in coronary artery density in these embryos (Hood and Rosenquist, 
1992; Hyer et al., 1999).
Alternative to the neural crest, another proposed source of the coronary vasculature was 
the PEO. Mikawa and Fischman (1992) used retroviral cell tagging and found that 
injection of the myocardium at or prior to HH stage 15 does not label any cells of the 
coronary vasculature, indicating that coronary progenitors are not yet present in the heart 
at this time. However, injection at or after HH stage 17 gives rise to clusters of cells, in 
the myocardium. At low titres, these clusters contain only one of a number of cell types, 
either myocytes, smooth muscle cells, endothelial cells, or interstitial connective tissue 
cells. Spirally arranged cells that were smooth muscle alpha actin-positive were found in 
the tunica media layer of arteries and arterioles. Interestingly, these clones were restricted
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to segments of a coronary artery, never the entire length of an artery, illustrating the 
formation of coronary vessels from discontinuous units, likely derived from a number of 
progenitor cells. Later studies using both retroviral and vital dye lineage analysis as well 
as quail/chick chimeras tracked the progenitors of these cell types back to the PEO, 
showing that epicardial cells can give rise to coronary vascular smooth muscle cells, 
vascular endothelial cells perivascular and intermyocardial fibroblasts (Poelmann et al., 
1993; Mikawa and Gourdie, 1996; Dettman et al., 1998). Furthermore, it was shown that 
even in the PEO, prior to outgrowth, progenitors are present that will only give rise to 
coronary smooth muscle cells, as evidenced by caldesmon-positivity and once again, 
these progenitors generate smooth muscle cells along only a portion of a single vessel 
(Mikawa and Gourdie, 1996).
As further confirmation of the PEO as the source of coronary vessels. Manner (1993) 
employed a method of PEO outgrowth inhibition, which prevented formation of the 
epicardium and resulted in chick embryos lacking a coronary vasculature. Similarly, 
genetic inactivations of VCAM-1 and integrin a4 in the mouse result in the lack of an 
epicardium and subsequent absence of coronary vessels.
As the epicardium forms, some cells of this tissue layer will undergo epithelial-to- 
mesenchymal transformation, delaminating from the epicardium and moving into the sub­
epicardial space. In one particular region, adjacent to the AV sulcus, the epicardium is 
especially thick and it is here that coronary vessels first begin to form (Viragh and 
Challice, 1981). Mesenchymal cells in the sub-epicardial space coalesce to form 
endothelial channels and subsequent nascent vessels. Surrounding mesenehymal cells are 
then recruited to these vessels and differentiate into smooth muscle cells. Fibroblasts are
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also recruited to form the adventitia of these vessels. This occurs in a basal-to-apical 
manner i.e. from the main left and right coronary arteries at the point where they connect 
to the base of the aorta, to the posterior (or “apical”) region of the heart and the more 
distal branches of the vasculature. A network of vessels therefore develops that ramifies 
throughout the subepicardium of the entire heart. Other epicardially-derived cells will 
invade the underlying myocardium, beginning at HH stage 26, and similarly form vessels 
within the myocardial wall (Vrancken Peeters et al., 1997, 1999). Mikawa and Fischman 
(1992) utilized retroviral cell tagging techniques to demonstrate this process to be largely 
vasculogenic, rather than arising from outgrowth from the aorta. Discontinuous clusters 
of vessels eventually connect to form a closed coronary system.
Despite the necessity of a vascular system that penetrates all regions of the heart to 
contact practically every myocyte, there is a surprising amount of variation in the 
patterning of the coronary vessels. The establishment of multiple connections of the 
vasculature, from a peri-truncal ring to the aorta, begins at E7.5 in the chick embryo 
(Bogers et al., 1989; Wang et al., 2001). Generally, only two final connections are 
usually maintained, one from the left coronary sinus and a second from the right, however 
in 50% of humans, a third artery also remains (Hurst, 1994). The mechanism for the 
persistence of some arteries and degeneration of others that contact the aorta remains 
unknown, although an interaction with neighbouring cardiac neural crest cells localized to 
sites of the definitive coronary arteries has been implied, as described above. 
Additionally, it appears that the recruitment of smooth muscle cells to these arteries may 
determine whether or not they persist (Vrancken Peeters et al., 1997).
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From these aortic connections, the two main branches, the left and right coronary arteries, 
emanate and develop. Both arteries branch to circle the AV region with the circumflex 
artery, while a branch of the left coronary artery also generates the anterior descending 
artery which courses along the interventricular groove of the heart. From these, a series 
of intramural arteries penetrate the myocardial wall. Again, much variation is seen here 
which does not appear to be detrimental to development. The most distal regions of the 
coronary vasculature, the capillaries, ramify throughout the myocardium so that virtually 
every myocyte is connected to the coronary blood supply. Finally, this vascular network 
connects to the systemic circulation at the base of the aorta. Final formation of a closed 
coronary vascular system occurs at E14 (Rychter and Ostadal, 1971).
The Origin of the Epicardium
Clearly, the PEO and subsequent epicardium have an important role in cardiac 
morphogenesis, providing a means of blood supply to the myocardium of the heart, as 
well as having a putative role in development of the myocardium itself. Much 
investigation of this important source of cardiac cells has therefore been undertaken for 
over a century.
For many years, the epicardium was thought to develop concurrently with the 
myocardium from the outer epithelium of the early heart tube. This cell layer was 
consequently designated the “myoepicardium” and epicardial cells were thought to 
develop in situ through dedifferentiation from the myocardium, to give the outer covering 
of the heart (Bruno, 1918; Gould, 1953). This hypothesis was generally accepted well 
into the second half of the twentieth century, despite a number of earlier reports that 
contradicted this theory. Wilhelm His (1885, quoted in Horstadius, 1950) and, a few
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years later, Kurkiewicz (1909) proposed that the “myoepicardium” consisted only of 
myocardial cells. His claimed that epicardial cells were of an endocardial origin, while 
Kurkiewicz claimed that an extracardiac source, namely the sinus venosus, gave rise to 
the epicardium.
It was not until fifty or so years later that Kurkiewicz’s paper was rediscovered and 
reinvestigated. With the advent of electron microscopy in the 1960’s, Kurkiewicz’s 
observations were confirmed by the studies of Manasek (1968, 1969a). This study of the 
ontogeny of epicardial development with both light microscopy and transmission electron 
microscopy showed that at early stages of tubular heart formation (HH stages 12-15) the 
outer epithelial layer contains a largely homogenous population of muscle cells, 
containing myofibrils. By HH stage 17, epicardial cells appear, initially covering a small 
portion of the heart as a discontinuous sheet. These cells contain neither myofibrils, nor 
glycogen pools, as seen in myocytes, and are separated from the myocardium by a layer 
of extracellular matrix. The epicardial cells eventually cover the entire heart tube by
around HH stage 24. Since then, this area has been studied, largely through a 
combination of light microscopy and transmission and scanning electron microscopy, to 
determine the sequence of events by which cells migrate from the PEO to the heart and 
subsequently envelop the myocardium. The PEO originates in the sinus venosus, which 
is incorporated into the dorsal wall of the pericardial cavity, just above the liver 
primordium (Viragh and Challice, 1981; Manner, 1992). PEO cells arise from and are 
continuous with the mésothélium of the sinus venosus (Ho and Shimada, 1978). These 
PEO cells are themselves mésothélial, transforming from the cuboidal cells of the 
coelomic lining, and underlying mesenchymal cells, separated by substantial amounts of 
extracellular matrix (Viragh et al., 1993). Protrusions from the sinus venosus appear as
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early as HH stage 14 (Hiruma and Hirakow, 1989; Manner, 1992) and then multiply and 
extend villi, towards the heart, giving a cauliflower-like appearance.
By HH stage 17, many of these villi have contacted the heart (Manasek, 1968; Manner,
1992). Upon contact with the heart at the dorsal aspect of the atrio-ventricular groove, 
cells advance on each side of the ventricle in a radial fashion, with long processes 
attaching to the myocardial surface (Manasek, 1968; Ho and Shimada, 1978). By HH 
stage 21 these two leading edges fuse, encircling the ventricle and then extend cranially 
and caudally to cover the entire heart by HH stage 24 (Manasek, 1968; Ho and Shimada, 
1978). A similar process of epicardial development has been shown to occur in the 
murine embryo as in the chick (Viragh and Challice, 1973; 1981; Komiyama et al., 1987). 
In the dogfish, however, epicardial covering of the heart occurs in a rather different 
manner, with clumps of PEO-derived cells apparently “floating” freely towards the 
myocardium. This raises the interesting possibility that PEO outgrowth occurs in a 
directed manner as a result of myocardially-derived signals, most likely emanating from 
the AV groove. This has been suggested by recent in vitro co-culture experiments with 
chick PEO and myocardial explants. Furthermore, careful histological analysis of the 
region between the PEO and tubular heart in the chick has demonstrated the presence of 
an ECM-rich scaffold between these two tissues, a likely bridge for PEO migration that 
allows cells to traverse this acellular space without deflection due to the peristaltic 
contractions of the beating heart (Patrick Nahimey and Donald Fischman, personal 
communication).
Epicardial cells contain tonofilament bundles and so an anti-cytokeratin antibody has 
been successfully used to immunostain cells of the PEO and epicardium (Viragh et al.,
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1993), while myocytes remain cytokeratin negative. Vrancken Peeters et al. (1995) used 
this antibody in the quail embiyo to confirm the data from histological and microsopic 
analysis. They showed that a cluster of cells located between the caudal surface of the 
sinus venosus and the coelomic wall are anti-cytokeratin positive and are therefore 
thought to represent the primordium of the PEO. Within this PEO, villous projections 
extend towards the heart, contact the myocardium and these cells migrate as a layer over 
the surface of the heart, as shown previously (Fig 1.4).
The Epicardium and Myocardial Morphogenesis
As well as providing cells of the coronary vasculature, a role for the epicardium in 
myocardial morphogenesis has been suggested by PEO ablation and inhibition studies in 
the chick embryo, and genetic inactivations in the mouse which impair epicardial 
development. Insertion of an eggshell membrane barrier between the PEO and heart tube 
at E3 in the chick physically inhibits PEO cell migration (Manner, 1993). This gives rise 
to a number of cardiac defects, including thinning of the ventricular myocardial wall, 
abnormal heart looping and ventricular septal defects, as well as embryonic lethality, 
likely due to impaired cardiac function. The fact that these abnormalities arise prior to 
the onset of coronary vasculogenesis suggests a separate mechanism by which the 
epicardium acts on the myocardium. This role appears to be concerned with patterning of 
the myocardium.
These findings correlate with a number of gene inactivations in the mouse which give rise 
to similar cardiac phenotypes. Mice deficient in VCAM-1, for example, lack an 
epicardium and display other heart defects, including thinning of the compact layer of the 
ventricular myocardium and the interventricular septum (Kwee et al., 1995). Similarly,
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mice with a null mutation in the gene for the a4 integrin subunit also lack an epicardium 
and coronary vessels (Yang et ah, 1995). The integrins a4pl and a4p7 are binding 
partners for VCAM-1 (Elices et al., 1990). Importantly, the a4 integrin is normally 
expressed in the PEO and epicardium, as well as in endocardial cushions and the outflow 
tract of the heart (Yang et al., 1995; Pinco et al., 2001), while VCAM-1 is expressed in 
the myocardium (Kwee et al., 1995), suggesting an essential interaction between these 
two cell adhesion factors, possibly for attachment of the epicardium and myocardium to 
each other.
To date, although significant progress has been made in dissection of the morphological 
processes involved in envelopment of the myocardium by the epicardium, many 
questions remain to be answered, particularly concerning the molecular interactions and 
the extent of cross-talk between these two tissue layers. Clearly, the presence of the 
epicardium is necessary for normal development of the myocardium. However, although 
a range of genes are expressed in the myocardium or epicardium, often with 
complimentary expression patterns in the two layers, relatively little is known about the 
nature of the signalling events and the mechanisms of influence and interaction between 
these tissues. Just as the endocardium appears to exert a mitogenic or survival-promoting 
influence over development of the trabeculated myocardium, it has been suggested that 
the epicardium promotes the survival and/or proliferation of myocytes of the compact 
myocardium, yet the precise mechanisms involved in this epicardial-myocardial cross­
talk remain to be deduced.
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Figure 1.4 Epicardial covering of the heart. (A-F) scanning electron micrographs 
of chick embryos at HH stages 16 (A), 17(B), 18+ (C), 19 (D), 21 (E) and 24 (F).
(A) Cauliflower-like villous protrusions from sinus venosus. (B) Villi attach to dorsal 
wall of looping heart tube. (0) A second tissue bridge forms between the sinus 
venosus and the dorsal wall of the presumtpive ventricle (asterisk). (D-F) The 
epicardium migrates over the heart (dotted line, leading edge). A, primitive atrium; 
V, ventricular loop; O, outflow tract; LI, liver. Scale bars, 200pm. Adapted from 
Manner et al. (2001).
Thesis Rationale
The work outlined in this thesis attempts to dissect the roles of the two major extracardiac 
regions, the cardiac neural crest and PEO, in cardiovascular development. The discovery 
that cells of the neural crest contribute to normal heart development took place almost 
two decades ago (Kirby et al., 1983). Since this time, the quail/chick chimera system has 
provided an invaluable tool for the study of migration patterns of these cells in vivo and 
the precise pathways of cardiac neural crest migration have been established (Phillips et 
al., 1987; Waldo et al., 1998). This technique however does not provide a means to 
modulate cardiac neural crest-specific signalling for elucidating the mechanisms that 
dictate the development of these cells. Similarly, the more recent development of 
transgenic mouse lines in which lacZ expression is driven in the cardiac neural crest cell 
population has allowed the study of cardiac neural crest cells in a mammalian system (Lo 
et al., 1997; Serbedzija and McMahon, 1997; Li et al., 1999; Jiang et al., 2000), yet this 
approach does not specifically target the cardiac neural crest population. Again, 
therefore, this system cannot be utilized to fully understand the mechanisms underlying 
cardiac neural crest cell development.
The use of retroviral-mediated gene transfer provides a valuable tool for cardiac neural 
crest cell-specific targeting and tracing in the readily accessible avian embryo. 
Furthermore, this system can be used to alter the expression of factors by cardiac neural 
crest cells in vivo, thus providing a means to elucidate the cell biological mechanisms that 
are influenced by the expression of such factors. Since mouse knockout models and in 
vitro studies have strongly implicated the ET signalling pathway in various aspects of 
neural crest cell development, we have chosen to modulate this pathway by retroviral- 
mediated overexpression of preproET-1, the precursor of mature ET-1 ligand, in the
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cardiac neural crest population. Changes in the processes of cell migration, proliferation, 
survival and differentiation upon preproET-1 overexpression will provide insight into the 
potential mechanisms by which ET acts to control this development. This analysis, 
together with examination of the spatial and temporal localization of ET family members 
will clarify the timing and regions in which ET signalling influences cardiac neural crest 
cell development.
Understanding the timing and localization of the influence of ET signalling, or any other 
signalling pathway, on cardiac neural crest development requires a full understanding of 
the stages of segregation of cardiac neural crest cell lineages. This information, coupled 
with the known expression patterns of signalling factors, provides a basis for 
understanding the spatial and temporal relationship between these factors and the stage of 
development of an individual cardiac neural crest cell. Studies are planned to trace the 
lineage of individual cardiac neural crest cells, from the time of emigration from the 
neural tube, to migration through the pharyngeal arches, and possibly beyond this to their 
colonization of the heart. A retroviral vector encoding the lacZ gene is already available 
and has been used previously for cell lineage analysis in the chick embryo (Mikawa and 
Fischman, 1992) and therefore a second, alkaline-phosphatase expressing retrovirus has 
been constructed to compliment this and aid in determining the clonal boundaries of 
labelled cells. Future studies to infect small numbers of cardiac neural crest cells with 
such viruses encoding histogenic markers, combined with immunochemical markers to 
determine the cell types generated by labelled cells will establish the timing of cell fate 
determination in the cardiac neural crest population.
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The final aim of the work outlined in this thesis concerns the influence of the epicardium 
on development of the myocardium. Mouse models of epicardial dysmorphogenesis as 
well as physical inhibition of PEO outgrowth in the chick embryo generate cardiac 
abnormalities, most prominently in the ventricular myocardium. Although the role of the 
epicardium as the source of cells of the coronary vasculature has been well established, its 
role in maintenance of the compact myocardial wall has yet to be fully characterized. 
The set of experiments described herein are aimed at understanding the cell biological 
processes that are altered in the absence of the epicardium. This study provides a new 
level of understanding of the interaction between the myocardium and the epicardium, 
which in turn will aid in the elucidation of the epicardially-derived signalling factor(s) 
that are essential to this process.
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Chapter 2: Materials and Methods
Preparation of RNA Probes for In Situ Hybridisation
Digoxigenin (DIG)-labelled riboprobes were in vitro transcribed from linearised cDNA 
templates using standard protocols (Sambrook and Russell, 2001). ET^ riboprobes were 
made from a EcoRI/Spel cDNA fragment encoding a 316 bp region of the 3’ UTR 
(Kanzawa et al., 2002). ECE-1 riboprobes were transcribed from a full-length cDNA 
clone (Takebayashi-Suzuki et al., 2000). After transcription, ECE-1 riboprobes were 
alkaline hydrolysed into approximately 300 bp fragments by treatment with 40mM 
NaHCOg and 60mM Na2C0 3  at 60°C, 13 minutes. The hydrolysis reaction was stopped 
with lp.1 (0.5% of reaction mixture) of 100% acetic acid. Riboprobes were precipitated 
with 0.1 volumes of 3M sodium acetate and 2.5 volumes of 100% ethanol. After 
centrifugation at 4°C for 10 minutes, pellets were washed with 70% ethanol, air-dried and 
resuspended in diethylpyrocarbonate-treated water. Analysis of size and concentration of 
nucleic acid solutions was performed by agarose gel electrophoresis of samples.
In Situ Hybridisation
Whole embryos at embryonic day (E) 4 and hearts at both E6 and ElO were dissected 
while removing the amniotic and chorionic membranes. Samples were fixed in 4% 
paraformaldehyde (PEA) in phosphate-buffered saline (PBS) overnight at 4°C and rinsed 
in PBS. Samples were processed for whole mount in situ hybridisation (based on the 
methods of Henrique et al. (1995)) as follows: to improve penetration of solutions, holes 
were poked in the forebrain and neural tube of E4 embryos, and E6 and ElO hearts were 
sliced in half frontally. Samples were treated with Proteinase K (20 minutes) at a 
concentration of 10p,g/ml for E4 embryos, 30p,g/ml for E6 hearts and 70p,g/ml for ElO
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hearts. Embryos were post-fixed with 4% PEA and 0.1% glutaraldehyde in PBS, samples 
were rinsed with PBS, preincubated with hybridisation mixture (50% formamide (Huka, 
Germany), 0.5% CHAPS (Sigma, Missouri), 50p,g/ml yeast RNA (Sigma), 1.3X SSC 
(pH5), 5mM EOT A, 0.2% Tween-20 (Sigma), lOOpg/ml heparin (Sigma)) for at least 1 
hour at 65°C and reacted overnight at 65°C with Ipg/ml DIG-labelled RNA probe. After 
repeated washing in hybridisation mixture at 65°C and blocking in a solution of 2% 
blocking reagent (Roche), 2% normal goat serum in MABT (lOOmM maleic acid (Sigma), 
15mM NaCl, 0.1% Tween-20 (Sigma), pH 7.5), samples were incubated overnight with 
alkaline phosphatase-conjugated anti-DIG antibody (Roche; 1:2000 dilution in blocking 
solution). In some cases, the antibody was pre-absorbed with embryonic powder prepared 
from whole E8 embryos to reduce background. Samples were washed in MABT at room 
temperature for at least 3 hours or overnight to remove unbound antibodies. Samples were 
then rinsed three times in NTMT (lOOmM NaCl, lOOmM Tris-HCl, pH 9.5, 50mM MgCl2, 
0.1% Tween-20) and incubated in 175|ig/ml 5-bromo-4-chloro-3-indolyl phosphate 
(BCIP, Roche) and 340p,g/ml 4-nitro blue tétrazolium chloride (NBT, Roche) in NTMT, 
for detection of alkaline phosphatase, at room temperature until colour developed. Some 
stained samples were refixed in 4% PEA and embedded in Paraplast (Oxford Labware, 
Missouri) for sectioning at 10pm, as described below.
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Retroviral Vectors
The pCXL viral construct is a replication-defective variant of spleen necrosis virus (SNV) 
encoding lacZ which is used as a reporter gene (Mikawa et al., 1991). pCXIZppET 
encodes the full coding region of the human preproET-1 cDNA (Yanagisawa et al., 1988) 
as well as lacZ, separated by an internal ribosome entry site (Takebayashi-Suzuki et al., 
2000).
Generation of an Alkaline Phosphatase-Expressing Retroviral Vector 
A replication-incompetent retroviral vector expressing alkaline phosphatase (AP) was 
constructed by excising the 1.93 kb AP insert of pRCASBP(A) (Fekete and Cepko, 1993) 
at the Clal sites. The AP insert was then ligated into the Clal site of pJDp', a spleen 
necrosis virus-based replication-defective vector (Dougherty and Temin, 1986). Prior to 
ligation, linearised vector DNA was treated with alkaline phosphatase (Promega, 
Wisconsin) to remove terminal phosphate groups and prevent self-ligation. Ipl of alkaline 
phosphatase was added to Ipg of linearised pJDp' (37°C, 20 minutes). The ligation 
reaction was performed using 1 U of T4 DNA ligase and ligation buffer (Promega, 
Wisconsin) in a 25\i\ reaction mixture (14°C, overnight). Optimal vector: insert ratio was 
determined to be 1:5.
Super-competent DH5a E.coli (Gibco BRL, Maryland) were transformed by adding 20pl 
of ligation mixture to 200p,l of freshly thawed cells. The cells were incubated on ice for 
30 minutes, heat-shocked at 42®C for 45 seconds and incubated on ice again for 2 minutes. 
The cells were then spread onto Luria-Bertani (LB) agar plates containing lOOjxg/ml 
carbenacillin (Sigma) and incubated overnight at 37°C. Colonies were picked from the 
plates and added to 3ml of LB broth and incubated overnight at 37°C with shaking.
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Small-scale preparation of plasmid DNA was performed via alkaline lysis using the 
Qiagen “Miniprep” kit (Qiagen, California), according to the manufacturer’s instructions. 
To verify AP insert was successfully ligated into the pJDp- vector and to select clones 
with the AP insert in the correct orientation, restriction endonuclease digests were 
performed and samples electrophoresed through agarose gels to analyze the size of DNA 
bands generated. One clone with the AP insert in the correct orientation was selected and 
named pCXAP.
To generate a stably transfected cell line producing the alkaline phosphatase-expressing 
virus, pCXAP DNA was transfected into D17.2G packaging cells (Dougherty and Temin, 
1988) as follows: D17.2G cells were plated in 6-well plates (Becton Dickinson) at a 
concentration of 2x10^ cells per well the day before transfection. Cells were cultured in 
Dulbecco’s modified Eagles Medium (DMEM) supplemented with 7% foetal bovine 
serum, 1% glutamine and 1% penicillin and streptomycin (Fisher Scientific, 
Pennsylvania). The following day, lOjxg of vector DNA plus Ipg of a second plasmid 
encoding neomycin resistance (pGEM-Neo) was added to a 15 ml tube containing 250pl 
of 2x HEPES-buffered saline. To this tube, 250p,l of 250mM CaClj solution was then 
added drop wise with shaking. The reaction mixture was left at room temperature for 30 
minutes. The entire contents of the tube was added drop wise to one well of packaging 
cells and incubated for at least 6 hours to overnight to allow for transfection of the plasmid 
DNA into the cells. The cells were then rinsed and fresh media added. Controls were as 
follows: a transfection with pGEM-Neo only, a transfection with pCXL (positive control) 
and a “transfection” with no DNA (negative control); each transfection reaction mixture 
was prepared in duplicate.
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After transfection, one well of each duplicate transfection was fixed and stained to check 
for either (3-gal or AP activity as appropriate (as described below) and the corresponding 
duplicate well was trypsinized and plated at serial dilutions on 100mm culture dishes in 
media containing 500 pg/ml geneticin (Gibco BRL), a more stable neomycin analogue. 
Only those cells transfected with pGEM-Neo survive in the presence of geneticin. These 
cells were cultured for several days in media containing geneticin (whose concentration 
was reduced to 100-200 pg/ml) until distinct colonies appeared. One plate of cells for 
each transfection was stained for p-gal or AP activity to determine the proportion of 
positive colonies. Colonies were isolated from the remaining plates. The number of 
colonies isolated was chosen to ensure that several p-gal/AP positive clones would be 
obtained. These colonies were plated on 24-well plates.
After 3-5 days the colonies were subconfluent. To calculate the purity of the colonies (i.e. 
the proportion of cells), cells were fixed and stained for either p-gal or AP production as 
appropriate. The media from these cells were used to test clones for viral production: the 
media was added to D17 fibroblast cells with lOpg/ml polybrene and incubated for 2-4 
hours. The media was changed and the cells incubated for a further two days. The cells 
were then fixed and stained for p-gal/AP activity to calculate the concentration of 
infecting units. Clones that were producing virus were selected for two more rounds of 
sub-cloning, essentially a repeat of the above screening process, to obtain a number of 
stably transfected, high titre cell lines.
Harvesting of Virus
Virus was harvested from packaging cells stably transfected with pCXL, pCXIZppET and 
pCXAP for microinjection experiments. Virus particles are released into the media of the
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D17.2G packaging cells. On the day of injection media was collected and centrifuged at 
2,000 rpm for 10 minutes at room temperature to remove cell debris. The supernatant was 
centrifuged in an ultracentrifuge (Beckman Instruments, California) with an SW28 
swinging bucket rotor at 15,000 rpm for 2 hours at 25°C. Pellets were resuspended in 50- 
100 pi of media. Viral titre was determined by infection of D17 fibroblast cells with 
known volumes of virus solution. Two days later the cells were fixed in 2% PFA (10 
minutes, room temperature), rinsed 3 times in PBS and stained for detection of p-gal or 
AP activity. The number of positive cells detected and the original volume of virus 
solution added to the cells were used to calculate the number of transducing units (TU)/ml 
in the original virus solution. Virus particles were concentrated to titres of the order of 
lOUlO" TU/ml.
Screening for Absence of Replication-Competent Virus
CXAP-containing medium from packaging cells was harvested and approximately 1 x 10^  
TU/ml was used to infect D17 cells. Medium from these infected D17 cells was then 
harvested after two days and assayed for the presence of AP-transducing virus by infection 
of fresh D17 cells. The presence of AP-positive D17 cells here indicates the existence of 
“helper” virus in CXAP viral stocks, able to infect host cells in a replication-independent 
manner.
Microinjection of Viral Solutions
Fertilized chicken and quail eggs (Spafas, New Jersey or Truslow Farms, Maryland) were 
incubated at 38°C under humidified conditions. For injection into the cardiac neural crest 
population of the neural tube, embryos were incubated until HH stages 8-11 (4-13 somite 
stage, approximately 38 hours of incubation). A small hole was made in the eggshell to
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gain access to the embryo. Embryos were visualized using neutral red-impregnated agar 
(lOmg of neutral red (Sigma) diluted in 100 ml of 1% agarose solution and poured onto 
Superfrost slides) placed over the embryo on the amniotic membranes for 1-2 minutes and 
then removed. Approximately 3-30nl (depending on whether low or high level infection 
was required) of concentrated viral solution was pressure-injected into the embryo. 
lOOpg/ml polybrene (Hexadimethrene bromide. Sigma) was added to viral solution to 
enhance infection efficiency. This solution was back-filled into glass capillaries pulled to 
produce fine needles. The needles were attached to a micromanipulator (Leitz, Germany) 
connected to a nitrogen gas pressure regulator (Picospritzer II, General Valve Co., New 
Jersey) for control of location and volume of virus solution injected. The area targeted for 
injection was the neural folds of the neural tube at the level between the otic placode and 
the caudal boundary of the third somite (Fig.3.3a). Fggs were resealed with Parafilm 
(American National Can, Wisconsin) and returned to a humidified incubator until various 
stages of development.
For injection of virus into the myocardium, either prior to contact of the PFO with the 
heart, or after physical inhibition of PFO outgrowth towards the heart, chick embryos 
were incubated until HH stages 16-17 (F3, approximately 72 hours of incubation). Again, 
a small window was made in the eggshell and the vitelline and chorionic membranes were 
tom open with fine forceps to gain access to the heart tube. For visualization of the heart 
and PFO, a 10% solution of India Ink (Koh-I-Noor, New Jersey) in Tyrode’s solution 
(lOX solution: 1.37M NaCl, 27mM KCl, 18mM CaCl2.2H20, 3mM NaH2P0 4 .2 H2 0 , 
15mM MgCl2.2H20 in IL distilled water) was injected under the embryo with a 1ml 
syringe attached to a 30-gauge needle (Becton Dickinson). Virus solution (l-30nl per
heart) was injected at 5-10 sites throughout the myocardium of the heart tube. Eggs were 
resealed and returned to a humidified incubator for further development.
Prior to harvest, a number of embryos were exposed to bromodeoxyuridine (BrdU) 
(Amersham Life Sciences, Illinois) for analysis of cell proliferation levels. 75|ig of BrdU 
was applied to the vitelline membrane of E6 and E6.5 embryos and 120pg to E8 embryos, 
according to the method of Lin et al. (1995). Embryos were incubated for a further four 
hours prior to sacrifice.
Surgical Manipulation for Inhibition of Proepicardial Outgrowth
To inhibit PEO outgrowth, surgical manipulation was performed essentially as described 
by Manner (1993). Embryos were incubated until HH stages 16-17 (E3), stages prior to 
contact of the PEO with the heart tube. As described above, a window was made in the 
eggshell, the vitelline membranes overlying the heart were tom open and India Ink 
injected undemeath the embryo to gain access to the PEO. A small, rectangular piece of 
shell membrane was inserted into the pericardial cavity between the dorsal wall of the 
heart tube and the region of proepicardial outgrowth. Sham-operated embryos underwent 
the same procedure but the shell membrane was removed immediately. Eggs were then 
resealed and retumed to a humidified incubator for further development. PEO outgrowth 
inhibition was performed by David Pennisi.
Histochemistry and Immunohistochemistry
Injected embryos or hearts were removed from the egg at various stages of development 
and fixed in 2% PEA/PBS for 2-4 hours at 4°C and rinsed three times in PBS. For 
detection of p-gal activity, embryos were incubated ovemight in a solution of 5-bromo-4-
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chloro-3-indolyl-p-galactopyranoside (X-gal, Shelton Scientific, Connecticut) at 37°C. 
Samples that had been injected with pCXAP were incubated at 65°C in PBS to inactivate 
endogenous AP activity. They were rinsed three times in NTMT and incubated ovemight 
at room temperature in 175pg/ml BCIP and 340pg/ml NBT in NTMT for detection of 
exogenous AP activity. Samples with AP- or p-gal-positive cells were photographed, 
embedded in Paraplast, serially sectioned at 10pm thickness and analysed.
Tissue samples were processed for paraffin embedding and subsequent sectioning as 
follows: Samples were dehydrated through an ethanol/PBS series at room temperature. 
To allow paraffin penetration, samples were washed twice for one hour in Citrisolv 
(Fisher Scientific) at room temperature and then 50% paraffin in Citrisolv at 60°C. 
Finally, samples were immersed in three changes 100% paraffin at 60°C for at least one 
hour each. Once embedded, lOum sections were cut on a rotary microtome (Microm, 
Germany) and collected on Superfrost slides (VWR). After warming ovemight at 42“C to 
ensure sections are well attached to the slides, sections were de-waxed in three ten minute 
washes in Citrisolv. For immediate histological analysis, or after immunohistochemical 
procedures, sections were mounted in a solution of 50% Permount (Fisher Scientific) in 
Citrisolv with glass coverslips (VWR).
The following primary antibodies were used for immunostaining of histological sections 
and whole mount samples: anti-HNK-1 antibody (Sigma), specific for neural cell adhesion 
molecule (N-CAM), for detection of neural crest or neuronal cells; anti-cytokeratin 
antibody (Biomedical Technologies Inc., Massachusetts) for immunostaining of epithelia, 
particularly that of the PFO and epicardium. Briefly, after sections were dewaxed in 
Citrisolv, they were rehydrated in an ethanol/HjG series and washed three times for 10-20
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minutes in PBS. Endogenous peroxidase activity was quenched by treatment with 0.3% 
H2O2 and background was blocked with a solution of 0.1% Tween-20, 2% bovine serum 
albumin in PBS (PBT-BSA). Sections/ hearts were incubated ovemight at 4”Cin a 1:100 
dilution of anti-HNK-1 antibody or a 1:200 dilution of anti cytokeratin antibody in PBT- 
BSA, as appropriate. Samples were rinsed three times in PBS and incubated in a 1:500 
dilution of secondary antibody (peroxidase-conjugated anti-mouse IgM (Jackson 
Immunochemicals, Pennsylvania) for HNK-1 detection, or peroxidase-conjugated anti­
rabbit IgG (Sigma) for cytokeratin) for 1 hour at room temperature. Immunoreactivity 
was detected using 500pg/ml diaminobenzidine (DAB, Sigma) and 0.003% H2O2 in PBS. 
Samples were then rinsed in PBS. Slides were coverslipped and samples were 
photographed. Cytokeratin immunostaining was performed by David Pennisi.
BrdU detection for analysis of cell proliferation was performed on paraffin sections as 
follows: sections were dewaxed, rehydrated and endogenous peroxidase activity quenched 
as described for HNK-1. Sections were digested with Proteinase K at a concentration of 10 
pg/ml for 10 minutes at room temperature. After rinsing, slides were incubated in 2M 
HCl for 10 minutes, rinsed and neutralized in a solution of O.IM Borax (Sigma). Sections 
were blocked in 5% horse serum in PBS for 30 minutes and incubated with horse anti­
mouse monoclonal-BrdU antiserum (DAKO, Denmark) ovemight at 4°C. Sections were 
then incubated for 1 hour at room temperature in biotinylated anti-mouse IgG and then in 
the Vectastain Elite ABS kit (Vector Laboratories, California), followed by visualization 
of signal with the Vector-VIP peroxidase substrate kit (Vector Laboratories).
Terminal transferase-mediated dUTP nick end labelling (TUNEL) assay was performed 
using the In Situ Cell Death Detection kit (Roche) according to the manufacturer’s
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instructions with a number of modifications. After dewaxing, rehydration and quenching 
of endogenous peroxidase activity, sections were incubated in TUNEL reaction mixture 
consisting of lOOpl terminal deoxynucleotidyl transferase (TdT), 1.1ml nucleotide mix 
and 600pl of PBS (or volumes of reaction mixture proportional to these quantities) for 90 
minutes at 37°C. After rinsing, slides were incubated in horseradish peroxidase- 
conjugated anti-fluoroscein antibody for signal conversion at 37°C for 45 minutes. 
Immunoreactivity was detected using 500pg/ml DAB and 0.003% H2O2.
Detection of nuclei was performed by adding a solution of 1 pg/ml DAPI (4’ ,6-diamidino- 
2-phenylindole, Molecular Probes, Inc. Oregon)
Photography and Digital Imaging
Images of embryos and histological sections were captured with either a Digital Photo 
Camera (DKC-5000, Sony, Japan) or a Spot RT Slider (2.3.1, Diagnostic Instruments Inc, 
USA) and Adobe Photoshop (version 6.0, Adobe Systems Inc, California) or Spot (version 
3.2.6 Diagnostic Instruments Inc, USA) software, respectively. Images were cropped and 
alterations in brightness and contrast were made in Adobe Photoshop.
Quantitative Analysis
NIH Image 1.62 software (National Institutes of Health, USA) was used to determine the 
area of tissue layers in histological sections. Cell numbers were counted and expressed 
per total cell number or per unit area.
92
Statistical Analysis
Standard deviations were calculated for all groups of quantitative data. Statistical analysis 
of data was performed using Student's t-test for unpaired samples.
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Chapter 3: The Role of Endothelin in Development of 
the Outflow Tract and Great Arteries
Introduction
ET has been implicated as having an important role in development of the cardiac neural 
crest population: knockouts of components of the ET-l/ECE-1/ ET^ signalling pathway in 
mice and pharmacological inactivation of the ET^ receptor in the chick give rise to 
cardiovascular defects that recapitulate the phenotypes seen upon ablation of the cardiac 
neural crest population in the chick (Kempf et al., 1998; Yanagisawa et al., 1998a, 1998b). 
However, the ET-dependent mechanisms underlying migration, proliferation, survival and 
differentiation of cardiac neural crest cells remain largely unclear.
The work outlined in this chapter was aimed at elucidating possible roles of ET signalling 
in cardiac neural crest cells. In situ hybridisation analysis of the ET receptor, ET^, and the 
ET-specific converting enzyme, ECE-1, in the pharyngeal arches and great vessels of the 
heart revealed dynamic patterns of expression. This suggests that selective exposure of a 
subpopulation of cardiac neural crest cells to ET signalling may act to regulate aspects of 
cardiac neural crest development. Subsequently, pre- and early-migratory cardiac neural 
crest cells were infected with preproET-1, the precursor of biologically active ET-1 
ligand, via retroviral-mediated gene transfer, to constitutively activate the expression of 
this factor and examine the resulting effects on the development of particular cardiac 
neural crest cell lineages.
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Results
Expression Patterns of ET^ and ECE-1 in the Pharyngeal Arches and Great Arteries 
An investigation of the role of ET signalling in the pharyngeal arches and great arteries 
requires a knowledge of the spatial localization of components of the ET signalling 
pathway at important points in the development of these structures. As mentioned above, 
gene knockout and in situ hybridisation studies in mice have shown that the predominant 
ET receptor in the heart/great arteries is ET^ (Clouthier et al., 1998; Yanagisawa et al., 
1998a). Similarly, experiments with antagonists specific for particular ET receptor 
isoforms have been performed in the chick embryo and show greater effect on 
cardiovascular development when ET^ receptor signalling is disrupted, rather than ET^ 
(Kempf et al., 1998). It is therefore likely that ET^ is the predominant ET receptor 
through which cardiac neural crest cells signal during their development in the pharyngeal 
arches and great arteries. In situ hybridisation analysis of ET^ in avian species has been 
limited to early expression patterns up to pharyngeal arch stage and in later development 
in both the chick/quail and mouse in the heart only, excluding the great arteries. In the 
current study, ET^ expression was therefore analysed during pharyngeal arch development 
and formation of the great arteries in the developing chick embryo.
Whole mount in situ hybridisation at E4 revealed that ET^ receptor is expressed in the 
pharyngeal arches (Fig. 3.1a,b). At this time cardiac neural crest cells are migrating 
through pharyngeal arches 3, 4 and 6 but have not yet reached the outflow tract of the 
heart (Waldo et al., 1998). Sectioning of whole mount samples demonstrated that ET^ 
expression was localized to the mesenchyme of the arches, adjacent to the aortic arch 
arteries (Fig. 3.1c), the region populated by cardiac neural crest cells (Le Lièvre and Le 
Douarin, 1975; Miyagawa-Tomita et al., 1991). By ElO, the great arteries have formed
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from arches 3, 4 and 6. ET^ expression became undetectable in the endothelium, tunica 
media and adventitia of the great arteries (Fig. 3.1e,f). These results show that ET^ is 
initially expressed by cardiac neural crest cells migrating through the pharyngeal arches, 
but is downregulated during subsequent development of the great vessels.
A second essential factor for ET signalling is the converting enzyme ECE. Again, 
previous studies of expression of ECE isoforms in chick and mouse embryos, as well as 
knockout studies of this enzyme, have shown that ECE-1 is the predominant form in the 
developing pharyngeal arches and heart (Yanagisawa et al., 1998b; Yanagisawa et al., 
2000). There is no published data regarding the expression of ECE-1 in the developing 
great arteries, although its presence is essential for processing of preproET-1 to mature, 
biologically active ET ligand. In the current study, ECE-1 mRNA expression was 
therefore analysed during development of the pharyngeal arches and great vessels. At E4, 
whole mount in situ hybridisation analysis demonstrated that ECE-1 was expressed in 
restricted regions of the arches at this time, at slightly higher levels than those broadly 
seen throughout embryos (Fig. 3.2a,b). Sectioning of these embryos revealed that ECE-1 
was preferentially expressed in the ectodermal layer of the arches, flanking the region in 
which ETa is expressed (Fig. 3.2c). By E6, the great vessels are forming from arches 3, 4 
and 6. Cardiac neural crest cells populate almost the entire tunica media layer of the 
vessels. At this time, ECE-1 expression in the ectoderm was downregulated, and instead 
was predominantly found in the innermost, endothelial layer of the developing great 
vessels (Fig. 3.2d,e). At ElO, ECE-1 expression was maintained in the endothelium of the 
vessels. Its expression was robust in this region, and was similar to that seen in 
atrioventricular valve leaflets (Fig. 3.2f,g). At all stages examined, no significant
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Figure 3.1 ET  ^expression in the developing pharyngeal arches and great arteries. In situ 
hybridisation of E4 chick embryos (a-d) and ElO embryonic hearts (e,f) with anti sense 
probes (a-c,e,f) and sense probes (d) for ET^. b is a high power view of the boxed area in 
a. (c,d) Sections of embryos after whole mount in situ hybridisation (purple staining in 
ectoderm in c represents background signal, as seen in section in d after in situ 
hybridisation with ET^ sense riboprobe). h, heart; I, II, etc., first arch, second arch, etc.; 
lumen of aortic arch artery in (c) and (d), lumen of great artery in (f); m, mesenchyme; e, 
ectoderm; Iv, left ventricle; rv, right ventricle; arrows, signal in pharyngeal arches in (b) 
and (c).
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expression of ECE-1 was detected in the areas through which cardiac neural crest cells 
migrate i.e. the pharyngeal arch mesenchyme and the smooth muscle and adventitial cell 
layers of the great vessels.
The pattern of expression of these two components in the developing chick cardiovascular 
system largely recapitulates that of the mouse embryo (Yanagisawa et al., 1998a). 
Although cardiac neural crest cells migrating through the pharyngeal arches express ET^ 
receptor, they do not express ECE-1, essential for production of mature ET-1. This pattern 
of complementary expression of ET receptor and ET converting enzymes is also seen in 
other regions of the developing embryo, suggesting a conserved mechanism for spatial 
restriction of ET signalling. Since ECE-1 is preferentially expressed in the ectoderm 
overlying cardiac neural crest cells, only the outer population of cardiac neural crest cells 
in apposition to the ectoderm may be exposed to production of mature ET ligand during 
pharyngeal arch and subsequent great artery development.
Retroviral Targeting of the Cardiac Neural Crest
The spatial restriction of ET signalling in the cardiac neural crest population may act as a 
means to segregate different lineages of the neural crest. This is the case in the 
myocardium of the heart, where ET^-expressing myocytes of the embryonic heart convert 
to Purkinje fibres under the influence of locally restricted expression of ECE-1 
(Takebayashi-Suzuki et al., 2000; Kanzawa et al., 2002). We therefore sought to test 
whether all or only a sub-population of cardiac neural crest cells are susceptible to ET 
signalling during pharyngeal arch and great artery development. PreproET-1, the 
precursor of mature ET ligand, was over-expressed in the cardiac neural crest population.
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Figure 3.2 ECE-1 expression in the developing pharyngeal arches and great arteries. In 
situ hybridisation of E4 chick embryos (a-d) and E6 (e,f) and ElO (g,h) embryonic hearts 
with anti sense probes (a-c,e-h) and sense probes (d) for ECE-1. b and f are high power 
views of the boxed areas in a and e, respectively. (c,d) Sections of embryos after whole 
mount in situ hybridisation, h, heart; I, II, etc., first arch, second arch, etc.; *, lumen of 
aortic arch artery in (c) and (d), lumen of great artery in (h); m, mesenchyme; e, 
ectoderm; Iv, left ventricle; rv, right ventricle; arrows, signal in pharyngeal arches in (b) 
and (c).
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This was performed by introduction of a replication-incompetent retrovirus encoding 
preproET-1 and p-gal (CXIZppET-virus; (Takebayashi-Suzuki et al., 2000)) (Fig. 3.3a) to 
the cardiac neural crest population. A virus encoding lacZ alone (CXL; (Mikawa et al., 
1991) was used as a control. Infection of D17 fibroblast cells with media from these 
packaging cell plates shows that after concentration of the media, the titre of both viruses 
is approximately 1x10^- 1x10  ^TU/ml and this is stably maintained after many rounds of 
passaging (Fig. 3.3b). Viral solution was injected into the neural folds between the otic 
placode and the caudal boundary of somite 3, the region from which cardiac neural crest 
cells are known to migrate, between HH stages 8 and 11 (Fig. 3.2c). The resulting 
embryos were then examined at specific time-points after re-incubation.
It was first established whether this technique could be used successfully to target the 
cardiac neural crest population. Embryos injected with control, CXL virus were examined 
at E4.5, three days after injection. This revealed that the progeny of infected cells 
(labelled blue after X-gal staining) were located dorso-laterally at the level of the 
pharyngeal arches as well as more ventrally in arches 3, 4 and 6 (Fig. 3.3d,). Histological 
sections of these embryos showed p-gal-positive cells migrating through the mesenchyme 
surrounding the aortic arch arteries (Fig. 3.3e,f). Again, these locations are characteristic 
of sites of cardiac neural crest migration at this stage (Le Lièvre and Le Douarin, 1975). 
Immunostaining with anti-HNK-1 antibody, a marker of neural crest cells (Tucker et al., 
1988), revealed colocalization of this signal with many infected cells (data not shown). 
The location of p-gal-positive cells, as well as this immunohistochemical data, strongly 
suggest that cardiac neural crest cells were successfully targeted by retroviral infection at 
or prior to their migration out of the neural tube. Importantly, the data also demonstrate
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Figure 3.3 Constitutive preproET-1 expression does not affect early cardiac neural crest 
development, (a) Proviral structures of CXL and CXIZppET. (b) Viral titre of CXL and 
CXIZppET over the course of 10 successive titre assays, (c) Viral solution was injected 
into the neural folds of embryos between HH stages 8 and 11, between the otic placode 
and the caudal boundary of somite 3, as indicated by asterisk. E4.5 embryos after infec­
tion with CXL (d-f) and CXIZppET (g-i). (e,f,h,i), sections through the pharyngeal arch 
region of infected embryos, f and i are high power views of the boxed areas in e and h, 
respectively. LTR, long terminal repeat; 1RES, internal ribosome entry site; I, II, etc., first 
arch, second arch, etc.; nt, neural tube; acv, anterior cardinal vein; da, dorsal aorta; at, 
atrium; v, ventricle; asterisk in e and h, lumen of aortic arch artery.
that a virally introduced exogenous gene can be expressed constitutively in infected 
cardiac neural crest cells during pharyngeal arch development.
Constitutive Expression of preproET-1 does not affect Early Cardiac Neural Crest 
Migration
Upon establishment of this gene transfer technique, CXIZppET virus was introduced into 
the cardiac neural crest population. At E4.5, as in control embryos, CXIZppET-infected 
embryos exhibited p-gal-positive cells dorsolaterally at the level of the arches and also 
within arches 3, 4 and 6 (Fig. 3.3g). Again, in section, labelled cells were seen migrating 
through the mesenchyme surrounding the aortic arch arteries (Fig. 3.3gh,i). Examination 
of gross anatomy showed no detectable morphological defects in CXIZppET-injected 
embryos at this stage.
A second group of injected embryos were examined at E6.5, as the great arteries are 
developing from the pharyngeal arches. In both control and CXIZppET-infected embryos, 
p-gal positive cells were found in these vessels (Fig. 3.4a,c). By this stage, a significant 
population of cardiac neural crest cells has reached the outflow tract, where they facilitate 
its septation (Kirby et ah, 1983). In histological sections of both control and CXIZppET- 
infected embryos, p-gal positive cells were found in the mesenchyme of the developing 
great arteries and more proximally in the central mesenchymal core of cells forming the 
outflow tract septum that separates this single vessel into the aorta and pulmonary trunk 
(Fig. 3.4b,d). In both groups, a significant number of labelled cells reached semilunar 
valve level and contributed to this septation. Overexpression of preproET-1 in the cardiac 
neural crest therefore did not appear to affect early migration of these cells, in terms of
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Figure 3.4 Constitutive preproET-1 expression does not affect migration of cardiac 
neural crest cells to the outflow tract. At E6.5, labelled cells were found in the develop­
ing great vessels and outflow tract region of the heart in both control (a,b) and 
CXIZppET-injected embryos (c,d). Arrows in a and c correspond to levels of sections in b 
and d, respectively, ao, aorta; pa, pulmonary artery; s, outflow tract septum.
their general pathway of migration and the timing of migration to their most distant sites. 
This data further confirms that retroviral introduction of an exogenous gene can be 
targeted to the cardiac neural crest population and that these genes are stably expressed 
through many days of embryonic development.
Expansion of the Great Arteries by Mid-Gestation
Following examination of injected embryos at E6.5, a third group of injected embryos 
were examined at E9.5, a time at which the great arteries are well developed and both 
proximal as well as distal outflow tract septation are complete (Waldo et ah, 1998). At 
this stage, control-injected embryos exhibit many p-gal positive cells in the great arteries 
(Fig. 3.5a). Sections show that the majority of these cells are found in the tunica media 
layer of the vessels, with a few also found in the thinner adventitial cell layer at both 
proximal and distal levels (Fig. 3.5b,c). Similarly, pCXlZppET-infected embryos showed 
significant labelling in the great arteries and outflow tract of the heart. Strikingly, 
however, the great arteries of these embryos appeared to be significantly larger than in 
controls (Fig. 3.5d). Upon sectioning, it was revealed that the increase in thickness of 
these vessels was due to an expansion in size of the adventitia, while the thickness of the 
tunica intima and media layers remained comparable to controls. This was observed both 
proximally and distally (Fig. 3.5e,f). The degree of expansion of the adventitia for each of 
the vessels was examined at two planes of section: proximally, at the level of the aorta and 
pulmonary artery, and more distally, where these two vessels have branched into five 
vessels (the left and right pulmonary artery, left and light brachiocephalic arteries and the 
aorta) (Fig. 3.6a). Five sections were examined per embryo at proximal levels and five 
sections per embryo at distal levels. The number of control- and CXIZppET-infected
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Figure 3.5 Expansion of the great arteries by E9.5 in CXIZppET-infected embryos. 
Hearts of CXL- (a-c) and CXIZppET- (d-f) infected embryos were examined in 
whole mount (a,d) and sections through the great arteries (b,e) and outflow tract (c, 
f). Magnification of images in b and e, and c and f, respectively are equal. Arrows 
in a and d correspond to level of sections in b,c,e and f as noted, rv, right ventricle; 
Iv, left ventricle; ao, aorta; pa, pulmonary artery; rba, right brachiocephalic artery; 
Iba, left brachiocephalic artery; rpa, right pulmonary artery; Ipa, left pulmonary 
artery; med, tunica media; ad, tunica adventitia.
embryos examined per group were four and three, respectively. In all vessels of embryos 
infected with CXIZppET virus, a similar degree of expansion was scored at both proximal 
and distal levels, compared with controls (Fig.3.6a). Only embryos with higher 
CXIZppET infection, i.e. at least 4%, were used for this analysis and in these embryos, the 
degree of adventitial expansion was approximately two-fold, compared with controls, in 
all arteries at both proximal and distal levels (Fig. 3.6a).
Furthermore, the degree of adventitial expansion was dependent on the level of infection 
(Fig. 3.6b). As an index of infection level, since the tunica media is made up almost 
entirely of cardiac neural crest cells, complete infection of this cell layer was considered 
100% infection. Levels of infection were of the order of 0 to 10%. With increased 
CXIZppET infection of the cardiac neural crest population there was a concomitant 
increase in the expansion of the adventitial layer of the great vessels, while the level of 
infection of cardiac neural crest cells with CXL had no effect on expansion of the 
adventitia (Fig. 3.6b). These results show that infection of cardiac neural crest with 
CXIZppET gives rise to a significant expansion of the great artery adventitia, but not the 
tunica media or intima, in a dose-dependent manner.
Expansion of the Adventitia is due to Increased Cell Nmber rather than Hypertrophy 
The increase in the thickness of the adventitia of the great arteries upon upregulation of 
preproET-1 expression may be the result of one of a number of mechanisms, such as 
adventital cell hypertrophy, increased cell proliferation and/or promotion of cell survival. 
Furthermore, this expansion may be a result of differential development of either of two 
cardiac neural crest cell populations found in this cell layer: neuronal cells or non-
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Figure 3.6 Quantification of adventitial expansion in CXIZppET-infected 
embryos, (a) The ratio of the thickness of the adventitia to that of the tunica 
media was compared for each of the great vessels at two planes of section: prox­
imally, at the level of the aorticopulmonary septum (indicated by arrows labelled c 
and f in figures 3.5a and 3.5d, respectively), and more distally (indicated by 
arrows labelled b and e in figures 3.5a and 3.5d, respectively). Measurements 
were taken from 5 sections at both proximal and distal levels for CXL- (n = 4) and 
CXIZppET- (n = 3) infected embryos. Bars indicate standard deviation from the 
mean, (b) Comparison of the ratio of adventitial thickness to tunica media thick­
ness with increasing viral infection with CXL and CXIZppET. ao, aorta; pa, pulmo­
nary artery; rba, right brachiocephalic artery; Iba, left brachiocephalic artery; rpa, 
right pulmonary artery; Ipa, left pulmonary artery; tm, tunica media; adv, adventi­
tia; *, p< 0.01; **, p<0.001 (comparison of CXL- vs. CXIZppET-infected samples).
neuronal fibroblasts. The potential effects of upregulated preproET-1 expression on these 
cell biological events were examined during cardiac neural crest development.
The changes in cell number and cell size were analysed by scoring the number and density 
of cell nuclei in sections of the great artery adventitia of embryos at E9.5 treated with 
DAPI to stain their nuclei (Fig. 3.7a,b). Three embryos were examined in both control 
and CXIZppET -injected groups and five sections were analysed per embryo at distal 
levels of the great arteries. A comparison of the number of nuclei per unit area in the 
adventitial layers of control and CXIZppET-injected samples revealed a slightly higher 
cell density in CXIZppET-injected embryos, though this was not statistically significant 
(Fig. 3.7c). Since the number of cells per unit area was comparable in both groups but the 
total area of the adventitia is increased in CXIZppET-injected samples compared to 
controls, the mechanism for this expansion is clearly due to increased cell number rather 
than cellular hypertrophy.
Neuronal Differentiation is Unaffected Surrounding the Great Arteries of preproET-1- 
Injected Embryos
As adventitial cell expansion was observed at mid-gestation, the cellular mechanisms that 
give rise to this expansion must occur prior to this time-point. We therefore examined 
injected embryos at E6.5, a time at which many morphogenetic events are occurring in the 
heart and great vessels, including septation and myocardialization of the outflow tract as 
well as extensive neuronal development (Pexieder, 1975; Thompson et al., 1987; Waldo et 
al., 1998; Verbeme et al., 2000)). To examine whether the expansion of the adventitia 
was largely due to neuronal cells or non-neuronal fibroblasts, immunohistochemistry was 
performed on sections of E6.5 embryos, using the HNK-1 antibody, a marker of neuronal
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Figure 3.7 Cell density in the adventitia. Using sections through the great 
vessels of E9.5 embryos infected with CXL (a) and CXIZppET(b), cell density in 
the adventitial layer of the great vessels was analysed by quantifying the number 
of DAPI-positive nuclei per unit area (c). One section through a distal region of 
the great vessels of three different embryos was examined per group. In each 
section, nuclei in the adventitial layer surrounding all five vessels were examined. 
Bars indicate standard deviation from the mean.
cell populations (Tucker et al., 1988). The distribution of neuronal bundles in the 
adventitia of the vessels was comparable in both control and CXIZppET-injected samples 
(Fig. 3.8a,b), suggesting that overexpression of preproET-1 does not significantly promote 
changes in the neuronal cell population. It may therefore be that the expansion of the 
adventitial layer is due to an increased number of adventitial fibroblasts, or that neuronal 
expansion occurs later, or a combination of both these events.
Cell Survival is Modulated by Upregulated ET Signalling
To examine potential mechanisms by which expansion of adventitial cell number in 
preproET-1 -injected embryos arises, sections from E6.5 embryos were analysed for levels 
of cell proliferation and programmed cell death. Levels of BrdU incorporation at this time- 
point were used to analyse the proportion of cells undergoing proliferation (Fig. 3.9a-c.). 
Transverse sections from the region of the forming outflow tract septum as well as at a 
more distal level, again, where the aorta and pulmonary artery have branched into five 
vessels, were used for this analysis. Three embryos were examined in both control and 
CXIZppET-injected groups and one section was analysed per embryo, one at proximal and 
one at distal levels of the great arteries. Interestingly, BrdU incorporation levels appeared 
to be much higher in the lateral walls of the outflow tract, in contrast to low levels of 
proliferation in the central mesenchymal core of the forming of the outflow tract septum. 
Almost no BrdU-positive cells were detected in the myocardialized sleeve of the outflow 
tract, based on analysis of at least six embryos from control- and preproET -1 -infected 
groups (Fig. 3.9a, b). The number of cells undergoing proliferation at this time-point was 
approximately 3100 cells/mm^ in control samples and 3500 cells/mm^ in preproET-1 
samples at proximal levels (sections from 3 embryos analysed per group). Distally, more 
variation was seen in levels of cell proliferation in both control- and
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Figure 3.8 Neuronal differentiation in the outflow tract. HNK-1 immunostaining 
was performed on sections from CXL- (a) and CXIZppET- (b) infected embryos 
at E6.5. Arrows, HNK-1-positive neuronal bundles; ao, aorta; pa, pulmonary 
artery.
CXIZppET -infected embryos (again, sections from 3 embryos were analysed per group). 
However, in either case no statistically significant difference was detected between the 
control and CXIZppET -infected groups.
Apoptosis was analysed in regions of the outflow tract and great arteries by TUNEL assay. 
This revealed a significant decrease in the numbers of apoptotic cells in the outflow region 
of the heart at E6.5 in CXIZppET-injected embryos, compared with controls (Fig. 3.10a- 
c). At proximal levels, control embryos displayed an average of 98 TUNEL-positive 
cells/mm^, while CXIZppET-injected samples had on average of 64 TUNEL-positive 
cells/mm^ (sections from three embryos analysed per group, one section proximally and 
one distally per embryo), representing a decrease of 35% in levels of apoptosis. At distal 
levels, more apoptotic cells were detected, though levels of apoptosis were more variable 
between samples and no significant difference was seen between control- and CXIZppET- 
infected embryos. These results show that there is a significant decrease in the numbers of 
cells undergoing apoptosis in the outflow region of the heart at E6.5 in CXIZppET- 
infected embryos, compared with controls. Thus, cells of the outflow tract are susceptible 
to preproET-1 overexpression, resulting in decreased levels of cell death. Together with a 
slight increase in the number of BrdU-positive cells, overexpresson of preproET-1 appears 
to increase adventitial cell number via promotion of cell proliferation and/or survival of 
neural crest-derived adventitial cells in this region.
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Figure 3.9 Overexpression of preproET-1 in the cardiac neural crest does not 
affect cell proliferation in the outflow tract and great arteries. Transverse sections 
at the level of the aorticopulmonary septum as well as at a more distal level of the 
great vessels were analysed for BrdU incorporation to assess relative levels of 
cell proliferation at E6.5. (a) Section through outflow tract of CXL-infected 
embryo, (b) Section through outflow tract of CXIZppET-infected embryo, (c) Com­
parison of levels of BrdU incorporation reveals no significant difference. At each 
level, one section was analysed per embryo; 3 embryos were analysed per group. 
Bars indicate standard deviation from the mean, ao, aorta; pa, pulmonary artery; 
s, outflow tract septum; m, myocardium.
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Figure 3.10 Cell survival is modulated by overexpression of preproET-1 in the 
cardiac neural crest. Transverse sections at the level of the outflow tract septum 
and more distally through the great arteries were analysed for apoptotic cell 
death using TUNEL assay at E6.5. (a) Section through outflow tract of CXL- 
infected embryo, (b) Section through outflow tract of CXIZppET-infected 
embryo, (c) Comparison of numbers of TUNEL-positive cells per unit area dem­
onstrate that there are lower levels of cell death in the outflow tract region of 
CXIZppET-infected embryos, compared with controls. At each level, 2-4 sec­
tions were analysed per embryo, 3-4 embryos were analysed per group. Bars 
indicate standard deviation from the mean, ao, aorta; pa, pulmonary artery; s, 
outflow tract septum; arrows, TUNEL-positive cells; *, p<0.05 (comparison of 
number of TUNEL-positive cells in sections of CXL- and CXIZppET-infected 
embryos at the level of the outflow tract).
Discussion
An Analysis of the Role of Endothelin in Cardiac Neural Crest Development 
This chapter outlines an investigation of the role of ET signalling in the development of 
the cardiac neural crest population, during its migration from the neural tube to the 
pharyngeal arches and during subsequent great artery and outflow tract development. The 
spatial and temporal expression patterns of the receptor, ET^, and converting enzyme, 
ECE-1, in the chick embryo were analysed using in situ hybridisation in these two regions 
to understand the timing of localized interactions between components of the ET 
signalling family, important for normal heart and great artery development. Secondly, 
expression of preproET-1, the precursor of the biologically active ET-1 ligand was 
constitutively expressed in the cardiac neural crest population, demonstrating for the first 
time that an exogenous gene can be restiictively introduced into the cardiac neural crest 
population via a retroviral-mediated gene transfer technique. Our data show that 
constitutive expression of preproET-1 has no apparent effect on early development of the 
pharyngeal arches or the outflow tract, but by E9.5 results in an expansion of the 
adventitial cell population of the great arteries. This adventitial expansion appears to be 
due, at least in part, to increased cell survival, rather than alteration of cell differentiation. 
No significant expansion is seen in the tunica media layer of the great arteries, the major 
cardiac-neural crest derived population here, suggesting independent susceptibility of the 
smooth muscle and adventitial cell lineages to ET-signalling in the cardiac neural crest 
population in vivo. Our data also suggest that the temporal and spatial patterns of 
expression of ET signalling components may be involved in this differential response of 
cardiac neural crest lineages to the exogenous preproET-1.
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Complimentary Patterns of Expression of ET^ and ECE-1 in the Pharyngeal Arches 
In order to understand the role of ET signalling in cardiac neural crest development, it is 
essential to have an idea of the temporal and spatial profiles of expression of ET signalling 
components. The expression of the receptor ET^ is well documented during pharyngeal 
arch development in avian species (Kempf et al., 1998; Nataf et al., 1998), yet the 
expression profile of the converting enzyme ECE-1 has received little attention. 
Furthermore, the patterns of expression of ET signalling factors in the great arteries have 
yet to be sufficiently addressed, despite the fact that genetic inactivations of ET signalling 
components in the mouse and pharmacological ET receptor blockade in the chick 
demonstrate that ET signalling is essential for correct morphogenesis and maintenance of 
these vessels.
In the mouse, Yanagisawa et al. (1998a, 1998b) and Clouthier et al. (1998) have suggested 
that restricted interaction of ET-1 in the pharyngeal arches with ET^ expression by neural 
crest cells, may set up a “microenvironmental signal” directing arch remodelling. In the 
absence of ET^ production, pharyngeal arch development is defective (Yanagisawa et al., 
1988; Kempf et al., 1998; Yanagisawa et al., 1998a). Since preproET-1 mRNA 
expression in the pharyngeal arches of the chick is widespread, located in the mesodermal 
core of the arches as well as the endoderm and ectoderm (Nataf et al., 1998) it is unlikely 
that this factor acts as a spatial regulator of ET signalling. Importantly, however, our 
expression analysis of ECE-1 suggests that it may be this component of the ET signalling 
pathway that establishes a similar scenario of restricted ET signalling in the pharyngeal 
arches of the chick. We have shown that ET^ mRNA is expressed in the arch 
mesenchyme, populated by cardiac neural crest cells, consistent with the findings of others 
(Kempf et al., 1998; Nataf et al., 1998). ECE-1, in contrast, is largely excluded from this
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region and is restricted to the overlying ectoderm. The restriction of ECE-1 and the fact 
that mature ET-1 ligand is known to act only over short distances (Yanagisawa, 1994) 
point to the likelihood that ET signalling will occur only in the outer region of the 
pharyngeal arches, in which expression of ECE-1 is apposed to that of ET^. Consistent 
with this, our data show that only a subset of neural crest cells, likely those adjacent to the 
ECE-1 expression in the phaiyngeal arches are affected by exogenous preproET-1 
expression.
There are numerous examples of complimentary epithelial and mesenchymal expression 
patterns that occur during pharyngeal arch development that suggest the occurrence of 
inductive events between the mesenchyme of the arches and the overlying ectoderm and 
endoderm. For example, cellular retinol-binding protein (CRBPl) is expressed in the 
endoderm and surface ectoderm of the pharyngeal arches of the mouse embryo. Cellular 
retinoic acid—binding protein (CRABP-1), on the other hand, is expressed concomitantly 
by the neural crest-derived mesenchymal cells of these arches (Maden et al., 1992; 
Gustafson et al., 1993), suggesting that interactions between these two tissues are 
necessary for RA metabolic pathways. Importantly, gene knockouts of RA signalling 
components or RA receptor antagonism generate defects in the pharyngeal arches (Dupe 
et al., 1999; Wendling et al., 2000), providing further evidence of a role for RA signalling 
in arch patterning. Similarly, BMP-2 and BMP-4 display complementary patterns of 
expression in the developing pharyngeal arches (Bennett et al., 1995). ET signalling 
appears to represent a further example of the complementary expression of signalling 
components in the arches. In the mouse, Clouthier et al. (2000) provide evidence that ET- 
1 expression (by the ectoderm and mesoderm) signals through the ET^ receptor (expressed 
by neural crest cells) and moderates expression of at least six transcription factors in the
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mesenchyme of the rostral pharyngeal arches that give rise to craniofacial tissues. It 
therefore appears that epithelial-mesenchymal interactions of ET signalling factors directs 
a network of downstream factors important for craniofacial development. It is also likely 
that similar signalling events occur in the caudal arches. Thomas et al. (1998), for 
example, have suggested that epithelial secretion of ET-1 regulates dHAND expression in 
the mesenchyme and subsequent Msxl expression in the growing arches.
Upregulation of ET Signalling Affects Late Rather than Early Cardiac Neural Crest 
Development
Gene inactivations of ET^, ET-1 and ECE-1 in the mouse result in a host of defects in both 
craniofacial and cardiovascular development (Clouthier et al., 1998; Thomas et al., 1998; 
Yanagisawa et al., 1998a, 1998b). Interestingly, early migration of cardiac neural crest 
cells and formation of the pharyngeal arches in these embryos appears to be normal 
(Yanagisawa et al., 1998a, 1998b; Clouthier et al., 2000). The idea that activation of ET 
signalling is spatially localized is supported by the fact that preproET -1 -infection of the 
cardiac neural crest does not appear to affect early migration of this population and that 
pharyngeal arch formation is normal. In the chick, ET^ is not expressed by neural crest 
cells until they reach the arches at E3 (Nataf et al., 1998). Additionally, ablation of the 
cardiac neural crest in the chick has shown that the arch arteries can form in the absence of 
the neural crest (though the presence of this cell type is required at later stages for 
maintenance of the vessels) (Waldo et al., 1996). It is therefore not surprising that there is 
little effect on pharyngeal arch development upon preproET-1 infection of pre- and early- 
migratory cardiac neural crest cells in the chick, since ET^ is not expressed at the earliest 
stages of cardiac neural crest migration.
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As the caudal arch arteries connect to the aortic sac and begin to form the great arteries, 
gross anatomical development continues to appear normal. Indeed, until the latest stage 
studied, E9.5, branching of the aorta and pulmonary artery, at least proximally, is normal. 
In ET knockouts, a major defect is the abnormal regression of some vessels and 
concomitant abnormal persistence of others (Yanagisawa et al., 1998a). This therefore 
suggests that a threshold level of ET signal is necessary for great artery remodelling, but 
that an excess level of ET is not detrimental to the normal patterning of these vessels.
By mid-gestation, an expansion of the adventitia of the great arteries is observed. 
Although a specific mechanism for this expansion is yet to be deduced, it appears to be 
due, at least in part, to increased survival of these cells. It is interesting that upregulated 
ET signalling at around E4 in the pharyngeal arches results in a phenotype that is observed 
many days later. Upregulated ET signalling in the already well-developed great arteries 
can be ruled out since ET^ is not expressed in this region. Consistent with this, our data 
shows that although ECE-1 is robustly expressed in the intima of the great arteries, 
expression of exogenous preproET-1 does not significantly affect the development of the 
adjacent, neural crest-derived tunica media population. Although ET-1 acts as a mitogen 
for adult vascular smooth muscle cells (Alberts et al., 1994; Weber et al., 1994; Damon, 
2000), in the great arteries of the developing chick embryo, the smooth muscle cells of the 
tunica media do not appear to be sensitive to constitutive preproET-1 expression, likely 
due to this absence of ET^ expression. Alternatively, selective adventitial expansion may 
reflect the fact that the adventitia of major vessels is the first tissue layer to respond to 
pathological stimuli such as hypoxia, as tested in a number of model systems (reviewed in 
Stenmark and Mecham, 1997; Das et al., 2002). This results in adventitial thickening, 
often as a result of increased cell proliferation or matrix deposition. In our in vivo system,
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despite high levels of exogenous preproET-1 expression in the tunica media of the great 
arteries, a response may be seen in the adventitial layer due to the greater susceptibility of 
this tissue to external stimuli. Pharmacological inactivation of ET^ signalling in the chick 
has revealed that the sensitivity of neural crest cells to ET^ disruption in the pharyngeal 
arches is likely restricted to a period between E3 and E4 (Kempf et al., 1998). ET^ 
blockade at this time-point results in subsequent craniofacial as well as aortic arch defects, 
at much later time-points, representing another example of delay in onset of a phenotype 
upon disruption of ET signalling.
Upregulated ET Signalling Promotes Cell Survival in the Outflow Tract 
In our study, preproET-1 infection of the cardiac neural crest appears to selectively 
promote the survival of adventitial cells. In vitro studies have shown that addition of 
exogenous ET ligands to neural crest cultures promotes selective proliferation and/or 
survival of specific neural crest cell lineages (Lahav et al., 1996; Lahav et al., 1998; 
Opdecamp et al., 1998; Wu et al., 1999). We therefore think that in a similar way, 
upregulated ET signalling may selectively act to promote adventitial fibroblast 
proliferation. However, this is based on our observations at a single time-point, E6.5, 
which show that the size and distribution of HNK-1-positive neuronal bundles in the 
outflow tract and great vessels at E6.5 appear comparable to controls. Currently, we 
cannot rule out the possibility that neuronal differentiation becomes selectively promoted 
at a later stage in development. Further analysis at later time-points to rule out or confirm 
this possibility is required.
Temporal and spatial distributions of apoptosis within the heart have been extensively 
studied by various techniques, including electron microscopy (Pexieder et al, 1975;
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Manasek, 1969b) and TUNEL analysis (Poelmann et al., 1998; Watanabe et al., 1998; 
Cheng et al., 2002). These studies have highlighted foci of apoptotic cells in areas such as 
the outflow tract cushions, atrioventricular cushions and, at late stages of development, 
smooth muscle cells of the great arteries. We have similarly observed apoptotic cells in 
the outflow tract cushions and myocardium as well as significant levels of cell death in the 
developing great arteries. In preproET-1-infected samples, we observed a significant 
decrease in cell death in the outflow tract, compared to controls. Clouthier et al. (2000) 
have studied the rates of proliferation and cell death in the mandibular segment of the first 
pharyngeal arch of ETA-deficient mice. These investigators found that proliferation at this 
site was lower in ET^-deficient embryos than in controls, while levels of apoptosis 
increased by almost four-fold. Although no difference was seen in the current study in 
levels of cell proliferation upon ET modulation, our observations of depressed levels of 
cell death upon up-regulated ET signalling compliment the findings of Clouthier et al. in 
the pharyngeal arch.
In the current study, it appears that upregulated ET signalling in an outermost 
subpopulation of cardiac neural crest cells in the arches selectively promotes their survival 
in the developing arch arteries, resulting in expansion of the great artery adventitia later in 
development. This sequence of events is consistent with the fact that infection of a small 
population of adventitial cells with preproET-1 generates a uniform, circumferential 
expansion of the adventitia, observed at E9.5. The mechanism by which ET signalling 
might act to control survival of neighbouring cells remains to be determined. 
Furthermore, our model proposes that restriction of ET signalling to the outer population 
of cardiac neural crest cells in the pharyngeal arches directs development of the adventitia 
of the great arteries. This model assumes that the outer population of the arches is the
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same population that will generate the adventitia later in development. Although this is a 
favourable assumption, there is currently no direct evidence to support this. We are 
therefore currently performing lineage analysis using retroviral-mediated single cell 
labelling to determine the clonal relationships between cardiac neural crest cells in the 
pharyngeal arches and their daughter cells found later in various regions of the great 
arteries. This approach should determine the timing of segregation of different cardiac 
neural crest cell lineages and aid in the interpretation of our findings.
ET Signalling and Great Artery Development
There is little data on the timing and mechanism of recruitment of adventitial cells to the 
great arteries, and their origin remains largely unknown. Adventitial cells surrounding the 
outflow tract below the level of the conotruncal boundary are derived from the 
proepicardium (Vrancken Peeters et al., 1995), yet the major source of adventitial cells 
above this level has not been identified. One source of these cells is the cardiac neural 
crest (Bergwerff et al., 1998) and our studies confirm this.
Studies of modifications in vessel morphology and physiology following injury or 
haemodynamic changes demonstrate that all three tissue layers of blood vessels (the 
intima, tunica media and adventitia) are capable of considerable remodelling, involving 
dynamic changes in levels of apoptosis and cell proliferation (Kalra and Miller, 2000). 
Since ET is a potent vasoconstrictor, upregulation of ET in the developing arch arteries 
and/or great arteries may generate physiological changes to which the adventitial cells of 
these vessels respond. Removal of adventitial cells from large arteries results in changes in 
the response of these vessels to neurotransmitter-induced contraction and relaxation 
(Gonzalez et al., 2001), indicating that the adventitia may play a role in the contractile
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capacity of vessels, as well as a supportive role for the inner tissue layers of the vessels 
and their neuronal cells.
Experimental Design
The use of replication-incompetent retroviral-mediated gene transfer has proved to be a 
powerful tool in the elucidation of a wide range of cellular processes and events important 
in embryonic development. The application of this technology for straightforward tagging 
of infected cells and their progeny, for example, has proved definitive in the clarification 
of lineage relationships in the developing eye (Turner et al., 1990; Fields-Berry et al., 
1992; Blanks et al., 1997), heart (Mikawa and Fischman, 1992; Mikawa and Gourdie, 
1996) and neuronal populations (Frank and Sanes, 1991; Gray and Sanes, 1992). 
Additionally, retroviral transfer of exogenous genes into particular cell populations has 
been used to disrupt or modulate signalling pathways in order to understand the 
importance, timing, etc. of these pathways in the development of various cell types 
(Mikawa, 1995; Mima et al., 1995; Lin et al., 2000). A retroviral-mediated approach was 
selected in the current study, despite the availability of other techniques for gene transfer 
to host cells. These include the use of adenoviral rather than retroviral constructs, 
hormone-inducible gene expression and DNA electroporation techniques. Each approach 
offers a range of particular advantages and disadvantages.
Replication-incompetent adenoviral vectors have been constructed that are able to infect 
dividing as well as non-dividing cells. A wide variety of cell types can be infected and 
importantly, higher viral titres are achievable, compared with retroviral constructs (typical 
adenoviral titres are of the order of 10^  ^TU/ml, compared with retroviral titres commonly 
of the order of 10^  TU/ml). Importantly, however, adenoviruses replicate extra-
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chromosomally, rarely integrating into the host cell genome. Adenovirus-mediated gene 
expression is therefore variable and viral gene expression can induce immune responses in 
the host cells. Furthermore, since the viral genome is episomal, only transient expression 
of the exogenous gene(s) is possible (reviewed in Robbins et al., 1998). In this study, we 
were interested in the effects of upregulated ET signalling throughout many days of 
embryonic development. The use of adenoviral gene transfer therefore would have 
limited our studies to a short time-window of analysis. For this reason, as well as the fact 
that inherent variations in gene expression levels would make interpretation of results 
more difficult, adenoviral-mediated gene delivery was deemed to be unsuitable for the 
nature of the current study.
A second alternative approach, DNA electroporation involves application of an electrical 
field across a tissue, causing pores to form in cell membranes. The surge of current causes 
transfer of DNA towards the anode and into the cells (reviewed in Schwartz et al., 2001). 
The neural tube provides an ideal structure for the use of such a technique, since a solution 
of DNA can be injected into the lumen of the neural tube and electrodes placed either side. 
A surge of current then draws the DNA into the neural tube cells on one side only, 
allowing the non-infected cells of the contralateral side to act as an internal control. This 
technique typically infects at least one third of the neural tube. Again, however, many 
copies of the DNA can infect a single cell and since this DNA remains extrachromosomal, 
there is progressive loss of exogenous DNA expression. Furthermore, control of the site 
of infection is less precise and restricted infection of just the dorsalmost neural tube cells 
(i.e. in the neural folds) at a restricted axial level would likely prove technically difficult. 
Recently, a microelectroporation technique has been developed for more precise targeting 
of cell populations (Nakamura et al., 2000; Yasuda et al., 2000). However, this system
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has been shown to cause tissue damage, notably of the extraembryonic vasculature, and so 
indirect and detrimental effects on embryonic development may ensue.
Thirdly, a technique of conditional, or inducible, gene expression has been developed in 
the last decade to spatially and temporally control gene expression in a number of species. 
The most commonly used approach is the tetracycline inducible system, which involves 
the use of the tetracycline transactivator, a protein that combines the E. coli tetracycline 
repressor and the viral transcriptional activator domainVP16 (Gossen and Bujard, 1992; 
Gossen et al., 1995). Depending on the transactivator used, the presence or absence of 
tetracycline (or a tetracycline analogue such as doxycycline) removes the repression and 
transcription is then activated. This technique has been used in vitro as well as in vivo in a 
number of animal systems, including Drosophila, Xenopus and mouse (for references, 
refer to Sato et al., 2002). Only very recently has this approach been explored in the chick 
embryo. Sato et al. (2002) have attempted to co-express a replication-competent virus 
encoding green fluorescent protein (GFP) driven by a tetracycline-responsive element 
promoter, with a retroviral vector encoding the tetracycline-dependent transactivator and 
CMV promoter in various tissues of early embryos. Following 24 hours of doxycycline 
treatment beginning at E7.5, embryos were examined and GFP expression was found to 
have been induced. However, as has been observed in other systems, low levels of GFP 
expression were detected in the absence of the tetracycline analogue, indicating that there 
is always a background level of gene expression. Although this is useful for analysis of 
gene expression which are usually lethal, our study of ET signalling would not benefit 
from such a gradient of gene expression and would make interpretation more difficult. 
Additionally, the success of the conditional gene expression approach requires that the 
cells of interest are infected with two viral constructs: one encoding the transcriptional
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activator and the second encoding the tetracycline-responsive element linked to the GFP 
gene. Differences in levels of infectivity between these two viruses and efficiency of 
infection of different cell types lead to as yet undetermined variations in transgene 
expression. Furthermore, the responsiveness of different cell types to tetracycline and to 
the tetracycline inducible system has also not been fully examined. In light of the many 
areas of variation and unknown cell response to this form of gene transfer, it therefore 
appears that use of the tetracycline-inducible system in the chick embryo is premature and 
requires further and extensive investigation before it can be used reliably.
There are a number of drawbacks to the use of the retroviral gene transfer technique. 
These include lower viral titres, compared to adenoviral vectors, for example, and the fact 
that retroviruses cannot infect non-dividing cells. This latter point however is not an issue 
when investigating an actively dividing cell population in the developing embryo. The 
physical disruption to which the embryos are exposed during microinjection is also a 
factor that may have some effect on embiyonic development. However, this is true of all 
the available techniques outlined above, and the level of invasiveness and damage 
inflicted by the microinjection system appears to be minimal. We therefore felt that the 
advantages of the retroviral approach, including the ability to control the site and timing of 
infection, maintenance of proviral integration in the host cell genome through many 
rounds of cell division and days of development and continuously coupled expression of 
the gene of interest with the reporter gene, made this approach the most favourable for the 
requirements of the current study.
Our experimental approach aimed to upregulate preproET-1 expression and subsequent 
ET signalling in the cardiac neural crest, for the purpose of understanding the
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mechanism(s) by which ET signalling regulates development of the cardiac neural crest 
population. Using this approach, we have been able to formulate certain ideas about the 
mechanism of ET action on the cardiac neural crest. These ideas are to some extent based 
on assumptions made about the action of our retrovirus and the subsequent change in ET 
signalling that appears to be generated. For example, microinjection of the retrovirus has 
led to incorporation of the lacZ gene into the cardiac neural crest population, demonstrated 
by X-gal staining of the resulting embryos. Because of previous experiments in our 
laboratory involving upregulation of preproET-1 expression in cardiac tissues using the 
CXIZppET construct (Takebayashi-Suzuki et al., 2000), and because it is known that 
incorporation of an 1RES site between the reporter gene and the second transgene 
generally facilitates expression of both gene products at high levels (Ghattas et al., 1991), 
reviewed in Hyer and Mikawa, 1997) we have assumed that preproET-1 is also expressed 
in all cells in which P-gal is expressed. Ideally, to confirm that preproET-1 is co­
expressed with p-gal, further studies involving Northern or Western analysis, or 
immunohistochemistry should be used to detect either preproET-1 mRNA or protein. 
Preliminary Northern blot analysis revealed that prepreET-1 mRNA is expressed in the 
packaging cell line transfected with the retroviral construct (data not shown). However, 
detection of preproET-1 mRNA in infected cardiac neural crest populations would prove 
exceedingly difficult, considering that the level of preproET-1 infection in the great 
vessels of the E9.5 embryo is of the order of 1-10%. Accumulation of enough total RNA 
from infected great vessels to detect preproET-1 mRNA expression is therefore too high to 
be realistically achievable. For the moment, we are therefore basing our assumption that 
we have overexpressed preproET-1 on the following facts: a) the pCXIZppET-transfected 
packaging cells express preproET-1 mRNA; b) harvesting of viral particles from these 
cells and their injection into host cells results in p-gal expression by these cells, which are
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therefore also likely to be expressing preproET-1; c) that infection of the cardiac neural 
crest population with this virus results in an observable phenotype (i.e. adventitial 
expansion), not seen upon infection with a control virus expressing lacZ alone; and d) the 
CXIZppET retroviral construct has previously been used in other studies for infection of 
other tissues of the chick embryo, with a resulting influence on ET signalling. Until the 
expression of preproET-1 in the pharyngeal arches and great vessels can be demonstrated 
directly, our hypotheses rely on the above assumptions for validation.
Related to this, our second major assumption is that introduction of exogenous preproET-1 
results in production of mature ET-1 in regions where preproET-1 expression overlaps 
with ECE-1 expression. Again, no direct evidence is presented to support this. Antibodies 
to ET-1 are available and have been used for ELISA analysis (Maemura et al., 1995), 
therefore protein expression levels might be feasibly determined (Clouthier et al., 2000) 
using Western blot analysis. However, since the half-life of ET-1 is very short, 
immunohistochemical analysis of ET-1 localization may not be reliable (Yanagisawa, 
1994). A second possible approach to investigating upregulated ET signalling might 
involve analysis of downstream targets of ET. A number of possible factors have been 
implicated in an ET signalling pathway, as mentioned above. These include Dlx-2 and -3, 
dHAND and eHAND and CRABP-1 in the developing pharyngeal arches (Thomas et al.,
1998). However, no factor has been definitively shown to be a specific downstream target 
of ET signalling and so we decided not to analyse these factors, since neither changes in 
their expression, nor lack of change in their expression would conclusively support or 
disprove our hypothesis. Endothelin has been extensively studied in a range of animal 
models in vivo and in vitro, mostly in post-natal or adult tissues, to understand the 
importance of ET signalling in both physiological and pathological situations. These have
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demonstrated that ET signalling activates a number of intracellular events typical of G 
protein-coupled receptors, including activation of phospholipase C, which results in 
production of inositol triphosphate and diacylglycerol and subsequent increases in 
intracellular calcium (reviewed in Hunley and Kon, 2001). Although these are well 
established biochemical changes, analysis of these intracellular events would prove very 
difficult, if not impossible, to monitor in individually preproET -1 -infected cardiac neural 
crest cells. Currently, therefore, inferences must be made about the upregulated 
production of ET-1 in our preproET -1 -infected embryos, again based on the fact that a 
modulation of development of the infected neural crest cells and their neighbours is seen, 
compared to control infected embryos.
Future Directions
Since in vivo verification of ET function in individual neural crest cells is technically very 
difficult, we plan to employ an alternative in vitro approach to complement our in vivo 
studies. The use of various markers of neural crest derivatives has allowed determination 
of the potential, proliferation and survival of the neural crest population and some of the 
factors that influence differentiation of particular derivatives (Cohen and Konigsberg, 
1975; Sieber-Blum, 1982; Sieber-Blum, 1989; Stemple and Anderson, 1992; Ito and 
Sieber-Blum, 1993). Specifically, the in vitro culture of neural crest cells has been used to 
study the effects of exogenous ET-3 ligand on development of trunk neural crest 
derivatives (Lahav et al., 1996; Lahav et al., 1998; Opdecamp et al., 1998; Wu et al.,
1999). Until now, however, no in vitro study of neural crest development has focused on 
the cardiac neural crest population. The technique of cardiac neural crest cell isolation 
and in vitro culture has been established in our laboratory (according to the technique of 
Margaret Kirby and colleagues, personal communication). The design of an in vitro
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system to study cardiac neural crest development in the presence of exogenous ET is 
therefore easily achievable, involving isolation of these cells and addition of commercially 
available ET-1 ligand, followed by analysis of cardiac neural crest cell differentiation. 
Antibodies against neuronal, smooth muscle and fibroblast cell types are also available 
and would be used to examine whether or not there is selective proliferation, 
differentiation and/or survival of adventitial fibroblasts. Alternatively, selective 
development of other cell types may be observed, or there may be no difference in 
development compared to control cultures. A selective expansion of the adventitial 
fibroblast lineage would provide strong support for our in vivo data, however a 
contradictory finding (such as expansion of another cell type) might not contradict our 
data, but would simply emphasize the many differences between the development of cell 
types in culture, as opposed to the development of neural crest cells in vivo, which 
involves a multitude of cell-cell and cell-environment interactions.
Further studies are also required to identify the exact timing of adventitial expansion. As 
described above, this is likely to be a fairly early event, since a low level of adventitial 
infection with CXIZppET results in a significant degree of adventitial expansion by E9.5 
that is evenly distributed around the inner endothelial and smooth muscle cell layers of the 
great vessels. Lineage analysis of the cardiac neural crest population is also essential to 
elucidate the timing of segregation of different derivatives of the cardiac neural crest. 
Although lineage analysis of trunk neural crest populations has been addressed (Bronner- 
Fraser and Fraser, 1988; Bronner-Fraser et al., 1991; Frank and Sanes, 1991), there has 
been little attempt to dissect the lineage relationships of cardiac neural crest cells. The 
study of this will prove important not only in understanding the timing of ET signalling 
events in cardiac neural crest development, but will provide valuable information about
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the cardiac neural crest population in general, essential for understanding many of the 
events in development of this cell type. With this in mind, we have begun low-level 
infection of cardiac neural crest cells to examine the pathways of migration and diversity 
of individual cells. Preliminary data is presented in chapter 4.
The biological significance of an expanded adventitial layer around the great arteries 
remains to be determined. Until E9.5, this expansion appears to have no deleterious effect 
on cardiovascular development, although physiological characteristics of the preproET-1- 
infected great vessels have not been monitored in the current study. However, it will be 
interesting to see whether an increase in adventitial cells affects later stage of 
development. Particular areas of interest include the connection of the coronary vessels of 
the heart to the aortic blood supply that generates a closed circulatory system by E14 in 
the chick embryo (Rychter and Ostadal, 1971). Secondly, an expansion of the adventitia 
may affect innervation of the great arteries. Maturation of neuronal development also 
occurs at around E14, and so physiological changes may be observable around this time. 
This would provide insight into the as yet incompletely defined role of the adventitia in 
blood vessel development and function.
Clearly, there are many remaining questions to be answered concerning the timing and 
mechanism of ET action on the cardiac neural crest. However, until now, insight into 
possible mechanisms has been largely inferred from genetic inactivation of ET signalling 
components and in vitro models of isolated non-cardiac neural crest cells. In this study, 
we have provided in vivo evidence for a role of ET, specifically in the cardiac neural crest 
population, that fits with a number of current hypotheses. Our data are consistent with the 
model that ET acts on post-migratory cardiac neural crest cells and is involved in selective
133
survival of particular neural crest-derived cell lineages. This study also provides some 
insight into the effects of changes in signalling on the dynamic processes of vascular 
remodelling, essential to our understanding of vascular biology in both physiological and 
pathological conditions. A range of approaches has been employed to target the neural 
crest population (Lo et al., 1997; Poelmann et al., 1998; Li et al., 1999). Here, we have 
demonstrated for the first time the ability to restiictively target the cardiac neural crest 
population for retroviral-mediated exogenous gene delivery. This technology represents a 
novel approach to the study of the cardiac neural crest, allowing the modulation of 
signalling events specifically in the great arteries and outflow tract of the heart. Genetic 
mutations in the mouse embryo have provided valuable evidence for the importance of 
particular genes in cardiac neural crest development. However, the global disruption of 
such genes has often made the findings of these approaches difficult to interpret. The use 
of retroviral-mediated gene transfer allows us to perform more subtle perturbations of the 
cardiac neural crest population that can be controlled both spatially and temporally, 
thereby complementing the mouse knockout system and bridging the gap between this 
approach and the in vitro study of neural crest cells.
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Chapter 4: Construction of an Alkaline Phosphatase- 
Expressing Replication-Incompetent Retrovirus
Introduction
Fate mapping and lineage analysis of embryonic cell types has successfully been 
performed with retroviral vectors in a number of different tissues, including those of the 
heart, central nervous system and eye (Mikawa and Fischman, 1992; Mikawa and 
Gourdie, 1996) (Frank and Sanes, 1991; Gray and Sanes, 1992). For lineage analysis, a 
single cell label is sufficient for tagging discrete colonies of cells that do not disperse or 
migrate over long distances (Frank and Sanes, 1991). However, in the case of cardiac 
neural crest cells, which migrate extensively from the neural tube through the pharyngeal 
arches and to the heart, a single label is inadequate for distinguishing labelled cells arising 
from two different cardiac neural crest precursors. An alternative approach is the use of 
two or more retroviruses expressing different histochemical markers, such as p-gal and 
AP. To study the lineage relationships between cardiac neural crest cells, we have 
constructed a replication-incompetent, AP-expressing retrovirus based on the pJD214 viral 
vector that can infect avian species (Dougherty and Temin, 1986). This can be used in 
conjunction with a second, replication-incompetent retrovirus, such as CXL, which 
expresses the lacZ gene (Mikawa et al., 1991) for better distinction of individual clonal 
populations. Preliminary data are presented to demonstrate the ability of this retrovirus to 
infect embryonic chick cells in a replication-incompetent manner.
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Results
The Generation of CXAP Virus Stocks
The retroviral vector pCXAP was constructed as outlined in chapter 2 (Materials and 
Methods). pCXAP DMA was cotransfected into D17.2G packaging cells (Dougherty and 
Temin, 1988) along with pGEMneo, a plasmid encoding the neomycin resistance gene, 
used as a selectable marker. Tables I and II illustrate the screening process performed to 
select a cell line of high purity and viral titre: 72 colonies of transfected cells were each 
grown as clonal lines. Of these, 24 colonies were screened for virus production and ability 
to infect D17 fibroblast cells. 3 colonies were then selected with high infection: virus 
production ratios for sub-cloning and a second round of screening. Viral titres were 
determined by infection of D17 cells and quantifying the number of AP-positive cells that 
were observed two days after infection. Titres are expressed as AP-transducing units/ml 
(TU/ml). From this, 2 colonies with high viral titres were selected. A cell line, #56-13, 
with a viral titre of the order of 10^  TU/ml, after concentration, was finally selected for use 
in this study (Fig. 4.1a,b). From hereon, the virus produced by this cell line is referred to 
as CXAP. The expression of AP in D17 cells infected with CXAP virus demonstrates an 
intense purple, punctate, cytoplasmic staining (Fig. 4. lb), in contrast to the diffuse blue 
precipitate observed after infection with the (3-gal-expressing CXL virus (Fig. 4.1c).
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Table I. Screening process for selection of alkaline phosphatase-expressing cells. Of 72 
isolated colonies of cells, 24 colonies were assayed for expression of AP, an indicator of 
virus production (P) and ability to infect D17 fibroblast cells (I). P and I are expressed as 
the percentage of cells expressing AP, compared with the total cell number. 2 clones of 
cells, #56 and #63, with high I:P ratios were selected for subcloning.
Table II. Subcloning of cells. Clones 56 and 63 were subcloned to isolate groups of cells 
with high viral titres. Cell line #56-13, with a titre of 2 x 10^  TU/ml, was selected for 
future studies.
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Table I
CLONE
NUMBER
INFECTMTY
(l,%)
VIRUS PRODUCTION 
(P,%)
l'P
25 0 <1 0
26 1 30 0.03
27 0 5 0
28 10 100 0.1
29 5 90 0.06
30 3 20 0.15
31 0 80 0
32 <1 60 -
33 10 100 0.1
35 10 100 0.1
36 0 60 0
37 2.5 30 0.08
38 0 100 0
39 0 <1 0
40 15 95 0.16
42 0 100 0
44 0 <1 0
45 0 5 0
46 0 0 0
47 5 100 0.05
48 90 100 0.9
55 95 100 0.95
56 100 100 1
63 95 100 0.95
Table II
CLONE VIRAL TITER
NUMBER (TU/ML)
56-13 2X  10^
56-15 2X 10-
63-16 8X10G
63-20 7 X1 0 ^
.•V
c
4f
«a
I
mm
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Figure 4.1 Assay for CXAP virus production and infection, (a) Packaging cell 
line #56-13 was assayed for viral production by staining for AP expression. 
Almost all cells were positive for AP activity, (b) D17 cells were infected with 
media from plates of #56-13 cells. AP staining was evident in many of these 
cells, in a punctate distribution throughout the cytoplasm, (c) D17 cells infected 
with CXL virus and stained for p-gal activity.
In Vitro Test for Replication-Competent Virus
The D17.2G packaging cell line into which pCXAP was transfected is designed to 
produce viral stocks free from replication-incompetent virus. However, recombination 
events can occur, albeit rarely, that generate replication-competent (or “helper”) viruses. 
This can allow the viral genome to be transferred to neighbouring cells via “horizontal” 
spreading. To monitor the presence of replication-incompetent helper virus, virus was 
harvested from pCXAP-transfected packaging cells and was used to infect D17 fibroblast 
cells. Two days after this infection, the media from these D17 cells was then tested for the 
presence of replication-competent virus by inoculation of a second batch of D17 cells. If 
helper virus was present in the CXAP viral stock, this virus could replicate within the D17 
cells and generate infectious virus particles carrying the AP gene. However, assay for AP 
activity in the second set of D17 cells revealed no such AP expression (data not shown). 
This suggests that no recombination events have occurred to render CXAP able to infect 
host cells in a replication-competent manner. The infected D17 cells will be continuously 
passaged and tested for AP activity over the course of several weeks to test for the 
presence of helper virus.
CXAP can Infect Embryonic Chick Cells In Vivo
To test the ability of the virus produced by this cell line to infect embryonic chick cells in 
vivo, CXAP was microinjected into the ventricular myocardium of E3 chick embryos. 
These embryos were then re-incubated until E6 and the hearts stained for detection of AP 
activity. Distinct colonies of AP-positive cells were identified on the ventricular surface 
of the heart (Fig. 4.2a,b). Histological sections of these hearts revealed colonies of AP- 
positive cells in both the compact myocardial layer as well as the trabeculated 
myocardium (Fig. 4.2c). Previous studies have demonstrated that the formation of the
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Figure 4.2 Analysis of myocyte clone size following CXAP infection. CXAP viral 
solution was injected into the ventricular region of the tubular heart at E3 at low titre 
levels to infect individual myocytes. (a,b) At E6, alkaline phosphatase-positive clus­
ters of cells are evident on the surface of the heart (arrows), (b) is a higher power 
view of the image in (a), (c) Sections of these hearts revealed clusters of labelled 
cells in the myocardium of the ventricles, (d) Analysis of myocyte clone size. 
Average clone size = 18 cells (n=7, standard deviation = 1.63). cm. compact myo­
cardium; tr, trabeculum.
ventricular myocardial wall occurs via establishment of cone-like clusters of myocytes, 
which themselves form from mixed clones of cells, each derived from a single precursor 
(Mikawa et al., 1992). Retroviral single cell tagging of myocardial precursors often 
results in the labelling of the progeny of an infected cell along a transmural pathway, i.e. 
extending from the epicardial side of the myocardium to the endocardial side (Mikawa, 
1992). Consistent with this, we observed clusters of labelled cells along such pathways 
(Fig. 4.2c), with no concomitant infection in the endocardium or epicardium, or in tissues 
adjacent to the heart. This provides further evidence that CXAP is transferred from cell to 
cell in a replication-independent manner, without horizontal transfer of virus in a 
replication-competent, or “helper” manner.
Colonies of labelled cells could easily be distinguished from CXAP-negative cells and 
analysis of colony size at E6 revealed that each colony contained an average of 18 labelled 
cells (Fig. 4.2d). If each of these colonies is the result of the infection of a single myocyte 
precursor, then the generation of 18 progeny over the course of three days (from E3-E6) 
suggests a cell doubling time of approximately 18 hours. This assumes that cell death is 
not a significant factor, as is the case in the ventricular myocardium (Pexieder, 1975; 
Cheng et al., 2002). This proliferation rate is consistent with previous analyses of 
myocyte cycling time (Jeter and Cameron, 1971; Mima et al., 1995; Lin et al., 2000) and 
suggests that each colony represents a clone derived from a single, infected cell. 
Furthermore, this suggests that infection of ventricular myocytes with CXAP does not 
alter cell proliferation.
In summary, this analysis suggests that CXAP is able to infect chick embryonic cells in a 
replication-independent manner. Like CXL, infected cells are easily detectable after
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staining for the histochemical marker (in this case, AP) and stable expression of the viral 
genes is evident after a number of days of development post-infection. Furthermore, 
introduction of this retrovirus does not appear to affect cell proliferation. Though further 
analysis is required, this suggests that CXAP is a suitable retroviral vector for cardiac 
neural crest cell tagging.
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Discussion
The Use of Retroviral Vectors for Fate Mapping and Lineage Analysis 
As mentioned above, the use of retroviral vectors has proved invaluable for fate mapping 
and lineage analysis of a variety of cell types in the developing embryo. Retroviral- 
mediated cell tagging and tracing has a number of advantages over alternative methods. 
The use of vital dyes, such as Dil and rhodamine dextran, for example, has proved 
successful in tracing neural crest cells during emigration from the neural tube and 
subsequent stages of early migration (Bronner-Fraser et al., 1991). These dyes, once 
injected into a cell are only transferred to daughter cells during cell division (i.e. in a 
replication-incompetent manner) due to their size or because they are trapped in the 
plasma membranes. However, with each successive round of cell division, the dye 
becomes progressively diluted and therefore long-range tracing of cells is not possible as 
the label becomes undetectable. Retroviral-mediated gene delivery has been used to infect 
many different cell types and the tracing of the progeny of these cells is feasible over 
many days of development, as the study outlined in chapter 3 demonstrates.
The use of a single cell tag has been sufficient in many instances to examine lineage 
relationships of a cell population that migrates as a discrete cluster or does not migrate 
over a long distance. However, since the cardiac neural crest is a highly migratory 
population that also disperses to populate various sites between the pharyngeal arches and 
the heart, a single cell tag is not sufficient for distinguishing labelled cells arising from 
two different cardiac neural crest precursors. In this case, one cannot determine whether 
two clusters of cells in different locations arise as a result of infection of one clone that 
gives rise to cells that migrate along two different pathways, or as a result of the original 
infection of two cells.
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Other studies where similar limitations have arisen have employed the use of two lacZ 
expressing retroviruses: one that localizes lacZ expression to the cytoplasm, and a second 
whose genome contains a nuclear localization signal for direction of lacZ expression to the 
nucleus (Hughes and Blau, 1990; Mikawa et al., 1992; Epstein et al., 1994; Galileo et al., 
1990; Frank and Sanes, 1991). A disadvantage of this approach is that distinction of 
nuclear and cytoplasmic staining in histological sections is often difficult in certain 
tissues. One such case is the tunica media layer of the great vessels, which is largely 
populated by cardiac neural crest-derived smooth muscle cells (personal observations). 
Similarly, distinction of nuclear and cytoplasmic signal in neuronal cells can be difficult 
since cytoplasmic labelling in cell bodies may be indistinguishable from labelling in the 
nuclei (Cepko et al., 1998). For lineage analysis of cardiac neural crest cells, therefore, 
we have chosen to employ two histochemical markers for single cell labelling, for better 
distinction of clonally related populations. This approach has been used in a number of 
studies, for example, in the mouse eye and brain to determine clonal boundaries (Fields- 
Berry et al., 1992; Halliday and Cepko, 1992). CXL, a replication-incompetent retrovirus 
expressing the lacZ reporter gene, was previously constructed (Mikawa et al., 1991). To 
compliment this, we have constructed a replication-incompetent retrovirus expressing AP. 
Other AP-expressing retroviral vectors have been used in both the chick and mouse and 
these studies suggest that introduction of exogenous AP does not affect development of 
function of infected cells (Fields-Berry et al., 1992).
Generation of a Replication-Incompetent Retrovirus Expressing Alkaline Phosphatase 
The retrovirus we have generated, CXAP, is based on the retroviral vector pJD214 
(Dougherty and Temin, 1986). This veetor is derived from spleen necrosis virus, and has
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had the structural genes removed, rendering any virus produced from this genome 
replication-incompetent. Into this vector, the AP gene was introduced and vector DNA 
was transfected into packaging cells containing the necessary structural genes, thus 
generating a cell line consistently producing CXAP with a viral titre of the order of 10^  
TU/ml.
To ensure that a viral vector such as the one we have constructed is truly replication- 
incompetent and does not affect development of the cells infected with it, a minimum 
number of criteria should be tested and satisfied. A replication-incompetent retrovirus 
should only permit transfer of viral RNA from cell to cell during the process of cell 
division. A helper virus encoding the structural genes gag, pol and env allows “horizontal” 
spread of virus from one cell to neighbouring cells without the necessity of mitosis for 
gene transfer. Such spreading can result in misinterpretation of lineage relationships 
between cell populations. Our initial studies to monitor the presence of helper virus in 
vitro suggest that virus harvested from CXAP-transfected packaging cells is unable to 
replicate in a replication-competent manner. Additionally, there are a number of 
indications of the presence of helper virus that can be detected after infection of cells in 
vivo. For example, if the targeted cell type usually generates progeny of only one cell 
type, then labelling of cells outside of this field would be suggestive of viral spread in a 
replication-competent manner. In our studies of infection of the myoeardium of the 
looping heart, clones of cells derived from myocyte infection did not contain labelled cells 
in adjacent tissues, such as the endocardium and epicardium or at extracardiac sites. This 
suggests that transfer of CXAP virus occurs only to daughter cells and not to neighbouring 
cells via horizontal transfer.
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Analysis of clone size provides further indication of the means of viral genome transfer. 
All cells of a particular cell type in one location should proliferate at approximately the 
same rate, generating clones of roughly the same size over a fixed period of time. 
Therefore, infection of cardiac myocytes with CXAP should generate clones of similar 
size to those resulting from CXL infection, since CXL is known to be replication- 
incompetent (Mikawa et al., 1991). This has been confirmed by injection of the 
ventricular myocardium, which generated clones of cells that suggest a mitotic rate of 
approximately 18 hours, in agreement with previous analyses of myocyte cycling time 
(Jeter and Cameron, 1971; Mima et al., 1995; Lin et al., 2000). A more rigorous test of 
this can be performed by infecting cells with different dilutions of retroviral solution. For 
example, myocardial infections can be performed with three different concentrations of 
viral solution, spanning three orders of magnitude. If the viral solution is helper-free, this 
should result in increasing numbers of infected clones with increasing viral titre, but the 
number of cells per clone should remain similar between all three groups, as should the 
range of infected cell types (Cepko et al., 1998). We have yet to perform analysis of 
CXAP infection levels with a range of viral titres, though comparisons of CXAP infection 
and clone size with that of CXL, as well as in vitro screening for replication-independent 
gene transfer provide strong evidence that this AP-expressing retrovirus also infects target 
cells in a replication-incompetent manner.
The above data therefore suggests that CXAP is a replication-incompetent retrovirus, 
though further investigation is required to show this conclusively. We have also 
confirmed the ability of this virus to infect chick embryonic cells, with stable expression 
of the AP gene over a number of days of development. Additionally, this virus can be 
injected at appropriate titres to infect individual cells to trace their progeny. These early
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findings strongly support the ability of the CXAP virus to infect cardiac neural crest cells 
for lineage analysis in conjunction with CXL, the gene products of which are easily 
distinguishable from each other. Using these two retroviruses to target the cardiac neural 
crest population, it is predicted that analysis of the lineage relationships and clonal 
boundaries of cardiac neural crest-derived cells is feasible in the chick embryo.
Future Directions: Analysis of Cardiac Neural Crest Lineages
With the used of the proposed labelling strategy, we hope to be able to draw conclusions 
about the clonal relationships between cardiac neural crest cells following emigration from 
the neural tube. Until now, no lineage analysis of the cardiac neural crest has been 
performed. Fate maps have identified the pathways of cardiac neural crest cell migration. 
This has been particularly well studied in the avian species with the use of quail-chick 
chimeras and the major migratory pathways of cardiac neural crest cells from the neural 
tube to their most distal sites of colonization in the heart have been well characterized 
(Miyagawa-Tomita et al., 1991; Waldo et al., 1998). In mammalian species, a number of 
attempts have been made to produce a similar fate map of cardiac neural crest migration, 
though this is hampered by the problems of poor accessibility to developing embryos and 
has required the use of embryo culture to follow the fate of labelled cells for relatively 
short periods of time (Tan and Morriss-Kay, 1986; Serbedzija et al., 1992). A number of 
transgenic models in the mouse have also been developed that constitutively express the 
lacZ gene in neural crest cells. This expression is activated using the Cre-lox system, 
driven by Pax3 (Li et al., 1999) or Wntl (Jiang et al., 2000). However, this technique 
cannot be said to represent a true cardiac neural crest fate map, since expression is not 
restricted to the cardiac neural crest, nor can it be conclusively confirmed by this approach 
alone that lacZ is expressed by all cardiac neural crest cells and their progeny.
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Despite the successes of some of the above techniques for the large-scale targeting of 
cardiae neural crest cells for the construction of fate maps, none of these approaches is 
appropriate for lineage analysis of this cell population. This requires the ability to target 
individual cells, and in the case of the cardiac neural crest, follow the development of their 
progeny as they migrate over long distances, likely dispersing along the way. The use of 
retroviral-mediated cell labelling provides a suitable approach for targeting single cells 
and tracing their progeny throughout development.
Lineage analysis and in vitro cultures of avian trunk and cranial neural crest cells have 
suggested that most of these neural crest cells are multipotent (Cohen and Konigsberg, 
1975; I to and Sieber-Blum, 1991; Stemple and Anderson, 1992; Sextier-Sainte-Claire 
Deville et al., 1994), often generating more than one cell type. Although this is likely to 
also be the case for most cardiac neural crest cells, this cannot be assumed, since the 
cardiac neural crest is clearly a unique cell population, with characteristics distinguishable 
from other neural crest types, such as their early pathways of migration and the range of 
derivatives that are formed (Kuratani and Kirby, 1991; Kuratani et al., 1991; Poelmann et 
al., 1998; Waldo et al., 1998). Lineage analysis of the cardiac neural crest will therefore 
establish the range of cell types that can be generated from individual cells in vivo.
However, what is probably more interesting is the use of such analysis to identify the sites 
of segregation of cardiac neural crest lineages. The targeting of individual pre-migratory 
cardiac neural crest cells will help to determine whether cardiac neural crest crest cell 
fates are determined soon after their emigration from the neural tube, thus generating 
clones limited to a single cell type, or whether specification of cardiac neural crest cells
149
takes place at further stages of development, generating mixed populations of cardiac 
neural crest-derived cells along the way. Our studies of the role of ET signalling in cardiac 
neural crest development (see Chapter 3) suggest that at least one crucial stage for the 
segregation of cardiac neural crest lineages is at the point when these cells are migrating 
through the pharyngeal arches. We postulate that cardiac neural crest cells migrating 
through the outer region of the pharyngeal arches, in close proximity to the ectoderm and 
the putative site of mature ET ligand production undergo selective exposure to ET 
signalling, and thereby become segregated from the remaining population of cardiac 
neural crest cells, possibly generating the outer, adventitial cells of the great vessels. The 
use of retroviral labelling to target cells at different positions within the pharyngeal arches 
can be used to determine whether there is indeed a segregation of cells migrating through 
the outer arch region, such that these cells alone will preferentially generate adventitial 
cells of the great vessels. Alternatively, cells labelled in the arches may generate mixed 
populations of different cell types, suggesting that environmental influences act later in 
development to specify acquisition of an adventitial or smooth muscle cell phenotype, for 
example. Thus, the use of this technique will likely prove invaluable for establishing the 
spatial and temporal windows of expression of particular factors, including ET, that play a 
role in the determination of cardiac neural crest cell fate.
Future Directions: Alternative Approaches to Lineage Analysis of the Cardiac Neural 
Crest
In order to determine whether the current strategy utilizing two histochemical markers is 
sufficient to clarify the lineage of infected cardiac neural crest cells, further studies are 
planned. The first of these involves the analysis of the initial stages of cardiac neural crest 
cell migration, as cells leave the neural tube, to determine whether cardiac neural crest
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cells can be infected by CXAP and produce AP at detectable levels. Labelled cells can be 
identified as being of cardiac neural crest origin by immunostaining for neural crest 
markers such as HNK-1 antibody (Tucker et al., 1988) as well as the localization of 
labelled cells along stereotypical pathways of cardiac neural crest cell migration.
Should it be concluded that cardiac neural crest cells can indeed be labelled and traced by 
infection with CXAP, the next step is to determine whether descendents of a single 
infected cell can be confidently identified as a clone. This relies on the progeny of one 
cell remaining as a fairly discrete cluster. Due to the nature of this approach, it is 
unfortunately much easier to determine that labelled cells are not clonally related (i.e. if a 
cluster contains a mixture of p-gal-positive and AP-positive cells) than to be confident that 
they are derived from a single precursor. If small groups of labelled cells are found in 
discrete regions and are all labelled with one marker, this may simply be due to infection 
of two neighbouring cells with the same reporter gene. If a sufficiently large number of 
injected samples are analysed for the number of labelled clusters of cells and the vast 
majority of these clusters contain cells of only one label, then it may be assumed that most 
of these clusters represent groups of clonally-related cells. This however assumes that 
each retrovirus has the ability to infect the cell type of interest equally, or that the two 
viral solutions are present in proportions that will ensure equal chance of infection by each 
of the viruses. In some cases, this designation of such a cluster of cells as a clone will be 
erroneous and may represent progeny of more than one cell. However, the chance of this 
occurring can be estimated using the following formula:
Number of bi-coloured clusters of labelled cells Fa 4- b)  ^/2abj = % error 
Number of total clusters
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Where a and b are the relative titres of the two viruses encoding the reporter genes (Cepko 
et ak, 1998). With a low percentage error of determination of clonal boundaries and a 
large sample size, lineage relationships between cells can be interpreted with a high 
degree of confidence.
For the study of the lineage of cardiac neural crest cells throughout extended periods of 
development or between widespread sites within the embryo, the use of only two reporter 
genes will clearly make the assignment of clonal relationships very difficult. Yet this 
study would be highly useful for understanding time-points at which subsets of cardiac 
neural crest cells are exposed to different signals that help to contribute to their 
commitment to a particular fate, say that of an adventitial cell versus a smooth muscle cell 
of the great vessels. However, considering the extensive cell proliferation that would take 
place throughout this period and the possibility of a certain level of cell death in the 
pharyngeal arches and great vessels, interpretation may be extremely difficult.
Two alternative approaches that have been developed in the laboratory of Dr. Constance 
Cepko may prove very useful for this type of long-term approach to lineage analysis 
(Walsh and Cepko, 1992; Golden et al., 1995). Both techniques are considerably more 
painstaking than the methods described above, but provide a highly increased number of 
cell labels, providing greater assurance of clonality among cells labelled with the same 
marker. The first approach involves construction of a library of viruses, with each virus 
carrying a DNA fragment from an unrelated species. Walsh and Cepko employed the 
used of Arabidopsis thalliana DNA, in addition to the lacZ or AP gene, generating 
approximately 100 different DNA fragments for distinction of clonally related cell 
populations (Walsh and Cepko, 1992 and references within). Using the histochemical
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markers, infected cells can be identified in cryosections and carefully removed from these 
sections. The exogenous DNA from these cells can then be amplified by PCR and 
characterized by their size and restriction digest patterns. Those cells containing markers 
with same size and restriction enzyme pattern of the A. thalliana DNA can be said to be 
clonally related with a high degree of certainty.
Should even more complexity in the number of cell labels be required, a more recently 
developed approach utilizing a greater number of DNA tags can be employed. The Cepko 
group have constructed a number of retroviral vectors for infection of chick and mouse 
that include degenerate oligonucleotides, providing a complexity that can theoretically 
generate an enormous number of different DNA labels, of the order of 1.7 x 10^  (Golden 
et al., 1995; Golden and Cepko, 1996; Szele and Cepko, 1996). As with the above- 
mentioned approach, cells labelled with p-gal or AP are extracted from cryosections and 
the DNA is amplified by PCR. The PCR products of individual cells are then sequenced 
and those cells with identical sequences are designated as clonally related.
In conclusion, we have successfully constructed a replication-incompetent retrovirus, 
CXAP, expressing AP. Our studies demonstrate that this virus is able to infect chick 
embryonic cells in vivo and that cells infected with this virus will constitutively express 
AP through many rounds of cell division and throughout many days of development at 
detectable levels. This construct therefore appears to be a suitable vector for replication- 
independent infection of the cardiac neural crest population for cell tracing and elucidation 
of the clonal relationships between the progeny of cardiac neural crest cells.
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Chapter 5: Myocardial Patterning in the Absence of the 
Epicardium
Introduction
As the origin of cells of the coronary vasculature, the PEO has an essential role in normal 
cardiovascular development. Recently, however, a separate role for the PEO-derived 
epicardium has been suggested: experiments in both the chick and mouse that result in an 
absence of the epicardial covering of the heart commonly display defects in development 
of the myocardium, including thinning of the compact layer of the myocardial wall and 
ventricular septal defects. We sought to characterize the cell biological mechanism(s) that 
give rise to a thinner myocardium by generating epicardium-deficient hearts via physical 
inhibition of PEO outgrowth. Subsequently, the compact myocardium of epicardium- 
deficient hearts was analysed for differences in cell density and levels of cell proliferation 
and cell death to determine whether these aspects were significantly disrupted in the 
absence of the epicardium.
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Results
A Model for Inhibition of Epicardial Outgrowth and Subsequent Morphological Defects 
PEO outgrowth inhibition was achieved by insertion of an eggshell membrane barrier, 
according to the method of Manner (1993). Epicardial cells arise from the PEO and 
contact the myocardium of the heart at around HH stage 17-18 (E3) (Viragh and Challice, 
1981; Hiruma and Hirakow, 1989). The shell membrane barrier was therefore introduced 
between the PEO and the myocardium of the heart tube of embryos at HH stage 16-17 
(Fig. 5.1a-c). After reincubation of embryos, hearts were dissected and examined.
Embryos in which PEO outgrowth was inhibited were examined at E5, when the 
epicardium has normally covered almost the entire heart tube, as well as at E6 and E8, 
time-points that are still prior to completion of a closed coronary vascular network. 
Analysis of gross morphology, in comparison with sham controls, revealed a range of 
cardiovascular defects, including reduction in size of the ventricles and elongation of the 
outflow tracts. These defects were observed as early as E5, with variation in the severity 
of defects, ranging from apparently normal-looking hearts to those with extensive 
morphological defects (Fig. 5.1d-o).
The extent of epicardial deficiency in operated hearts was analysed by immunostaining for 
cytokeratin, a marker of epithelia, which is expressed by epicardial cells (Viragh et al., 
1993; Vrancken Peeters et al., 1995). Wild type and sham-operated hearts exhibit a 
progressive wave of envelopment of the myocardium by cytokeratin-positive epicardial 
cells. At E3, cytokeratin signals are observed in the PEO itself (Fig. 5.2a,b). By E6 in 
sham-treated embryos, the cytokeratin-positive epicardial sheet is shown enveloping the 
entire heart, up to the level of the cono-truncal boundary of the OFT, as has been
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Figure 5.1 PEO outgrowth inhibition in the chick embryo. PEO migration towards the 
looping heart tube was inhibited by insertion of an eggshell membrane barrier at HH stage 
17-18, according to the method of Manner (1993). (a) Cartoon and (b) photograph of a 
HH stage 17 embryo indicating position of eggshell membrane insertion, c. Scanning 
electron micrograph of PEO outgrowth. Adapted from Manner (1993). (d) E5 heart from 
a sham-operated embryo, (e-g) E5 hearts from embryos after PEO outgrowth inhibition, 
(h) E6 heart from a sham-operated embryo, (i-k) E6 hearts from embryos after PEO 
outgrowth inhibition. (1) E8 heart from a sham-operated embryo, (m-o) E8 hearts from 
embryos after PEO outgrowth inhibition. V, ventricle; A, atrium; P, proepicardial organ; 
LI, liver primordium.
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previously reported (Vrancken Peeters et al., 1995)(Fig. 5.2c). In operated samples at E6, 
the extent of epicardial deficiency ranged from patches of myocardium with no obvious 
epicardial covering, to almost complete absence of the entire epicardium of the heart (Fig. 
5.2d-f).
Analysis of cytokeratin immunostaining in sections of control hearts showed high levels 
of staining in the outermost epicardial layer and lower levels of signal in the underlying 
subepicardial layer of mesenchymal cells. An even lower level of staining was also 
observed in the myocardium (Fig. 5.3a,c,e). Consistent with whole mount 
immunostaining, operated hearts showed a range of deficiency in the epicardial covering 
of the heart, from those with a complete and intact epicardium to those completely lacking 
epicardial cells (Fig. 5.3b,d,f).
Upon establishment of a technique to inhibit epicardial contact with the myocardium, 
samples exhibiting the most extreme lack of an epicardial layer were selected for further 
analysis, and were compared with sham controls.
Thinning of the Myocardium in Epicardium-Deficient Hearts
Analysis of cytokeratin-immunostained sections showed that coincident with a lack of 
epicardium in operated hearts, the compact myocardial layer of the ventricular walls of 
these samples were noticeably thinner, even as early as E5, just two days after epicardial 
inhibition. At E6 and E8, ventricular septal defects were also observed, consistent with 
previously reported observations (Manner, 1993; Gittenberger-de Groot et al., 2000) (see 
thin, fenestrated interventricular septum in Fig. 5.3d and compare to interventricular 
septum in Fig. 5.5e). Quantification of the difference in wall thickness between E6 and
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Figure 5.2 Whole mount cytokeratin immunostaining of control and epicardium-deficient 
hearts. Cytokeratin staining of E3 embryos (a,b), and E6 hearts (c-f). (a) E3 heart shows 
preferential cytokeratin expression in the PEO and ventral body wall, with lower signal in 
the myocardium of the heart tube, (b) Negative control with no primary antibody, (c) E6 
control heart with almost total epicardial covering as detected by cytokeratin-positive 
outer tissue, (d-f) Operated hearts displaying increasing levels of epicardium deficiency, 
d, patches of cytokeratin-negative areas are seen on the ventricles and outflow tract 
(arrows), e, almost half of the ventricles and most of the outflow tract lack a cytokeratin- 
positive epicardial covering, f, most of the ventricular myocardium and outflow tract are 
lacking epicardium.
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Figure 5.3 Section immunostaining of sham control and operated embryos for detection of 
cytokeratin expression. Sections of E6 (a,b) and E8 (c-f) hearts stained for cytokeratin 
after sham operations (a,c,e) and PEO outgrowth inhibition (b,d,f). e and f are high power 
images of selected areas of the sections in c and d, respectively. Note the lack of 
epicardium as well as the thinner compact myocardial layer in b,d and f, compared with a, 
c and e, respectively, m, compact myocardium; e, epicardium; absence of epicardium. 
Scale bars in a-d, 200pm; scale bars in e and f, 50pm.
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E8 controls and operated samples was performed using NIH Image 1.62 software (Fig. 
5.4). In this study, we have defined the compact myocardial layer as the outermost, 
untrabeculated region of the myocardium. The area of the compact layer of the ventricular 
myocardial wall was measured in sections and divided by the length of the outer perimeter 
of the wall, thus giving a “width index” of the compact layer of the ventricular wall. 
Measurements of E6 samples showed that control hearts had a mean width index of 37pm, 
while operated hearts had a width index of 21 pm, representing a 43% decrease in wall 
thickness. Similarly at E8, control hearts had a mean width index of 36 pm, while 
epicardium deficient hearts had a width index of only 25 pm, a reduction of 31% in 
thickness of the compact myocardium. Three embryos were examined per group and the 
entire compact myocardium of one section was examined per embryo. Sections were 
taken from a level approximately one third of the way up the ventricle from the apex of 
the heart.
Increased Cell Density in the Compact Myocardial Layer of Epicardium-Deficient Hearts 
The decrease in thickness of the compact myocardium of the ventricles in epicardium- 
deficient hearts may be due to either a decrease in cell density, or a decrease in absolute 
number of cells in this tissue layer. To analyse this, sections from sham- and epicardium- 
deficient hearts were stained with haemotoxylin and eosin (Fig. 5.5a-h) and cell density in 
the compact layer of the myocardium in these sections was calculated (Fig. 5.5i). One 
section from three embryos was analysed per group. The entire area of the compact 
myocardium was analysed per section and all sections were taken from the level of the 
ventricle approximately one third above the apex. At E6, we estimated control hearts to 
have an average cell density in the compact myocardium of approximately 9000 cells/mm^ 
(Fig. 5.5a,b,i). Operated hearts at this age had an average density of this cell layer of
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Figure 5.4 Epicardium deficiency is correlated with a thinner compact 
myocardium. The thickness of the compact myocardium in control and 
epicardium-deficient hearts was quantified at E6 and E8 by calculating 
the “width index”, i.e. the ratio of the total area of the compact myo­
cardial layer (in sections through the ventricle) to the total length of the 
outer perimeter of the compact myocardium. Sections were taken from 
the level approximately one third up from the apex of the ventricle. 3 
embryos were analyzed per group, 1 section per embryo. The width 
index was significantly lower in epicardium-deficient hearts at both E6 
and E8, compared to controls. *, P < 0.1 ; **, P < 0.005 (comparison of 
width index in control vs. epicardium-deficient hearts).
approximately 9900 cells/mm^, representing an increase of approximately 11% (Fig. 
5.5c,d,i). At E8, a similar relationship was observed, with the cell density of the compact 
myocardium of control hearts being approximately 16,100 cells/mm^ (Fig. 5.5e,f,i), while 
that of operated hearts was approximately 19,000 cells/mm^, representing a difference of 
18% (Fig. 5.5g-i). This increase in cell density in the absence of an epicardium may 
therefore partly account for the thinning of the compact myocardium of the ventricular 
wall in these hearts.
Increased Apoptosis in the Compact Layer of Epicardium-Deficient Hearts 
Increases in cell density of the compact myocardium in the range of 10-20% in epicardium 
deficient hearts are insufficient alone to account for ventricular wall thinning of up to 43% 
upon inhibition of epicardial development. We therefore sought to elucidate other 
mechanisms that may be involved in the development of this phenotype. In normal heart 
development, cell death plays a minimal role in modelling of the myocardium (Pexieder, 
1975; Zhao and Rivkees, 2000). It is therefore possible that the epicardium may normally 
provide some form of survival signal to neighbouring myocytes, which might otherwise 
undergo apoptosis. To examine this, sections of control and operated hearts were 
processed for TUNEL analysis to examine levels of apoptosis in the ventricular compact 
myocardium (Fig. 5.6a-j). At E6 in control hearts (n = 3), levels of TUNEL-positive cells 
were estimated to be approximately 1 in 10,000 of the total cell number (approximately 
0.08%), consistent with previous reports (Manasek, 1969b) (Fig. 6a,b,i). By comparison, 
epicardium-deficient hearts (n = 5) exhibited numbers of TUNEL-positive cells of the 
order of 1 in 400 (0.25%), a three-fold difference in the level of apoptosis (Fig. 5.6c,d,i). 
At E8, levels of apoptosis in control and epicardium-deficient hearts were 1.2% (n = 3)
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Figure 5.5 Cell density is slightly increased in the compact myocardium of epicardium- 
deficient hearts. Sections of E6 (a-d) and E8 (e-h) control (a,e) and epicardium-deficient 
hearts (c,g) were stained with haematoxylin and eosin for detection of nuclei. b,d,f and h 
are high power views of a,c,e and g, respectively, (i) Cell density in the compact 
myocardium was quantified and revealed a slight increase in density of epicardium- 
deficient hearts at E8, compared to controls, n = 3-5 per group, 1-2 sections analysed per 
embryo, m, compact myocardium; e, epicardium; P <  0.15, P < 0.05. Scale bars in 
a and c, 200pm; scale bars in e and g, 500 pm, scale bars in b,d,f and h, 20 pm.
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and 2.7% (n = 5), respectively, representing a more than two-fold difference in levels of 
cell death (Fig. 5.6e-h,j).
These increases in the percentage of cells undergoing apoptosis in the absence of 
epicardium suggest that the epicardium may provide a signal for myocyte survival during 
normal heart development. However, even the highest levels of cell death observed in the 
absence of the epicardium represent less than 3% of the total number of myocytes present 
in the compact myocardium, and it is therefore highly unlikely that cell death is the major 
mechanism causing myocardial thinning in operated hearts.
Myocyte Proliferation is Down-Regulated in Epicardium-Deficient Hearts 
As well as changes in cell death and cell density, a third important factor that may 
influence thickness of the ventricular wall is cell proliferation. It has been shown that 
proliferation is active in the developing chick myocardium, particularly in the outer 
compact layer (Jeter and Cameron, 1971; Mikawa et al., 1995; Mima et al., 1995; Lin et 
al., 2000). The proportion of cycling cells in the compact myocardium of control and 
operated hearts was evaluated by analysis of BrdU incorporation at E6 and E8. At both 
stages, a large proportion of myocytes in the compact layer of the ventricles are actively 
proliferating (Jeter and Cameron, 1971; Lin et al., 2000). At E6, 42% of cells in the 
compact zone of control hearts were positive for BrdU incorporation (n = 3; Fig. 5.7a,b,e). 
In comparison, 37% of myocardial cells in the compact zone were BrdU-positive in 
epicardium-deficient hearts at the same age (n = 3; Fig. 5.7c-e). By E8, the rate of 
proliferation in this cell population had decreased significantly, such that less than 10% of 
myocytes in the compact layer were BrdU-positive in control hearts (n = 3) and 
approximately 8% in operated hearts (n = 4; Fig. 5.7e). Importantly, this data illustrates
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Figure 5.6 Apoptotic cell death is increased in the compact myocardium of epicardium- 
deficient hearts. Sections of E6 (a,b,d,e) and E8 (g,h,j,k) control (a,b,g,h) and epicardium- 
deficient hearts (d,e,j,k) were analysed for apoptotic cells using the TUNEL assay. b,e,h 
and k are high power views of the boxed areas in a,d,g and j, respectively, n = 3-5 
embryos analysed per group. Sections were taken from the level of the ventricle 
approximately one third up from the apex. 1-2 sections were analysed per embryo and 
TUNEL-positive cells were counted throughout the entire compact myocardium of each 
section. Levels of cell death in the compact myocardium were quantified per unit area 
(c,i). Mean = 6.81 cells/mm^ (E6, control; std. dev. = 7.11); 24.7 (E6, epicardium- 
deficient; std. dev. = 21.1); 199 (E8, control; std. dev. = 67.2); 511 (E8, epicardium- 
deficient; std. dev. = 623). (c,i) Bars represent number of TUNEL-positive cells per unit 
area in the compact myocardium of individual sections. The mean values in (c) and (i) per 
group were divided by the average cell density per group (refer to figure 5.5) to estimate 
the number of TUNEL-positive cells per total cell number in the compact myocardium 
(f,l). This analysis revealed an increase in levels of apoptosis in the compact myocardium 
of epicardium-deficient hearts at both E6 (c,l) and E8 (i,l), compared to controls. Arrows, 
TUNEL-positive cells; P < 0.005 (comparison of number of TUNEL-positive cells per 
unit area in control vs. epicardium-deficient hearts). Scale bars in a,b,e and f, 50 pm; 
scale bars in c,d,g and h, 20 pm.
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that myocytes of the ventricles may actively proliferate, even in the absence of the 
epicardium. Furthermore, the transmural gradient of cell proliferation is maintained in 
epicardium-deficient hearts i.e. cell proliferation is consistently higher in the outer 
compact myocardium, compared with the inner trabeculated myocardium.
From analysis of BrdU levels, it is not entirely clear whether the subtle changes in the 
proportion of mitotically active cells in the compact myocardium of control and 
epicardium-deficient hearts is sufficient to account for the abnormally thin myocardial 
wall. To directly examine the cell cycling time of myocytes in the compact myocardium, 
individual myocytes of the ventricular region of the tubular heart at E3 were infected with 
CXL, a replication-incompetent retrovirus expressing the lacZ reporter gene (Fig. 5.8a). 
After 4 more days of development, hearts were removed and fixed at E7 and stained with 
X-gal for detection of (3-gal expression. In whole mount, clusters of (3-gal-positive cells 
could be seen on the surface of the heart (Fig. 5.8b). Sections of these hearts revealed 
clusters of labelled cells, often spanning the myocardium from the epicardial to the 
endocardial side (Fig. 5.8c). Previous studies strongly suggest that clonally related cells 
are found along such transmural pathways (Mikawa et al., 1992). Analysis of the size of 
these clones showed that the average myocyte clone size in control hearts was 49 cells, 
consistent with previous estimates (Mima et al., 1995), while the average clone size in 
epicardium-deficient hearts was 29 cells, demonstrating a decrease of 41%. Thus, a 
significant slowing in the rate of myocyte proliferation occurs in the absence of the 
epicardium, resulting in the generation of approximately 40% less cells during the course 
of 4 days from E3 to E7. It therefore appears that a decrease in cell proliferation is largely 
responsible for the formation of an abnormally thin myocardial wall in the absence of the 
epicardium.
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Figure 5.7 Myocyte proliferation is slightly depressed in the absence of the epicardium. 
Sections of E6 (a-d) and E8 control (a,b) and epicardium-deficient hearts (c,d) were 
assayed for BrdU incorporation, b and d are high power views of the boxed areas in a and 
c, respectively, n = 3 (E6 control, E8 control and E6 epicardium-deficient groups) or 4 
(E8 epicardium-deficient group) embryos analysed per group. Sections were taken from 
the level of the ventricle approximately one third above the apex. 1 section was analysed 
per embryo and BrdU-positive cells were counted throughout the entire compact 
myocardium of each section. Levels of BrdU incorporation in the compact myocardium 
were quantified per unit area (e). Mean = 3752 cells/mm^ (E6, control; std. dev. = 2789); 
3662 cells/mm^ (E6, epicardium-deficient; std. dev. = 1039); 1568 cells/mm^ (E8, control; 
std. dev. = 446); 1454 cells/mm^ (E8, epicardium-deficient; std. dev. = 653). (e) Bars 
represent number of BrdU-positive cells per unit area in the compact myocardium of 
individual sections. The mean values per group in (e) were divided by the average cell 
density per group (refer to figure 5.5) to estimate the number of BrdU-positive cells per 
total cell number in the compact myocardium, expressed as a percentage (f). This revealed 
a slight, though not statistically significant depression in the number of mitotic cells in the 
compact myocardium of epicardium-deficient hearts at both E6 and E8 (e), compared to 
controls. Scale bars in a and b, 50 pm; scale bars in c and d, 20 pm.
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Figure 5.8 Myocyte clone size is decreased in the compact layer of epicardium deficient- 
hearts. (a) The ventricular region of the tubular heart of E3 embryos was infected with 
CXL retroviral solution to tag individual myocytes. Subsequently, PEO outgrowth was 
inhibited or sham operations were performed. Control (b) and operated (c) hearts stained 
for (3-gal expression at E7, demonstrating infection of clusters of cardiomyocytes (arrow­
heads). (d) Sections of these hearts reveal clones of |3-gal-positive cells traversing the 
compact myocardial wall from the epciardial to the endocardial side, (e) The number of 
P-gal-positive cells per myocyte clone was assessed in both control and epicardium- 
deficient hearts. Average clone size in sham-operated hearts was 49 (3-gal-positive cells 
(n=7; standard deviation = 13.8), compared to 29 (3-gal-positive cells (n=7; standard 
deviation = 13.0) in epicardium-deficient hearts. P < 0.015 (comparison of clone size in 
control vs. epicardium-deficient hearts).
Conclusions
In this study, we have successfully inhibited PEO outgrowth and subsequent epicardial 
development. Inhibition of epicardial covering of the heart at E3 results in gross 
anatomical cardiac defects as early as E5, including elongation of the outflow tract and 
distortion of the ventricular chambers. Sections of epicardium-deficient hearts displayed 
thinner ventricular compact myocardium, compared to controls. At E6, the ventricular 
compact myocardium of epicardium-deficient hearts was almost 50% thinner than in 
control hearts. This is due to the combination of a number of cellular mechanisms, 
including an increase in cell density and apoptosis, as well as a decrease in levels of 
myocardial cell proliferation. Importantly, we have shown that myocardial cells can 
maintain significant levels of proliferation in the absence of the epicardium as well as 
differential levels of proliferation between the compact myocardium and the trabeculated 
region. Together, this data indicates that the epicardium, though not essential for the 
initial formation of the compact myocardium, the epicardium plays an important role in 
maintenance and growth of this tissue layer, via a number of different mechanisms.
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Discussion
Chapter 5 describes a study of the influence exerted by the epicardium on morphogenesis 
of the myocardium. We employed a method of physical inhibition of PEO outgrowth in 
the chick embryo, which prevented epicardial ensheathing of the developing heart tube. 
This method limits widespread, non-cardiac specific abnormalities, allowing us to focus 
solely on epicardial-myocardial interactions. The method has previously been developed 
and used to examine gross morphological defects in heart development (Manner, 1993; 
Gittenberger-de Groot et al., 2000). In our study, we have addressed the cell biological 
and molecular mechanisms that underlie the phenotypes observed in the epicardium- 
deficient heart.
The Role of the Epicardium in Myocardial Development
There is growing evidence for the importance of the epicardium in influencing myocardial 
development. This evidence is based on studies in which the absence of the epicardium is 
correlated with myocardial dysmorphogenesis. Importantly, these myocardial 
abnormalities occur at time-points prior to invasion of the myocardium by epicardially- 
derived cells for formation of the coronary vasculature. In the chick, direct physical 
inhibition of PEO outgrowth and subsequent epicardial development results in the 
generation of an abnormally thin ventricular myocardium (Manner, 1993). Similarly, 
genetic knockouts of the cell adhesion molecules VCAM-1 and a4-integrin in the mouse 
result in embryos lacking an epicardium, and again, possessing an abnormally thin 
myocardial wall (Kwee et al., 1995; Yang et al., 1995).
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Whether the role of the epicardium in this myocardial development is as a regulator of cell 
proliferation, apoptosis and/or patterning has been largely unclear. In the current study, 
we have shown that the epicardium exerts influences over myocardial development in a 
number of ways, particularly in the regulation of myocyte proliferation, though also 
through subtle effects on myocyte survival and density. Importantly, however, we have 
shown that in the absence of the epicardium, myocyte proliferation continues, albeit at 
slightly depressed levels. Furthermore, the transmural gradient of proliferation, in which 
the rate of proliferation is higher in the compact myocardium of the ventricle compared to 
the inner, trabeculated myocardium, appears to be maintained.
Myocyte Proliferation in the Absence of the Epicardium
Our findings show that the abnormally thin compact myocardium of the epicardium- 
deficient heart is generated largely as a result of a decrease in cell proliferation rates in 
myocytes of the compact layer. Interestingly, thinning of the ventricular myocardium in 
E8 hearts was less pronounced than in E6 hearts. This may reflect selection against severe 
cases of thinner myocardial walls such that only those with milder phenotypes would 
survive to this later stage. Indeed, hearts with abnormally thin myocardia at E6 are 
unlikely to withstand increasing haemodynamic load imposed upon them by the 
expanding circulation of the rapidly growing embryo. Jaber et al. (1996) have shown that 
in mice in which the p-adrenergic receptor kinase-1 (pARKl) gene is disrupted, a thin 
myocardial wall is also found and this correlates with a 70% decrease in ejection fraction, 
a likely contributory cause of heart failure by E15.5 in homozygous mice.
Two independent methods of analysis of myocyte proliferation levels were utilized in the 
current study. Both approaches have inherent advantages and drawbacks, but the
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combination of these approaches allows us to make conclusions about the influence of the 
epicardium on myocyte proliferation. The measurement of BrdU incorporation levels 
allows us to survey the number of positive cells across large areas of compact 
myocardium and we were able to analyse the proportion of BrdU-positive cells across 
whole histological sections. However, this technique merely labels cells that have entered 
one stage of the cell cycle, S-phase, and is therefore not a direct measurement of cell 
proliferation. We therefore cannot draw conclusions about the length of the cell cycle of 
the myocytes based on this kind of data. However, analysis of a large number of cells 
allows us to compare relative levels of proliferation in two different groups of myocytes, 
for example those in the trabeculated myocardium compared to those in the compact 
myocardium, or compact myocytes in control hearts compared to those in epicardium- 
deficient hearts.
The data derived from this analysis suggests that the transmural gradient of myocyte 
proliferation between the trabeculated and compact myocardium is maintained in 
epicardium-deficient hearts. A comparison of proliferation rates in the compact 
myocardium of control and epicardium-deficient hearts revealed a slight difference in 
these rates though this was not statistically significant, possibly due to the fact that the 
sample size of each group was rather low. To provide further support for this data we 
utilized an alternative approach, allowing us to directly estimate cell cycle time in each 
group of compact myocytes. Infection of single myocytes of the compact layer at E3 
allowed us to trace the progeny of these cells and examine the number of progeny 
generated from a single myocyte. This approach has been used previously to examine 
differences in cell cycle length between control myocytes and those in which FGF or NT3 
signalling has been modulated (Mikawa et al., 1992; Mima et al., 1995; Lin et al., 2000).
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Our data show that a singly infected myocyte in a control heart at E3 will generate, on 
average, 46 labelled cells by E7. This suggests an average cell division rate of 17 hours, 
according to the following calculations:
2“=46, where n=number of cell cycles 
Therefore, n=5.6
If 5.6 cell cycles elapse in 4 days, or 96 hours, then the average cell cycle time is 
96/5.6 = 17 hours
This value is consistent with previous estimates of the rate of cell division in ventricular 
myocytes during this developmental time window (Jeter and Cameron, 1971; Mikawa et 
al., 1992; Mima et al., 1995; Lin et al., 2000). In comparison, we showed that in 
epicardium-deficient hearts, clone size was approximately half that of those in control 
hearts (on average, 24 cells/clone in epicardium-deficient hearts). A 50% decrease in 
clone size over the course of 4 days (from E3 to E7) represents a lapse of one cell cycle in 
this time in the epicardium-deficient hearts.
This approach to analysing mitotic levels has disadvantages, since labelling of individual 
clones of cells means that only discrete areas of the compact myocardium are examined 
each time. However, the strength of this method is that the labelling of a single cell and 
the subsequent counting of its progeny is a direct method for demonstrating the number of 
mitotic cycles a cell must go through to achieve this final colony size. Further evaluation 
of approaches to myocyte proliferation analysis is discussed below.
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In the absence of the epicardium, we estimate that the cell cycle rate of compact myocytes 
is slowed, resulting in the net loss of one cell cycle over the course of 4 days of 
development from E3 to E7. BrdU analysis also suggests a decrease in cell proliferation 
in epicardium-deficient hearts. Jeter and Cameron (1971) demonstrated that the peak of 
myocyte proliferation in the myocardium occurs between E3 and E5 and then rapidly 
declines. This implies that signalling to induce myocyte proliferation is more influential 
at these earlier stages and may explain the very modest differences in levels of BrdU 
incorporation observed by E6 and E8. Nevertheless, relying on the analysis of myocyte 
clone size, it appears that the major mechanism by which a thinner myocardial wall is 
produced in epicardium-deficient hearts is due to this decreased rate of cell division, with 
less significant contributions from decreased cell density and increased cell death. Rather 
than playing a major role in establishing or controlling myocardial growth in the 
developing ventricle, the epicardium therefore appears to play a secondary, or more 
regulatory role, involving fine-tuning of myocardial development.
Potential Epicardially-Derived Signals involved in Myocardial Development 
The nature of the experiments outlined in this chapter do not allow us to elucidate the 
molecular signals which may be mediating the epicardial influence over compact 
myocardium development. To begin to address this, the effects of epicardial inhibition on 
expression of members of the FGF family were examined, concurrently with these 
experiments (David Pennisi, unpublished results). FGF signalling is a major mediator of 
ventricular myocyte proliferation, as shown by Mima et al. (1995). While overexpression 
of FGFR does not appear to affect the proliferation of ventricular myocytes, infection of 
these cells with replication-incompetent retroviruses expressing either a dominant- 
negative form of FGFRl or FGFRl in the anti-sense orientation resulted in myocyte
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clones that were up to 90% smaller than clones from control-infected myocytes. This 
illustrates the necessity of threshold levels of FGF signalling for maintenance of 
appropriate levels of myocyte proliferation (Mima et al., 1995). We therefore sought to 
examine whether FGF-mediated myocyte proliferation is mediated through epicardial 
signalling.
FGFRl is highly expressed in the developing chick (Parlow et al., 1991; Patstone et al., 
1993; Sugi et al., 1995) and rodent (Engelmann et al., 1991; Jin et al., 1994; Sheikh et al.,
1997) heart, while there is significantly less or no expression of FGFR2 and -3 
(Engelmann et al., 1993; Patstone et al., 1993). In the chick, FGFRl is expressed in both 
the endocardium and the myocardium (Parlow et al., 1991; Sugi et al., 1995), though 
expression has not been shown in the epicardium. Expression of FGF ligands FGFl, 
FGF2, FGF4 and FGF7 in the myocardium of avian and rodent species has also been 
illustrated (Joseph-Silverstein et al., 1989; Consigli and Joseph-Silverstein, 1991); 
(Engelmann et al., 1991; Spirito et al., 1991; Engelmann et al., 1993; Grothe et al., 1996; 
Zhu et al., 1996; Morabito et al., 2001), while FGFl, -2 and -7 are expressed in the 
epicardium (Morabito et al., 2001). The expression of these factors is thought to mediate 
epithelial-to-mesenchymal transformation of epicardial cells, generating cells that will 
invade the myocardium and generate the coronary vasculature (Morabito et al., 2001). 
However, the expression of FGFs in both the myocardium and epicardium may also 
reflect cross-talk in these apposing tissues to promote myocardial proliferation, in addition 
to the putative autocrine and/or paracrine signals within the myocardium thought to 
mediate myocyte proliferation.
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In the current study, in conjunction with examination of the rates of myocyte proliferation 
in epicardium-deficient hearts, immunostaining for detection of FGFl, FGF2 and FGFRl 
on sections of E5, E6 and E8 hearts was performed to determine whether FGF expression 
in the myocardium is maintained in the absence of the epicardium (David Pennisi, 
unpublished results). In control embryos, the localization of all three FGF factors to the 
myocardium was confirmed, and expression of the receptor and both ligands was also 
found in the epicardium. Furthermore, both FGFl and FGF2 displayed seemingly higher 
levels of expression in the compact layer than in the trabeculated myocardium, which is 
maintained at least into the second week of development. This is consistent with the 
observations of Consigli and Joseph-Silverstein (Consigli and Joseph-Silverstein, 1991), 
who demonstrated a transmural gradient of FGF2 expression in the chick heart, thought to 
reflect the transmural gradient of myocyte proliferation (Jeter and Cameron, 1971). In 
epicardium-deficient hearts, the patterns of expression of FGFRl and ligands FGFl and 
FGF2 was maintained in the myocardium, suggesting that transmural expression of FGF 
signalling components occurs largely independently of inductive signals from the 
epicardium. This data correlates with our findings on comparative levels of BrdU 
incorporation in control and epicardium-deficient hearts. Subtle differences in FGF 
receptor and ligand levels may be present that correlate with the modest change in cell 
proliferation levels observed in the absence of the epicardium. Immunohistochemistry 
does not allow a qualitative analysis of protein expression levels, therefore two 
approaches, RT-PCR analysis and Western immunoblotting are currently being performed 
to determine whether the subtle, though significant, decrease in cell proliferation rate 
observed in epicardium-deficient hearts (as measured by retroviral labelling) is reflected 
by changes in the levels of FGF ligand and/or receptor expression in the myocardium, at 
both the RNA and protein levels. If this is the case, it can therefore be imagined that FGF-
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mediated myocyte proliferation occurs largely via autocrine and/or paracrine interactions 
within the myocardium, but that there is a moderate influence of epicardial-derived FGF 
signalling on this proliferation. This would further strengthen our proposal that the 
epicardium is required for subtle modulation of myocyte proliferation.
Besides FGFs, a number of other factors are suggested to be important players in 
epicardial-myocardial signalling, based on their expression patterns and the defects that 
result in their absence. A major factor that has been proposed to have an epicardially- 
mediated role in either the survival or proliferation of myocardial cells is retinoic acid and 
its associated synthesizing enzymes and receptors. Deficiencies in vitamin A (from which 
retinoic acid is metabolized) in rats, as well as null mutations of the retinoic acid receptors 
RXRa and RAR in the mouse, result in hypoplastic ventricular walls and ventricular 
septal defects (Wilson and Warkany, 1948; Kastner et al., 1994; Kastner et al., 1997; 
Mendelsohn et al., 1994; Sucov et al., 1994; Gruber et al., 1996; Luo et al., 1996). The 
retinoic acid-synthesizing enzymes RALDHl and RALDH2 are both expressed in the 
epicardium of the developing heart (Moss et al., 1998; Xavier-Neto et al., 2000; 
Niederreither et al., 2001), suggesting that the production of retinoic acid in the 
epicardium either directly or indirectly promotes growth of the ventricular myocardium. 
In the absence of the epicardium, and/or the absence of a proliferative or survival cue from 
the epicardium, myocytes might resort to a default state and enter into an apoptotic 
pathway. Null mutations of RXRa generate hearts with thinner ventricular walls, thus it 
has been suggested that myocyte proliferation may be regulated by epicardially-derived 
RA signalling (Kastner et al., 1994; Sucov et al., 1994). This is somewhat consistent with 
our current findings. However, these genetically based studies involved interference in 
signalling mechanisms in the myocardium as well as the epicardium and so observations
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cannot exclusively be credited to the lack of an epicardium. This drawback highlights the 
advantage of our chosen method of physical inhibition of epicardial development for 
understanding the mechanisms underlying epicardial-myocardial interactions.
Recently, in vitro studies have suggested that an intermediate, RA-regulated trophic factor 
may be the source of this mitogenic signal (Sucov, 2002). Although this factor has yet to 
be identified, a number of candidates, including endothelin, IGF, erythropoetin and PDGF 
have been ruled out on the basis of their inability to promote myocyte proliferation in 
vitro.
A number of transcription factors have also been implicated in the process of epicardial- 
myocardial cross-talk to promote myocardial development. Mutations in the Wilms 
Tumor suppressor gene, WT-1, in mice results in urogenital and heart defects (Moss et al.,
1998)). In these embryos, the ventricular myocardium is thin, and oedema and pericardial 
bleeding are suggestive of heart failure, which results in embryonic lethality between E13 
and E15. WT-1 is thought to function in a variety of processes, including transcriptional 
repression of growth factor genes and other transcription factors (reviewed in Little et al.,
1999). As in the mouse models of the various factors described above, the cause of the 
thin myocardium seen in WT-1 null mice is thought to result from the disruption of 
epicardial development, since WT-1 is normally expressed in the PEO and the epicardium 
as well as in epicardial-derived cells invading the myocardium (Carmona et al., 2001).
Despite the fact that WT-1 is expressed in areas of epithelial-to-mesenchymal 
transformation (EMT) (Moore et al., 1999) and WT-1 expression is found in regions of 
Slug expression (a transcription factor commonly expressed by cells undergoing EMT
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(Nieto et al., 1994), WT-1 may not be essential to this process, since EMT in other regions 
of the WT-1 null mouse, such as in neural crest or endocardial cushion formation, are not 
affected. Carmona et al. (2001) have suggested that the invasion of the myocardium by 
WT-1-positive cells may be required for the delivery of RA and that in embryos deficient 
in WT-1, epicardial cells may continue to invade the myocardium, but would differentiate 
prematurely and therefore cease RA production. To date, no evidence exists for this 
hypothesis, which remains circumstantial. An alternative hypothesis is that as a known 
transcriptional suppressor, WT-1 may act on RA-producing cells of the epicardium to 
suppress RA production, thus generating the cardiac defects observed in both RA and 
WT-1 mutant mice. Though intriguing, this possibility also remains speculative, and 
further study is required to clarify the signalling mechanisms involved.
Mutations in a number of other transcription factors, including p-ARKl (Jaber et al., 
1996), N-myc (Charron et al., 1992) and TEF-1 (Moens et al., 1993) also generate the so- 
called “thin-myocardium” phenotype. In p-ARKl mutant mice, as in the WT-1 mutant 
mouse, epicardial development appears normal and therefore it is later signalling between 
the epicardium and myocardium that is likely defective (Jaber et al., 1996). A comparison 
of our study in which the epicardium is absent and these studies of transcription factors 
suggest that two independent mechanisms may be required for the epicardial-mediated 
development of the myocardium: the first which requires the physical presence of the 
epicardium for paracrine signalling to the underlying myocardium (as evidenced by our 
studies) and a second, acting either in parallel or consecutively, in which the presence of 
the epicardium is not sufficient to sustain normal myocardial development, but requires 
signals transferred via the invasion of the myocardium to stimulate myocyte proliferation 
and/or suppress myocardial differentiation. Clearly much more investigation is required
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to elucidate the sequence of events, as well as all the factors involved in this epicardial- 
myocardial interaction.
Apoptosis and Cell Density
As well as harbouring a role in induction of myocyte proliferation, our study demonstrates 
that the epicardium exerts a subtle influence over myocyte survival in the embryonic 
heart. It has previously been reported that there is no difference in cell death in 
epicardium-deficient hearts after PEO outgrowth inhibition in the chick embryo 
(Gittenberger-de Groot et al., 2000). However, no data was presented to illustrate this and 
it is not clear whether this observation is based on an impression of levels of apoptosis or 
actual quantification of these levels. In the current study, we have shown that apoptosis in 
the compact myocardium increased up to three-fold in epicardium-deficient hearts, 
compared to controls. However, since cell death in the normally developing ventricular 
myocardium occurs with a very low incidence of the order of just 1 in 10,000 cells 
(Manasek, 1969b; our observations), it does not seem that apoptosis is a factor as 
important in the development of the ventricular myocardium as it is in other regions of the 
developing heart, most notably in the myocardium and endocardial cushions of the 
outflow tract (Pexieder, 1975; Hurle et al., 1977; Hurle and Ojeda, 1979; Poelmann et al., 
1998; Watanabe et al., 1998). In other words, rather than significant remodelling of the 
ventricular myocardium to remove unneeded cells, as occurs in many other areas of 
embryonic sculpting (reviewed by Jacobson et al., 1997), development of this tissue 
occurs by an economical approach in which proliferation of myocytes produces 
approximately the correct number of cells in the correct positions. As a mechanism for 
generating a thinner myocardium, increased cell death in epicardium-deficient hearts is 
not likely to be the major mechanism, since the levels of cell death detected at E6 in our
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study represent less than 1 apoptotic cell in 400 in the compact myocardium. However, it 
is interesting that the absence of the epicardium nevertheless promotes a three-fold 
increase in the levels of apoptosis in the neighbouring myocardium. An alternative 
possibility is that this induced apoptosis is a secondary result of the loss of the epicardium. 
In other words, it may be that the haemodynamic changes resulting from the loss of a 
robust ventricular myocardial wall may induce stresses and pathological conditions in 
myocytes, causing some cells to die.
Other Gross Morphological Heart Defects in the Absence of the Epicardium: Elongation 
of the Outflow Tract
A further observation that was apparent in E5 operated samples was the elongation of the 
outflow tract. Currently, this finding is based on observation of gross anatomy and future 
experiments are aimed at determining whether there is indeed significant lengthening of 
this structure. Furthermore, we must definitively show the correlation of this abnormality 
with concomitant loss of the epicardium in this region. If this is in fact the case, this raises 
the intriguing possibility that the epicardium plays a role in the modelling of the outflow 
tract as well the ventricular chambers.
The elongation observed would suggest that it is the mechanism of outflow tract 
shortening that is defective or delayed in the absence of the epicardium. During septation, 
the outflow tract is estimated to shorten to one quarter of its original length ((de la Cruz et 
al., 1977; Thompson et al., 1987). Recently, the shortening of this vessel was found to 
involve apoptosis of outflow tract myocytes (Watanabe et al., 1998). The outflow tract is 
known to be ensheathed by the epicardium, up to the border of the cono-truncal boundary 
(Vrancken Peeters et al., 1995), therefore it appears that the epicardium may play some
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inductive role in outflow tract morphogenesis. In fact, a recent paper proposes that 
absence of the epicardium surrounding the outflow tract region of the heart results in a 
considerable decrease in the number of apoptotic cells found in the outflow tract 
myocardium (Rothenberg et al., 2002). This suggests that the presence of the epicardium 
is necessary for normal levels of myocardial apoptosis in this tissue, which is in itself 
essential for the normal shortening of the outflow tract. Together, this data present a 
favourable model for the role of the epicardium in remodelling of the outflow tract, though 
the mechanism of induction of apoptosis by the epicardium remains to be identified.
If this model represents the true interaction between the epicardium and the myocardium, 
then it is curious that at later ages, the outflow tracts in epicardium-deficient hearts appear 
similar to controls (though again, this remains to be conclusively shown). Consistent with 
Gittenberger-de-Groot et al. (2000), we observed a few instances of formation of a 
compensatory epicardial covering to ensheath the conotruncal region of the outflow tract 
in the absence of the authentic epicardium in E6 hearts. Gittenberger-de-Groot et al. 
(2000) suggest this is an expansion of the mésothélium of the pharyngeal arch area, 
although there is no published evidence to support this. Though highly speculative, it is 
therefore possible that signalling from this compensatory “epicardium” may somehow 
restore normal developmental shortening of the outflow tract in epicardium-deficient 
hearts, since little, if any difference in the morphology of the outflow tracts of E6 and E8 
control and operated hearts were observed.
It is interesting that the lack of an epicardium may result in abnormalities in two 
myocardial populations: those of the compact zone of the ventricular myocardium as well 
as the outflow tract myocardium (as demonstrated by Rothenberg et al. (2002) and
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suggested by our data). Paradoxically, the effects on these two myocardia may be veiy 
different, i.e. myocardial proliferation may be inhibited in the ventricles, whereas 
myocardial survival is promoted in the outflow tract. This leads to the speculation that 
differential signalling may occur in different regions of the epicardium, dependent on the 
interaction with the target tissues. Alternatively, this may reflect differences in timing, 
since the peak of myocardial proliferation in ventricular myocytes is around E4 (Jeter and 
Cameron, 1971), while the highest levels of apoptosis in the outflow tract myocardium 
occur at approximately E6 (Watanabe et al., 1998).
The Experimental Approach
The technique of PEO outgrowth inhibition using a physical barrier has been employed in 
the chick embryo by a number of groups for investigating the effects of the lack of an 
epicardium on the developing heart (Manner, 1993; Gittenberger-de Groot et al., 2000; 
Rothenberg et al., 2002). This approach has proved to be successful in preventing 
epicardial development, as evidenced by cytokeratin immunostaining of the resulting 
hearts. Though this epicardial inhibition should be the only effect on embryonic 
development, we have taken care to avoid anomalies due to incidental changes that can 
take place using this technique. In particular, we were careful to discard embryos in 
which the extraembryonic membranes had clearly become wrapped around the heart 
during intervention. In these cases, more gross morphological defects were often seen, 
such as the formation of pouches or blebs on the surface of the ventricular chambers, 
suggesting constriction of the myocardial wall in particular regions. With these 
precautions in mind and with the use of sham-operated controls, we can therefore be 
confident that the procedure used results in abnormalities solely due to the absence of the 
epicardium enveloping the heart.
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This is in contrast to genetic models of epicardial deficiency in the mouse. For example, 
as mentioned above, knockouts of factors involved in RA synthesis and signalling disrupt 
signalling mechanisms in both the myocardium and epicardium (Kastner et al., 1994; 
Sucov et al., 1994). Since RA is synthesized in the epicardium, these models equally 
demonstrate the necessity of the epicardium in myocardial development, though 
elucidating the mechanisms underlying this role is confounded by the concurrent 
disruption of myocardial signals. Similarly, knockouts of the cell adhesion molecules 
VCAM-1 and a4-integrin demonstrate disturbances of epicardial development (Kwee et 
al., 1995; Yang et al., 1995) but since VCAM-1 is normally expressed in the myocardium, 
this phenotype may be the result of changes in myocardial development per se, as well as 
interference in epicardial-myocardial cross-talk. This highlights a particular strength of 
our approach in addressing the influence of the epicardium in myocardial development, 
which allows us to separate this process from the process of primary autocrine or 
paracrine signals within the myocardium that may regulate aspects of its own 
development. Using this approach we have been able to establish that the role of the 
epicardium in myocardial proliferation is subtle, though with dramatic effects on 
myocardial development. The major myocyte proliferative signals, however, are likely to 
be intrinsic to the myocardium.
One drawback of all techniques of physical PEO inhibition is that changes primarily due 
to this inhibition cannot be distinguished from secondary defects. We have observed 
changes in myocyte proliferation, survival and cell density as a result of PEO outgrowth 
inhibition, yet, as previously discussed, it is not clear whether changes in cell survival, for 
example, are a direct result of abolition of epicardial-myocardial signalling, or a
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subsequent event of myocardial thinning. One advantage of our technique is that this 
uncertainty is preferable to the effects of widespread gene disruption in mouse knockout 
models, in which primary defects may occur at much earlier stages, even before 
interactions of the epicardium and myocardium might take place. Conversely, conclusions 
from gene knockout studies in mice have often been drawn from observations at relatively 
late stages, when cells of the coronary vasculature, which are of epicardial origin, would 
normally have invaded the heart (Kastner et al., 1994; Sucov et al., 1994). This may 
provide further confusion, since defects will not only occur at these stages due to the lack 
of epicardial signalling to the myocardium, but also as a result of a lack of a sufficient 
blood supply for myocardial tissue. In our study, we have avoided this issue by dealing 
only with embryos only up to E8. Epicardially-derived cells do not invade the 
myocardium until around E5 (HH stage 26) and at these early stages, functional blood 
vessels are not formed. By far the major population of cells in the compact myocardium 
remains the cardiac myocytes at these early stages. Capillary connections to the aorta do 
not occur until E7 or E8 (Rychter and Ostadal, 1971; Rogers et al., 1989) and since a 
closed vascular system is not formed in the chick heart until E14 (Rychter and Ostadal, 
1971) analysis at E6 and E8 simply concerns changes in the interaction of the epicardium 
with the myocardium.
An alternative approach to directly study epicardial-myocardial interactions, is the in vitro 
culture of these two tissues in apposition. Both epicardial and myocardial cells can be 
cultured successful and levels of proliferation and apoptosis can be assayed, providing 
information about primary influences of the epicardium on the myocardium. This method 
has been used to show that an epicardial-derived factor stimulates myocyte proliferation 
(Sucov, 2002). Such a technique however also has drawbacks: the spatial organization of
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the epicardial and myocardial tissues is not maintained; it is difficult to maintain the 
correct ratio of epicardial to myocardial cells; environmental influences such as 
haemodynamic changes are not reflected, etc. Therefore, as with many in vitro 
approaches, a number of aspects of the in vivo situation are not maintained, and although 
changes in mechanisms such as cell survival and proliferation can be examined, these 
often do not truly reflect the in vivo situation.
Our experimental design utilized two approaches to examine changes in cell proliferation 
and survival and the validity of these approaches warrants some discussion. Firstly, 
analysis of BrdU incorporation levels, although useful for comparisons of relative 
proliferation rates, is an indirect method of studying the mitotic cycle within a cell 
population. In order to estimate cell cycle time therefore, a more rigorous experimental 
design than that used here is required.
There are a number of approaches that can be taken to gain information about the rate of 
cell proliferation based on BrdU incorporation levels, all of which involve the pulse 
labelling of samples with BrdU for a range of time-periods. One approach involves the 
labelling of embryos (or cells in in vitro experiments) for 1 hour, 2 hours, etc. and plotting 
the percentage of BrdU-positive cells present against the labelling time. This will produce 
a curve that rises fairly linearly, representing the accumulation of BrdU as cells 
progressively enter S-phase, and then a levelling off at the point when most cells have 
entered S-phase and a minor population, those cells that had just exited S-phase at the start 
of labelling, begin to enter S-phase for the first time during the labelling period and 
accumulate BrdU. Until this time-point, these cells have been progressing through the 
other phases of the cell cycle, therefore the labelling time at this point is an estimate of the
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total length of phases G2 + M + Gl. This estimate assumes a number of things: that cells 
progress through the cell cycle at a constant rate and that all mitotic cells have the same 
cycle length. The number of cells that are labelled at the plateau in the plot can also be 
regarded as an estimate of the number of mitotic cells within the population. From this 
information, it can be further assumed that the proportion of cells labelled shortly after 
introduction of the label (e.g. after a 1 hour pulse) is relative to the proportion of mitotic 
cells. Given this information and the total length of phases G2 + M + Gl, an 
approximation of the length of the S phase can be deduced (Alexiades and Cepko, 1996; 
Baserga, 1998).
Rather than utilize this sort of approach to deduce the length of the cell cycle of 
ventricular myocytes in this study, we chose to use the retroviral labelling technique to 
trace cells and their progeny. The use of retroviral labelling is a simple and direct method 
of analysis of proliferation, providing a direct correlation of the rate of mitosis of a cell to 
the number of progeny generated, with the assumptions that cell death is not a factor (as 
appears to be the case in the majority of ventricular myocytes at the time-points studied, as 
evidenced by our TUNEL analysis (see also Pexieder (1975) and Poelmann et al. (2000)) 
and that cells progress through the cell cycle at a fairly uniform rate (without, for example, 
undergoing quiescence). The combination of these two independent approaches has made 
us confident of our findings and the fact that a decrease in myocyte proliferation rates is 
the major cause of the thinner myocardium generated in epicardium-deficient hearts.
Summary and Future Directions
The future direction of this project will begin with quantification of the expression of FGF 
receptor and ligand expression in the myocardium of epicardium-deficient hearts. This
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will be achieved by RT-PCR and Western blot analysis and should clarify whether the 
modest changes in myocyte proliferation observed in the absence of the epicardium are 
correlated with subtle changes in FGF expression, undetectable by immunohistological 
techniques. Should this in fact turn out to be the case, it would therefore appear that 
despite a major role in autocrine or paracrine mediated myocyte proliferation, a certain 
level of FGF signalling from the epicardium is also needed to establish threshold levels of 
myocyte proliferation for normal development of the myocardium. To further investigate 
this, rescue experiments can be conducted to determine the time-window of myocardial 
susceptibility to FGF signalling in which FGF family members are sufficient to restore 
normal levels of myocyte proliferation. Although FGF-expressing cells have been used in 
a number of systems to mimic endogenous FGF ligand expression (Tanaka et al., 2000), 
this would prove technically difficult to achieve on the myocardial surface of the 
epicardium-deficient heart, since the peristaltic movements of the beating heart would 
quickly displace any physical object that was placed upon it. An alternative method 
would be the injection of retroviral constructs engineered to over-express FGF signalling 
molecules. Suitable replication-incompetent retroviruses expressing FGF4 (Hyer et al.,
1999) and FGFR-1 (Mima et al., 1995) are available and have been successfully used to 
infect chick embryo cardiomyocytes. Alternatively, a viral construct encoding a 
constitutively active FGFR can be constructed to upregulate FGFR-mediated signalling. 
A point mutation has been identified in several forms of human cancer which results in the 
constitutive activation of FGFR3 (Takebayashi-Suzuki et al., 2001). This mutation has 
been recapitulated in FGFRl and FGFR4 sequences and likewise results in constitutive 
activation of these receptors, with stimulation of downstream signals, such as 
phosphorylation of MARK and phospholipase C (Hagiwara et al., 1988). This mutation 
could be similarly exploited to constitutively activate FGF signalling in the myocardium
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of epicardium-deficient hearts. Of course, these experiments would not faithfully reflect 
the epicardial secretion of FGFs or expression of FGF receptors, since these factors would 
be directly applied to the myocardium in the absence of the epicardium. However this 
approach would examine whether the loss, or slowing, of myocardial proliferation can be 
restored to normal levels by enhanced FGFR signalling. Similarly, the work of Sucov et 
al. (Sucov et al., 1994, 2002) strongly suggests that RA has an important role in the 
epicardial-mediated stimulation of myocyte proliferation, therefore analogous experiments 
using retroviruses encoding RA or retinoic-acid synthesizing enzymes might prove useful 
to confirm this putative mechanism.
Our clonal analysis of myocyte proliferation in the current study suggests that slowing of 
the rate of myocyte proliferation results in the loss of one cell cycle between E3 and E7 in 
epicardium-deficient hearts. On the other hand, BrdU incorporation analysis suggests 
there is little, if any, difference in the rate of myocyte proliferation between control- and 
epicardium-deficient hearts at either E6 or E8. It is therefore likely that myocardial 
proliferation in the absence of the epicardium is more severely affected at earlier stages. 
This correlates with the peak of myocyte proliferation in the ventricles at around E4, 
followed by a rapid decrease in cell cycle rate over subsequent days (Jeter and Cameron, 
1971). Further analysis of these earlier time-points may therefore more accurately define 
the time-points at which epicardial signalling is most crucial to development of the 
myocardium. Additionally, the role of the epicardium in development of the outflow tract 
myocardium remains an intriguing area which should be pursued to a) establish whether 
the absence of the epicardium truly results in failure or delay in outflow tract shortening; 
and if so, b) whether the influence of the epicardium is mediated by similar signals as 
those involved in ventricular myocardial development. Since the effect of absence of the
195
epicardium in both cases is very different, it may be that very different signals are 
involved in signalling to the outflow tract. Rothenberg et al. (2002) have proposed that 
signals from epicardially-derived cells that have invaded the myocardium may have a role 
in this signalling, since QHl-positive endothelial cells were intermingled with apoptotic 
cells in the outflow tract myocardium. This correlates with the hypothesis of Carmona et 
al. (2001) that epicardially-derived signals may be delivered to the ventricular 
myocardium via WT-1-positive cells. Similar to the above-described experiments to test 
factors able to restore myocardial proliferation to normal levels in the ventricular 
myocardium of epicardium-deficient hearts, over-expression of epicardially-derived 
factors could be also performed in the outflow tract myocardium. The results of this may 
prove difficult to interpret however due to the fact that cardiac NC-derived cells are also 
present in the outflow tract. This problem could be circumvented by injections into the 
secondary heart field, which generates myocardium of the distal outflow tract (Waldo et 
al., 2001). This analysis would prove useful not only for a deeper understanding of the 
role of the epicardium in outflow tract morphogenesis that has been hinted at by the 
current study and the work of Rothenberg et al. (2002), but would also add to our 
knowledge of outflow tract morphogenesis itself, an area in which our knowledge of 
signalling factors important to this process is and, until now, has mostly been studied on a 
morphological level.
In conclusion, the work outlined in this chapter illustrates the necessity of the epicardium 
for normal myocardial morphogenesis, particular in the ventricular region of the 
developing chick heart, consistent with the previous results of other groups (Manner, 
1993; Gittenberger-de Groot et al., 2000). Although mouse models of disrupted 
myocardial development had suggested a failure of myocyte proliferation, our analysis of
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the mechanisms involved in epicardial-myocardial cross-talk provide the first definitive 
and quantitative evidence that the role of the epicardium in the development of this 
myocardium is primarily a mitogenic one, with less prominent, and possibly secondary 
effects on myocyte survival and cell density. Importantly, not only are certain levels of 
myocyte proliferation maintained in the absence of the epicardium, but transmural 
gradients of proliferation are also maintained and these are further reflected in the 
gradients of FGF ligand and receptor expression that are found both in the presence and 
the absence of the epicardium. This suggests that the major mitogenic signals for myocyte 
proliferation are intrinsic to the myocardium, but that the epicardium plays a subtler, 
though essential role in myocardial proliferation. The major signal for epicardial-mediated 
myocyte proliferation in the ventricles is an area of intense investigation. Although FGF 
may play some role in this activity, attention is currently focused on another factor, RA. 
With the information gained from the current study and the approaches used, future 
experiments to determine whether RA, an alternative factor, or a combination of factors is 
the major signal should be aimed at identifying a factor that is capable of similarly subtle, 
but substantial, effects on myocyte proliferation. Our study has therefore provided a 
framework that dictates the cell biological mechanisms that this unknown factor induces, 
and this knowledge will aid in its identification.
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Chapter 6: Summary
Our studies represent the first example of the use of retroviral gene delivery to modulate 
the development of the cardiac neural crest population. Using this technology, we have 
been able to evaluate the potential cell biological mechanisms of ET signalling on cardiac 
neural crest development, without whole-scale disruption of this network of factors. Our 
findings support those of ET knockout studies in the mouse (Clouthier et al., 1998; 
Yanagisawa et al., 1998a) that suggest that ET does not act at the earliest stages of cardiac 
NC development, but rather plays a role in developmental decisions made within the 
pharyngeal arches or at later stages. We have determined the pattern of expression of ET^ 
receptor and the converting enzyme, ECE-1 in the developing pharyngeal arches and great 
vessels of the chick embryo. The localization of these components to restricted regions 
within the arches presents a favourable scenario for generating an active site of ET 
signalling, thereby segregating sub-populations of neural crest cells for exposure to ET 
signals. In support of this, the retroviral-mediated upregulation of ET-precursor 
expression appears to promote the development of a subset of cardiac neural crest 
derivatives, namely the adventitial cells of the great arteries. Furthermore, the mechanism 
of expansion of this population appears to be at least partly due to increased cell survival 
within these cells. It is intriguing to hypothesize that the outer population exposed to ET 
signalling in the arches represents the precursors of the outer population of the great 
arterie, i.e. adventitial cells. To date however, there is no evidence for this. To examine 
this possibility we have therefore constructed a replication-incompetent retrovirus 
expressing AP, to be used in conjunction with a similar virus expressing an alternative 
histochemical marker, to perform lineage analysis of cardiac neural crest cells. This will
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prove vital for dissecting the clonal boundaries between cardiac NC cells, in turn 
providing a spatiotemporal map for understanding the timing and segregation of 
interactions of cardiac neural crest cells with ET signals, as well as other factors, that may 
direct their development.
The second part of this thesis describes work aimed at characterizing the nature of the 
epicardial signalling that is necessary to maintain ventricular myocardial development. 
Though many studies have highlighted the importance of the epicardium for this process 
(Yang et al., 1995; Gittenberger-de Groot et al., 2000), the specific mechanisms that 
epicardial signalling acts to promote or maintain in the myocardium have yet to be 
defined. The approach of physical inhibition of epicardial development has allowed us 
examine the specific cell biological changes that occur in the absence of the epicardium. 
Interestingly, despite the detrimental loss of ventricular tissue that arises in the absence of 
the epicardium, transmural gradients of myocyte proliferation and expression of FGF 
ligands, mitogenic factors for ventricular myocytes (Mima et al., 1995), are maintained in 
its absence. The increases in levels of cell death observed in these hearts are not 
significant enough to account for this loss. Therefore, rather than playing a major role in 
patterning and formation of the mature myocardium, the epicardium is likely to play a 
more subtle role in the maintenance of myocardial development. This is reflected in the 
fact that despite very moderate changes in levels of BrdU incorporation between control 
and epicardium-deficient hearts, analysis of myocyte clone size demonstrates the loss of 
one cell cycle over a period of four days of development, from E3 to E7. Thus, despite 
playing a secondary role in myocyte proliferation, mitogenic signals from the epicardium 
are clearly essential for maintaining the integrity of the developing myocardium.
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Appendix I: Abbreviations
AV atrioventricular
BCIP 5-bromo-4-chloro-3-indolyl phosphate
P-gal p-galactosidase
BMP bone morphogenetic protein
Bp base pairs
BSA bovine serum albumin
cDNA complementary DNA
DMA deoxyribonucleic acid
DIG digoxigenin
E embryonic day
ECE endothelin converting enzyme
EDTA ethylenediaminetetra-acetic acid
ET endothelin
FGF fibroblast growth factor
FGFR fibroblast growth factor receptor
HH Hamburger and Hamilton (chick embryonic stages)
Kb kilobase pairs
M molar
MRNA messenger RNA
NBT 4-nitro blue tétrazolium chloride
neo neomycin resistance gene
NT-3 neurotrophin-3
PBS phosphate-buffered saline
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PEO proepicardial organ
RNA ribonucleic acid
RTK receptor tyrosine kinase
TGF transforming growth factor
Tris tris [hydroxtmethyl] aminomethane
Trk-C tyrosine receptor kinase-C
TUNEL terminal transferase-mediated dUTP nick end labelling
X-gal 5-bromo-4-chloro-3-indolyl-p-galactopyranoside
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Appendix II: Hamburger and Hamilton Staging of Chick Embryonic
Development
HH Stage Hours/Days of Incubation Stages in Heart Development
1 < 7 hours
2 6-7
3 12-13
4 18-19 cardiac precursors in primitive streak
5 19-22 diversification of atrial and ventricular lineages
6 23-25
7 23-26 endocardial and myocardial precursors segregate
8 26-29 emigration of cardiac neural crest cells
9 29-33 fusion of cardiac primordial (heart tube)
10 33-38 heart looping
11 40-45
12 45-49
13 48-52
14 50-53
15 50-55
16 51-56
17 52-64
18 65-69 AV cushion formation
19 68-72
20 70-72
21 3.5 days
22 3.5
23 3.5-4
24 4
25 4.5
26 4.5-5
27 5
28 5.5
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29 6
30 6.5 truncal septation complete
31 7 interventricular septation complete
32 7.5
33 7.5-8
34 8
35 8-9 conus septation complete
36 10
37 11
38 12
39 13
40 14 formation of closed coronary vascular network
41 15
42 16
43 17 conduction system completion
44 18
45 19-20
46 Newly hatched
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